Carlos E. Bueso-Ramos, M.D., Ph.D.

Peer-Reviewed Articles

1. Ly, C, Veletic, I, Pacheco, CD, Dasdemir, E, Jelloul, FZ, Ferri-Borgogno, S, Basi, A, Gomez, JA, Root, J, Reville, PK, Jindal, S, Basu, S, Sharma, P, Quesada, AE, Bueso-Ramos, CE, Manshouri, T, Cuglievan, B, Garcia, MB, Burks, JK, Abbas, HA. Multimodal spatial proteomic profiling in acute myeloid leukemia. npj Precision Oncology 9(1), 2025. e-Pub 2025. PMID: 40394148.
2. Bazinet, A, Loghavi, S, Wei, Y, Bataller Torralba, A, Sasaki, K, Arani, N, Darbaniyan, F, Chien, KS, Hammond, DE, Bouligny, IM, Kanagal Shamanna, R, Thongon, N, Tang, G, Urrutia, S, Kadia, TM, DiNardo, C, Daver, N, Short, NJ, Issa, GC, Pemmaraju, N, Jabbour, EJ, Wang, S, Wang, W, Borthakur, G, Bueso-Ramos, CE, Ravandi-Kashani, F, Medeiros, LJ, Kantarjian, HM, Garcia-Manero, G, Montalban Bravo, G. Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy. Leukemia 39(9):2256-2265, 2025. e-Pub 2025. PMID: 40691503.
3. Kanagal-Shamanna R, Weinberg OK, Bueso-Ramos CE. Genomics of T-lymphoblastic leukemia/lymphoma: 2023 SH/EAHP workshop proceedings. Am J Clin Pathol 164(1):76-84, 2025. e-Pub 2025. PMID: 40646674.
4. Weinberg OK, Bueso-Ramos CE, Kanagal-Shamanna R. T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop. Am J Clin Pathol 164(1):26-35, 2025. e-Pub 2025. PMID: 40646675.
5. Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Chapman MS, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Ogata S, Hanache S, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Kanagal-Shamanna R, Bueso-Ramos C, Nakada D, Al-Atrash G, Molldrem J, Futreal P, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation. Nat Genet 57(7):1695-1707, 2025. e-Pub 2025. PMID: 40596442.
6. Saul, EE, Urrutia, S, Yang, H, Montalban Bravo, G, Tang, G, Toruner, GA, Patel, KP, Luthra, R, Bueso-Ramos, CE, Wang, S, Chien, KS, Sasaki, K, Atluri, H, Goulart, H, Thakral, B, Garcia-Manero, G, Kanagal Shamanna, R. A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome Mapping. JNCCN Journal of the National Comprehensive Cancer Network 23(6), 2025. e-Pub 2025. PMID: 40345240.
7. Nahmod, KA, Miranda, R, Vega Vazquez, F, Thakral, B, Pemmaraju, N, Montalban Bravo, G, Loghavi, S, Jelloul, FZ, Wang, W, Wang, S, Muzzafar, T, Patel, KP, Bueso-Ramos, CE, Medeiros, LJ, Kanagal Shamanna, R. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation. Leukemia and Lymphoma 66(4):764-772, 2025. e-Pub 2025. PMID: 39704386.
8. Thongon, N, Ma, F, Baran, N, Lockyer, P, Liu, J, Jackson, C, Rose, A, Furudate, K, Wildeman, B, Marchesini, M, Marchica, V, Storti, P, Todaro, G, Ganan Gomez, I, Ademà Llobet, V, Rodriguez-Sevilla, JJ, Qing, Y, Ha, MJ, Fonseca, R, Stein, C, Class, CA, Tan, L, Attanasio, S, Garcia-Manero, G, Giuliani, N, Berrios Nolasco, DA, Santoni, A, Cerchione, C, Bueso-Ramos, CE, Konopleva, M, Lorenzi, PL, Takahashi, K, Manasanch, EE, Sammarelli, G, Kanagal Shamanna, R, Viale, A, Chesi, M, Colla, S. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38331987.
9. Urrutia, S, Kantarjian, H, Ravandi-Kashani, F, Bueso-Ramos, CE, Kanagal-Shamanna, R, Jabbour, EJ, Montalban-Bravo, G, Short, NJ, Daver, N, Borthakur, G, DiNardo, CD, Kadia, TM, Masarova, L, Bose, P, Pemmaraju, N, Garcia-Manero, G, Sasaki, K. Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis. Journal of Hematology and Oncology 17(1), 2024. e-Pub 2024. PMID: 39548557.
10. Kim, DH, Jia, F, Patel, KP, Bose, P, Wang, S, Bueso-Ramos, CE, Ok, CY. Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow. Clinical Lymphoma, Myeloma and Leukemia 24(11):e878-e882, 2024. e-Pub 2024. PMID: 39107203.
11. Crane, GM, Geyer, JT, Thakral, B, Wang, S, Wool, GD, Li, KD, Davis, AR, Boiocchi, L, Bosler, D, Bueso-Ramos, CE, Arber, DA, George, T, Bagg, A, Hasserjian, RP, Orazi, A, Hsi, ED, Rogers, HJ. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable. American journal of clinical pathology 162(3):233-242, 2024. e-Pub 2024. PMID: 38597584.
12. Marques-Piubelli, ML, Lyapichev, KA, Fnu, A, Adrada, BE, Stewart, J, Hunt, KK, Clemens, MW, Iyer, S, Wu, Y, El Hussein, S, Xu, J, Ok, CY, Li, S, Pierson, DM, Ferrufino-Schmidt, MC, Nahmod, KA, Yoga, A, Hunsicker, L, Evans, MG, Resetkova, E, Qiu, L, Khanlari, M, Garces, S, Bueso-Ramos, CE, Medeiros, LJ, Miranda, R. The Spectrum of Non-neoplastic Changes Associated with Breast Implants. American Journal of Surgical Pathology 48(6):E43-E64, 2024. e-Pub 2024. PMID: 38451836.
13. Wei, Q, Bueso-Ramos, CE. Thymoma with aberrant expression of CD20. Blood 143(15):1551, 2024. e-Pub 2024. PMID: 38602694.
14. Hu, S, Jabbour, EJ, Hu, CY, Tang, G, Wang, W, Medeiros, LJ, Bueso-Ramos, CE. Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge. American journal of hematology 99(4):721-726, 2024. e-Pub 2024. PMID: 38240333.
15. Qiu, L, Lin, P, Khanlari, M, Xu, J, Cohen, E, Garces, S, Miranda, RN, Wang, W, Fang, H, Bueso-Ramos, CE, Medeiros, LJ, Li, S. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Modern Pathology 36(12), 2023. e-Pub 2023. PMID: 37820764.
16. Montalban Bravo, G, Kanagal Shamanna, R, Li, Z, Hammond, DE, Chien, KS, Rodriguez-Sevilla, JJ, Sasaki, K, Jabbour, EJ, DiNardo, C, Takahashi, K, Short, NJ, Issa, GC, Pemmaraju, N, Kadia, TM, Ravandi-Kashani, F, Daver, N, Borthakur, G, Loghavi, S, Pierce, S, Bueso-Ramos, CE, Kantarjian, HM, Garcia-Manero, G. Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British Journal of Haematology 203(4):581-592, 2023. e-Pub 2023. PMID: 37608562.
17. Urrutia S, Chien KS, Li Z, Bataller A, Almanza E, Sasaki K, Montalban-Bravo G, Short NJ, Jabbour E, Kadia TM, Ravandi F, Borthakur G, Alvarado Y, Daver N, Kanagal-Shamanna R, Bueso-Ramos C, Pierce SA, Kantarjian H, Garcia-Manero G. Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. Am J Hematol 98(10):E281-E284, 2023. e-Pub 2023. PMID: 37515433.
18. Foucar K, Bagg A, Bueso-Ramos CE, George T, Hasserjian RP, Hsi ED, Orazi A, Tam W, Wang SA, Weinberg OK, Arber DA, Pathology Group BM. Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach. Am J Clin Pathol 160(4):365-393, 2023. e-Pub 2023. PMID: 37391178.
19. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You MJ, Hu S, Xu J, Li S, Yin CC, El Hussein S, Le N, Futreal PA, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros LJ, Wang W. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia 37(9):1919-1921, 2023. e-Pub 2023. PMID: 37443196.
20. Jelloul FZ, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, You MJ, Patel KP, Medeiros LJ, Quesada AE. DDX41 mutations in patients with non-myeloid hematologic neoplasms. Am J Hematol 98(8):E193-E196, 2023. e-Pub 2023. PMID: 37154083.
21. Urrutia S, Li Z, Almanza E, Bataller A, Kanagal-Shamanna R, Senapati J, Sasaki K, Chien K, Montalban-Bravo G, DiNardo C, Borthakur G, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G. Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia 37(6):1397-1400, 2023. e-Pub 2023. PMID: 37185307.
22. Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, Basu S, Kadia T, Daver N, Borthakur G, Konopleva M, Pemmaraju N, Parry E, Wu CJ, Khoury J, Bueso-Ramos C, Garg N, Wang X, Lopez W, Ayala A, O'Brien S, Kantarjian H, Keating M, Allison J, Sharma P, Wierda W. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL. Blood Adv 7(10):1958-1966, 2023. e-Pub 2023. PMID: 36287248.
23. Ramia de Cap M, Wu LP, Hirt C, Pihan GA, Patel SS, Tam W, Bueso-Ramos CE, Kanagal-Shamanna R, Raess PW, Siddon A, Narayanan D, Morgan EA, Pinkus GS, Mason EF, Hsi ED, Rogers HJ, Toth L, Foucar K, Hurwitz SN, Bagg A, Rets A, George TI, Orazi A, Arber DA, Hasserjian RP, Weinberg OK, Pathology Group BM. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leuk Lymphoma 64(5):972-980, 2023. e-Pub 2023. PMID: 36960680.
24. Suknuntha K, Geyer JT, Patel KP, Weinberg OK, Rogers HJ, Lake JI, Lauridsen L, Patel JL, Kluk MJ, Arber DA, Hsi ED, Bagg A, Bueso-Ramos C, Orazi A. Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. Leuk Res 127:107033, 2023. e-Pub 2023. PMID: 36774789.
25. Al-Ghamdi YA, Lake J, Bagg A, Thakral B, Wang SA, Bueso-Ramos C, Masarova L, Verstovsek S, Rogers HJ, Hsi ED, Gralewski JH, Chabot-Richards D, George TI, Rets A, Hasserjian RP, Weinberg OK, Parilla M, Arber DA, Padilla O, Orazi A, Tam W. Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Mod Pathol 36(3):100016, 2023. e-Pub 2023. PMID: 36788093.
26. Cantu, MD, Kanagal-Shamanna, R, Wang, S, Kadia, TM, Bueso-Ramos, CE, Patel, S, Geyer, JT, Tam, W, Madanat, Y, Li, P, George, T, Nichols, MM, Rogers, HJ, Liu, YC, Aggarwal, N, Kurzer, JH, Maracaja, DL, Hsi, ED, Zaiem, F, Babu, D, Foucar, K, Laczko, D, Bagg, A, Orazi, A, Arber, DA, Hasserjian, RP, Weinberg, OK. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia. JCO Precision Oncology 7, 2023. e-Pub 2023. PMID: 36689697.
27. Aitken, MJ, Malaney, P, Zhang, X, Herbrich, SM, Chan, LE, Benitez, O, Rodriguez, AG, Ma, H, Jacamo, RO, Duan, R, Link, T, Kornblau, SM, Kanagal Shamanna, R, Bueso-Ramos, CE, Post, SM. Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing. NAR Cancer 4(4), 2022. e-Pub 2022. PMID: 36518526.
28. Aitken MJL, Malaney P, Zhang X, Herbrich SM, Chan L, Beneitez O, Rodrigues AG, MA H, Jacamo R, Duan R, Link TM, Kornblau SM, Kanagal-Shamanna R, Bueso-Ramos CE, Post SM. Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing. Nar Cancer 4(4), 2022. e-Pub 2022.
29. Qiu, L, Nwogbo, OV, Medeiros, LJ, Thakral, B, Li, S, Xu, J, You, MJ, Wang, W, Quesada, AE, Bueso-Ramos, CE, McDonnell, TJ, Thomas, SK, Lin, P. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein. Human Pathology 130:47-57, 2022. e-Pub 2022. PMID: 36244464.
30. Adema V, Ma F, Kanagal-Shamanna R, Thongon N, Montalban-Bravo G, Yang H, Peslak SA, Wang F, Acha P, Sole F, Lockyer P, Cassari M, Maciejewski JP, Visconte V, Gañán-Gómez I, Song Y, Bueso-Ramos C, Pellegrini M, Tan TM, Bejar R, Carew JS, Halene S, Santini V, Al-Atrash G, Clise-Dwyer K, Garcia-Manero G, Blobel GA, Colla S. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts. Blood Cancer Discov 3(6):554-567, 2022. e-Pub 2022. PMID: 35926182.
31. Tashakori M, Khoury JD, Routbort MJ, Patel KP, Wang SA, Ok CY, El-Hussein S, Kanagal-Shamanna R, Luthra R, Hu S, Lin P, Pemmaraju N, Bose P, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Mod Pathol 35(11):1677-1683, 2022. e-Pub 2022. PMID: 35690645.
32. Fang H, Wang SA, You MJ, Hu S, Miranda RN, Tang Z, Lin P, Jorgensen JL, Xu J, Thakral B, Schlette EJ, El Hussein S, Bueso-Ramos C, Medeiros LJ, Wang W. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors. Cytometry B Clin Cytom 102(6):440-447, 2022. e-Pub 2022. PMID: 36156384.
33. Kim, K, Ong, F, Montalban Bravo, G, Kanagal Shamanna, R, Kadia, TM, Jabbour, EJ, Alvarado, Y, Sasaki, K, Dong, XQ, Pierce, S, Bueso-Ramos, CE, Kantarjian, HM, Chien, KS, Garcia-Manero, G. MDS-406 Prognostic Implication of the Molecular Profiles of Patients With Hypocellular Myelodysplastic Syndrome. Clinical Lymphoma, Myeloma and Leukemia 22:S310, 2022. e-Pub 2022. PMID: 36163955.
34. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, Bueso-Ramos CE, Cortes JE, Dal Cin P, DiNardo CD, Dombret H, Duncavage EJ, Ebert BL, Estey EH, Facchetti F, Foucar K, Gangat N, Gianelli U, Godley LA, Gökbuget N, Gotlib J, Hellström-Lindberg E, Hobbs GS, Hoffman R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh ML, Löwenberg B, Macintyre E, Malcovati L, Mullighan CG, Niemeyer C, Odenike OM, Ogawa S, Orfao A, Papaemmanuil E, Passamonti F, Porkka K, Pui CH, Radich JP, Reiter A, Rozman M, Rudelius M, Savona MR, Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, Döhner H, Tefferi A. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200-1228, 2022. e-Pub 2022. PMID: 35767897.
35. Yang H, Garcia-Manero G, Sasaki K, Montalban-Bravo G, Tang Z, Wei Y, Kadia T, Chien K, Rush D, Nguyen H, Kalia A, Nimmakayalu M, Bueso-Ramos C, Kantarjian H, Medeiros LJ, Luthra R, Kanagal-Shamanna R. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance. Leukemia 36(9):2306-2316, 2022. e-Pub 2022. PMID: 35915143.
36. Sakhdari A, Class C, Montalban-Bravo G, Sasaki K, Bueso-Ramos CE, Patel KP, Routbort MJ, Loghavi S, Ok CY, Quesada A, Khoury JD, Konoplev SN, Kantarjian HP, Garcia-Manero G, Medeiros LJ, Kanagal-Shamanna R. Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes. Mod Pathol 35(9):1212-1219, 2022. e-Pub 2022. PMID: 35504958.
37. Fang H, Toruner GA, Tang Z, Tang G, Weissferdt A, Tashakori M, El Hussein S, Thakral B, Quesada AE, Wang W, Patel KP, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE, Jelloul FZ. Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation: A report of two cases. Ann Diagn Pathol 59:151951, 2022. e-Pub 2022. PMID: 35489185.
38. Wang X, Tang G, Hu Z, Fang H, Wang W, Tang Z, Toruner GA, Zhou T, DiNardo CD, Garcia-Manero G, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Hu S. Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival. Br J Haematol 198(3):604-608, 2022. e-Pub 2022. PMID: 35645146.
39. Thakral B, Bueso-Ramos CE. Unexpected presentation of cold agglutinin syndrome with B-acute lymphoblastic leukemia. Blood 139(26):3778, 2022. e-Pub 2022. PMID: 35771556.
40. Ganan-Gomez I, Yang H, Ma F, Montalban-Bravo G, Thongon N, Marchica V, Richard-Carpentier G, Chien K, Manyam G, Wang F, Alfonso A, Chen S, Class C, Kanagal-Shamanna R, Ingram JP, Ogoti Y, Rose A, Loghavi S, Lockyer P, Cambo B, Muftuoglu M, Schneider S, Adema V, McLellan M, Garza J, Marchesini M, Giuliani N, Pellegrini M, Wang J, Walker J, Li Z, Takahashi K, Leverson JD, Bueso-Ramos C, Andreeff M, Clise-Dwyer K, Garcia-Manero G, Colla S. Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. Nat Med 28(5):1097, 2022. e-Pub 2022. PMID: 35484266.
41. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol 35(5):705, 2022. e-Pub 2021. PMID: 34903824.
42. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol 35(4):470-479, 2022. e-Pub 2021. PMID: 34775472.
43. Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, Ghosh S, Lu C, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE, Battula VL, Mi Y, Wang J, DiNardo CD, Andreeff M, Tyner JW, Schimmer A, Letai A, Padua RA, Bueso-Ramos CE, Tiziani S, Leverson J, Popovic R, Konopleva M. Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther 7(1):110, 2022. e-Pub 2022. PMID: 35365596.
44. Mankar R, Gajjela CC, Bueso-Ramos CE, Yin CC, Mayerich D, Reddy RK. Polarization Sensitive Photothermal Mid-Infrared Spectroscopic Imaging of Human Bone Marrow Tissue. Appl Spectrosc 76(4):508-518, 2022. e-Pub 2022. PMID: 35236126.
45. Ganan Gomez, I, Yang, H, Ma, F, Montalban Bravo, G, Thongon, N, Marchica, V, Richard-Carpentier, G, Chien, KS, Manyam, GC, Wang, F, Alfonso Pierola, A, Chen, S, Class, CA, Kanagal Shamanna, R, Ingram, JP, Ogoti, Y, Rose, A, Loghavi, S, Lockyer, P, Cambo, B, Muftuoglu, M, Schneider, S, Ademà Llobet, V, McLellan, MD, Garza, J, Marchesini, M, Giuliani, N, Pellegrini, M, Wang, J, Walker, J, Li, Z, Takahashi, K, Leverson, JD, Bueso-Ramos, CE, Andreeff, M, Dwyer, KC, Garcia-Manero, G, Colla, S. Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. Nature medicine 28(3):557-567, 2022. e-Pub 2022. PMID: 35241842.
46. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. Mod Pathol 35(3):419-426, 2022. e-Pub 2021. PMID: 34608246.
47. Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, Ghosh S, Lu C, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE, Battula VL, Mi Y, Wang J, DiNardo CD, Andreeff M, Tyner JW, Schimmer A, Letai A, Padua RA, Bueso-Ramos CE, Tiziani S, Leverson J, Popovic R, Konopleva M. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther 7(1):51, 2022. e-Pub 2022. PMID: 35185150.
48. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation. Ann Diagn Pathol 56:151860, 2022. e-Pub 2021. PMID: 34823075.
49. Venugopal, S, Takahashi, K, Daver, N, Maiti, A, Borthakur, G, Loghavi, S, Short, NJ, Ohanian, M, Masarova, L, Issa, GC, Wang, X, Bueso-Ramos, CE, Yilmaz, M, Kadia, TM, Andreeff, M, Ravandi-Kashani, F, Konopleva, M, Kantarjian, HM, DiNardo, C. Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood cancer journal 12(1), 2022. e-Pub 2022. PMID: 35078972.
50. El Hussein S, Hu S, Fang H, Garces S, Muzzafar T, Wang SA, Medeiros LJ, Bueso-Ramos C, Jelloul FZ. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity. Leuk Lymphoma 63(1):1-4, 2022. e-Pub 2021. PMID: 34510998.
51. Evans MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, Ortiz-Hidalgo C, Pina-Oviedo S, Morine A, Clemens MW, Hunt KK, Iyer S, Hu Q, Recavarren C, Demichelis R, Romero M, Sohani AR, Misialek M, Amin MB, Bueso-Ramos CE, Carballo-Zarate AA, Lee HJ, Ok CY, Xu J, Miranda RN. Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol 34(12):2148-2153, 2021. e-Pub 2021. PMID: 34155351.
52. Abbas HA, Reville PK, Geppner A, Rausch CR, Pemmaraju N, Ohanian M, Sasaki K, Borthakur G, Daver N, DiNardo C, Bueso-Ramos C, Pierce S, Jabbour E, Garcia-Manero G, Konopleva M, Ravandi F, Kantarjian H, Kadia TM. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia. Leuk Lymphoma 62(14):3402-3410, 2021. e-Pub 2021. PMID: 34380367.
53. Thongon N, Ma F, Santoni A, Marchesini M, Fiorini E, Rose A, Adema V, Ganan-Gomez I, Groarke EM, Gutierrez-Rodrigues F, Chen S, Lockyer P, Schneider S, Bueso-Ramos C, Montalban-Bravo G, Class CA, Soltysiak KA, Pellegrini M, Sahin E, Bertuch AA, DiNardo CD, Garcia-Manero G, Young NS, Dwyer K, Colla S. Hematopoiesis under telomere attrition at the single-cell resolution. Nat Commun 12(1):6850, 2021. e-Pub 2021. PMID: 34824242.
54. Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, DiNardo CD, Borthakur G, Pierce SA, Jabbour E, Wang SA, Bueso-Ramos C, Loghavi S, Tang G, Cheung CM, Alexander L, Kornblau S, Andreeff M, Garcia-Manero G, Ravandi F, Konopleva MY, Daver N. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer 127(20):3761-3771, 2021. e-Pub 2021. PMID: 34171128.
55. Kanagal-Shamanna R, Montalban-Bravo G, Sasaki K, Darbaniyan F, Jabbour E, Bueso-Ramos C, Wei Y, Chien K, Kadia T, Ravandi F, Borthakur G, Soltysiak KA, Routbort M, Patel K, Pierce S, Medeiros LJ, Kantarjian HM, Garcia-Manero G. Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 127(19):3552-3565, 2021. e-Pub 2021. PMID: 34161603.
56. Tang G, Tam W, Short NJ, Bose P, Wu D, Hurwitz SN, Bagg A, Rogers HJ, Hsi ED, Quesada AE, Wang W, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Nardi V, Hasserjian RP, Arber DA, Orazi A, Foucar K, Wang SA. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Mod Pathol 34(9):1673-1685, 2021. e-Pub 2021. PMID: 33990705.
57. Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Masarova L, Naqvi K, Jabbour E, DiNardo CD, Takahashi K, Konopleva M, Pemmaraju N, Kadia TM, Ravandi F, Daver N, Borthakur G, Estrov Z, Khoury JD, Loghavi S, Soltysiak KA, Pierce S, Bueso-Ramos C, Patel KP, Verstovsek S, Kantarjian HM, Bose P, Garcia-Manero G. Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. Cancer 127(17):3113-3124, 2021. e-Pub 2021. PMID: 33914911.
58. Pemmaraju N, Carter BZ, Bose P, Jain N, Kadia TM, Garcia-Manero G, Bueso-Ramos CE, DiNardo CD, Bledsoe S, Daver NG, Popat U, Konopleva MY, Zhou L, Pierce S, Estrov ZE, Borthakur GM, Ohanian M, Qiao W, Masarova L, Wang X, Mak PY, Cortes J, Jabbour E, Verstovsek S. Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis. Blood Adv 5(16):3163-3173, 2021. e-Pub 2021. PMID: 34424319.
59. Montalban-Bravo G, Kanagal-Shamanna R, Darbaniyan F, Siddiqui MT, Sasaki K, Wei Y, Yang H, Chien KS, Naqvi K, Jabbour E, Kadia TM, Daver N, DiNardo C, Ravandi F, Pemmaraju N, Bose P, Verstovsek S, Pierce S, Bueso-Ramos C, Patel K, Do KA, Kantarjian H, Garcia-Manero G. Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS). Am J Hematol 96(7):E246-E249, 2021. e-Pub 2021. PMID: 33811786.
60. Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J, Loghavi S, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E, Patel KP, Bueso-Ramos CE, DiNardo CD, Ravandi F, Jabbour E, Andreeff M, Cortes J, Bhalla K, Garcia-Manero G, Kantarjian H, Konopleva M, Nakada D, Navin N, Beerenwinkel N, Futreal PA, Takahashi K. Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun 12(1):2823, 2021. e-Pub 2021. PMID: 33972555.
61. Hu Z, Wang W, Thakral B, Chen Z, Estrov Z, Bueso-Ramos CE, Verstovsek S, Medeiros LJ, Wang SA. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution. Cytometry B Clin Cytom 100(3):352-360, 2021. e-Pub 2021. PMID: 32157815.
62. Morita K, Jabbour E, Ravandi F, Borthakur G, Khoury JD, Hu S, Garcia-Manero G, Wierda W, Issa G, Daver N, Pemmaraju N, Montalban-Bravo G, Soltysiak KA, Pierce S, Bueso-Ramos C, Cortes J, Sasaki K. Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome. Clin Lymphoma Myeloma Leuk 21(5):338-344, 2021. e-Pub 2021. PMID: 33597098.
63. Borthakur G, Ofran Y, Tallman MS, Foran J, Uy GL, DiPersio JF, Showel MM, Shimoni A, Nagler A, Rowe JM, Altman JK, Abraham M, Peled A, Shaw S, Bohana-Kashtan O, Sorani E, Pereg Y, Foley-Comer A, Oberkovitz G, Lustig TM, Glicko-Kabir I, Aharon A, Vainstein-Haras A, Kadosh SE, Samara E, Al-Rawi AN, Pemmaraju N, Bueso-Ramos C, Cortes JE, Andreeff M. BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study. Cancer 127(8):1246-1259, 2021. e-Pub 2021. PMID: 33270904.
64. Kanagal-Shamanna R, Montalban-Bravo G, Katsonis P, Sasaki K, Class CA, Jabbour E, Sallman D, Hunter AM, Benton C, Chien KS, Luthra R, Bueso-Ramos CE, Kadia T, Andreeff M, Komrokji RS, Al Ali NH, Short N, Daver N, Routbort MJ, Khoury JD, Patel K, Ganan-Gomez I, Wei Y, Borthakur G, Ravandi F, Do KA, Soltysiak KA, Lichtarge O, Medeiros LJ, Kantarjian H, Garcia-Manero G. Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis. Blood Cancer J 11(3):Article #52, 2021. e-Pub 2021. PMID: 33677472.
65. Montalban-Bravo G, Darbaniyan F, Kanagal-Shamanna R, Ganan-Gomez I, Class CA, Sasaki K, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien KS, Bueso-Ramos C, Do KA, Kantarjian H, Garcia-Manero G. Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia. Leuk Res 101:106511, 2021. e-Pub 2021. PMID: 33517186.
66. Lyapichev KA, Tang G, Li S, You MJ, Cheng TJ, Miranda RN, Iyer S, Yin CC, Konoplev S, Bueso-Ramos C, Vega F, Medeiros LJ, Xu J. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22-31, 2021. e-Pub 2021. PMID: 33221344.
67. Montalban-Bravo G, Kanagal-Shamanna R, Guerra V, Ramos-Perez J, Hammond D, Shilpa P, Naqvi K, Sasaki K, Jabbour E, DiNardo C, Takahashi K, Konopleva M, Pemmaraju N, Kadia T, Ravandi F, Daver N, Borthakur G, Estrov Z, Khoury JD, Loghavi S, Pierce S, Bueso-Ramos C, Patel K, Kantarjian H, Garcia-Manero G. Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia. Am J Hematol 96(2):E50-E53, 2021. e-Pub 2021. PMID: 33156969.
68. Ok CY, Trowell KT, Parker KG, Moser K, Weinberg OK, Rogers HJ, Reichard KK, George TI, Hsi ED, Bueso-Ramos CE, Tam W, Orazi A, Bagg A, Arber DA, Hasserjian RP, Wang SA. Chronic Myeloid Neoplasms Harboring Concomitant Mutations in Myeloproliferative Neoplasm Driver Genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol 34(1):20-31, 2021. e-Pub 2021. PMID: 32694616.
69. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma 61(12):1-3, 2020. e-Pub 2020. PMID: 32657180.
70. Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J, Loghavi S, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E, Patel KP, Bueso-Ramos CE, DiNardo CD, Ravandi F, Jabbour E, Andreeff M, Cortes J, Bhalla K, Garcia-Manero G, Kantarjian H, Konopleva M, Nakada D, Navin N, Beerenwinkel N, Futreal PA, Takahashi K. Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun 11(1):5996, 2020. e-Pub 2020. PMID: 33214561.
71. Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J, Loghavi S, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E, Patel KP, Bueso-Ramos CE, DiNardo CD, Ravandi F, Jabbour E, Andreeff M, Cortes J, Bhalla K, Garcia-Manero G, Kantarjian H, Konopleva M, Nakada D, Navin N, Beerenwinkel N, Futreal PA, Takahashi K. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun 11(1):5327, 2020. e-Pub 2020. PMID: 33087716.
72. Gupta SK, Jain N, Tang G, Futreal A, Wang SA, Khoury JD, Yang RK, Fang H, Patel KP, Luthra R, Routbort M, Barkoh BA, Chen W, Mao X, Zhang J, Medeiros LJ, Bueso-Ramos CE, Loghavi S. A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications. J Natl Compr Canc Netw 18(10):1300-1304, 2020. e-Pub 2020. PMID: 33022638.
73. Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, You MJ, Lin P, Li S, Xu J, Han H, Bueso-Ramos CE, Medeiros LJ, Qiu X, Yin CC. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. Eur J Haematol 105(4):449-459, 2020. e-Pub 2020. PMID: 32535947.
74. Aitken MJL, Benton CB, Wang F, Zhang J, Herbrich SM, Takahashi K, Bueso-Ramos CE, Short NJ. Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient. Am J Hematol 95(9):1117-1120, 2020. e-Pub 2020. PMID: 32356323.
75. Wang W, Beird H, Kroll CJ, Hu S, Bueso-Ramos CE, Fang H, Tang G, Tang Z, Wang F, Takahashi K, You MJ, Khoury JD, Medeiros LJ, Futreal PA. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid. Leukemia 34(9):2509-2512, 2020. e-Pub 2020. PMID: 32099038.
76. Quesada AE, Montalban-Bravo G, Luthra R, Patel KP, Sasaki K, Bueso-Ramos CE, Khoury JD, Routbort MJ, Bassett R, Hidalgo-Lopez JE, Zhao C, Lin P, Loghavi S, Ok CY, Kadia T, DiNardo CD, Kantarjian H, Garcia-Manero G, Kanagal-Shamanna R. Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1. Mod Pathol 33(9):1678-1689, 2020. e-Pub 2020. PMID: 32238878.
77. Foucar K, Hsi ED, Wang SA, Rogers HJ, Hasserjian RP, Bagg A, George TI, Bassett RL, Peterson LC, Morice WG, Arber DA, Orazi A, Bueso-Ramos CE, Pathology Group BM. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. Int J Lab Hematol 42(4):418-422, 2020. e-Pub 2020. PMID: 32297416.
78. Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, Sukhanova M, Bagg A, Bueso-Ramos CE, Orazi A, Arber DA, Hsi ED, Hasserjian RP. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol 95(7):799-808, 2020. e-Pub 2020. PMID: 32249963.
79. Montalban-Bravo G, Kanagal-Shamanna R, Class CA, Sasaki K, Ravandi F, Cortes JE, Daver N, Takahashi K, Short NJ, DiNardo CD, Jabbour E, Borthakur G, Naqvi K, Issa GC, Konopleva M, Khoury JD, Routbort M, Pierce S, Do KA, Bueso-Ramos C, Patel K, Kantarjian H, Garcia-Manero G, Kadia TM. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. Am J Hematol 95(6):612-622, 2020. e-Pub 2020. PMID: 32112433.
80. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma. Eur J Haematol 104(4):1-8, 2020. e-Pub 2020. PMID: 31944390.
81. Xie W, Tang G, Wang E, Kim Y, Cloe A, Shen Q, Zhou Y, Garcia-Manero G, Loghavi S, Hu AY, Wang S, Bueso-Ramos CE, Kantarjian HM, Medeiros LJ, Hu S. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?. Ann Hematol 99(3):487-500, 2020. e-Pub 2020. PMID: 32006151.
82. Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol 33(3):367-379, 2020. e-Pub 2020. PMID: 31383966.
83. Myers KC, Furutani E, Weller E, Siegele B, Galvin A, Arsenault V, Alter BP, Boulad F, Bueso-Ramos C, Burroughs L, Castillo P, Connelly J, Davies SM, DiNardo CD, Hanif I, Ho RH, Karras N, Manalang M, McReynolds LJ, Nakano TA, Nalepa G, Norkin M, Oberley MJ, Orgel E, Pastore YD, Rosenthal J, Walkovich K, Larson J, Malsch M, Elghetany MT, Fleming MD, Shimamura A. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. Lancet Haematol 7(3):e238-e246, 2020. e-Pub 2020. PMID: 31879230.
84. Montalban-Bravo G, Class CA, Ganan-Gomez I, Kanagal-Shamanna R, Sasaki K, Richard-Carpentier G, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien K, Bueso-Ramos C, Do KA, Kantarjian H, Garcia-Manero G. Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes. Leukemia 34(3):872-881, 2020. e-Pub 2020. PMID: 31719677.
85. Montalban-Bravo G, Kanagal-Shamanna R, Benton CB, Class CA, Chien KS, Sasaki K, Naqvi K, Alvarado Y, Kadia TM, Ravandi F, Daver N, Takahashi K, Jabbour E, Borthakur G, Pemmaraju N, Konopleva M, Soltysiak KA, Pierce SR, Bueso-Ramos CE, Patel KP, Kantarjian H, Garcia-Manero G. Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes. Blood Adv 4(3):482-495, 2020. e-Pub 2020. PMID: 32027746.
86. Mankar R, Bueso-Ramos CE, Yin CC, Hidalgo-Lopez JE, Berisha S, Kansiz M, Mayerich D. Automated osteosclerosis grading of clinical biopsies using infrared spectroscopic imaging. Anal Chem 92(1):749-757, 2020. e-Pub 2020. PMID: 31793292.
87. Gallardo M, Malaney P, Aitken MJL, Zhang X, Link TM, Shah V, Alybayev S, Wu MH, Pageon LR, Ma H, Jacamo R, Yu L, Xu-Monette ZY, Steinman H, Lee HJ, Sarbassov D, Rapado I, Barton MC, Martinez-Lopez J, Bueso-Ramos C, Young KH, Post SM. Uncovering the role of hnRNP K, an RNA-binding protein, in B-cell lymphomas. J Natl Cancer Inst 112(1):95-106, 2020. e-Pub 2020. PMID: 31077320.
88. Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N. Patient with mixed-phenotype acute leukemia with CBFB rearrangement. Leuk Lymphoma 60(11):1-3, 2019. e-Pub 2019. PMID: 31012358.
89. Lyapichev KA, Kurt H, Sukswai N, Konoplev S, Bueso-Ramos CE, Khoury JD, Huh YO. Chronic lymphocytic leukemia with plasmacytic differentiation. Ann Hematol 98(10):2437-2438, 2019. e-Pub 2019. PMID: 31451834.
90. Sakhdari A, Tang Z, Ok CY, Bueso-Ramos CE, Medeiros LJ, Huh YO. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Cancer Genet 238:18-22, 2019. e-Pub 2019. PMID: 31425921.
91. Swaminathan M, Borthakur G, Kadia TM, Ferrajoli A, Alvarado Y, Pemmaraju N, Bodden K, Yearby B, Konopleva M, Khoury J, Bueso-Ramos C, Garcia-Manero G, DiNardo CD. A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leuk Lymphoma 60(9):1-7, 2019. e-Pub 2019. PMID: 30773968.
92. Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge. Am J Hematol 94(9):1049-1051, 2019. e-Pub 2019. PMID: 30916805.
93. Shuai W, Wagner CE, Sukswai N, Medeiros LJ, Bueso-Ramos C, Oo TH. Gaucher disease type 1 first recognized in an elderly patient with thrombocytopenia and lung adenocarcinoma. Clin Case Rep 7(9):1804-1805, 2019. e-Pub 2019. PMID: 31534758.
94. Hoff FW, Hu CW, Qutub AA, Qiu Y, Hornbaker MJ, Bueso-Ramos C, Abbas HA, Post SM, ESJM DB, Kornblau SM. Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse. Proteomics Clin Appl 13(4):e1800133, 2019. e-Pub 2019. PMID: 30650251.
95. Strati P, Garcia-Manero G, Zhao C, Kadia T, Borthakur G, Konopleva M, Daver N, DiNardo CD, Short NJ, Yilmaz M, Naqvi K, Alvarado Y, Pierce SA, Cortes J, Bueso-Ramos C, Kantarjian H, Ravandi F. Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. Am J Hematol 94(7):E188-E190, 2019. e-Pub 2019. PMID: 30977182.
96. Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94(7):757-766, 2019. e-Pub 2019. PMID: 30963592.
97. Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Mod Pathol 32(4):490-498, 2019. e-Pub 2019. PMID: 30401948.
98. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136. e-Pub 2019. PMID: 31004601.
99. Hidalgo-Lopez JE, Kanagal-Shamanna R, Reyes S, Zhao C, Medeiros LJ, Bueso-Ramos CE. Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase. Ann Diagn Pathol 40:45-48. e-Pub 2019. PMID: 30928887.
100. Hu, Z, Bueso-Ramos, CE, Medeiros, LJ, Zhao, C, Yin, CC, Li, S, Hu, S, Wang, W, Thakral, B, Xu, J, Verstovsek, S, Lin, P. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis. Human Pathology 85:290-298, 2019. e-Pub 2019. PMID: 30447300.
101. Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Patel K, Ganan-Gomez I, Jabbour E, Kadia T, Ravandi F, DiNardo C, Borthakur G, Takahashi K, Konopleva M, Komrokji RS, DeZern A, Kuzmanovic T, Maciejewski J, Pierce S, Colla S, Sekeres MA, Kantarjian H, Bueso-Ramos C, Garcia-Manero G. NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood Adv 3(6):922-933, 2019. e-Pub 2019. PMID: 30902805.
102. Sakhdari A, Tang G, Ginsberg LE, Hirsch-Ginsberg CF, Bueso-Ramos CE, Medeiros LJ, Miranda RN. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy. Case Rep Pathol 2019:4915086. e-Pub 2019. PMID: 30941227.
103. Daver N, Garcia-Manero G, Basu S, Boddu PC, Alfayez M, Cortes JE, Konopleva M, Ravandi-Kashani F, Jabbour E, Kadia T, Nogueras-Gonzalez GM, Ning J, Pemmaraju N, DiNardo CD, Andreeff M, Pierce SA, Gordon T, Kornblau SM, Flores W, Alhamal Z, Bueso-Ramos C, Jorgensen JL, Patel KP, Blando J, Allison JP, Sharma P, Kantarjian H. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study. Cancer Discov 9(3):370-383, 2019. e-Pub 2019. PMID: 30409776.
104. Kanagal-Shamanna R, Jain P, Patel KP, Routbort M, Bueso-Ramos C, Alhalouli T, Khoury JD, Luthra R, Ferrajoli A, Keating M, Jain N, Burger J, Estrov Z, Wierda W, Kantarjian HM, Medeiros LJ. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. Cancer 125(4):559-574, 2019. e-Pub 2019. PMID: 30508305.
105. Angelova EA, Li S, Wang W, Bueso-Ramos C, Tang G, Medeiros LJ, Lin P. IgM plasma cell myeloma in the era of novel therapy: a Clinicopathologic study of 17 cases. Hum Pathol 84:321-334, 2019. e-Pub 2019. PMID: 30266252.
106. Ohanian M, Rozovski U, Kanagal-Shamanna R, Abruzzo LV, Loghavi S, Kadia T, Futreal A, Bhalla K, Zuo Z, Huh YO, Post SM, Ruvolo P, Garcia-Manero G, Andreeff M, Kornblau S, Borthakur G, Hu P, Medeiros LJ, Takahashi K, Hornbaker MJ, Zhang J, Nogueras-González GM, Huang X, Verstovsek S, Estrov Z, Pierce S, Ravandi F, Kantarjian HM, Bueso-Ramos CE, Cortes JE. MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma 60(1):1-12, 2019. e-Pub 2019. PMID: 29741984.
107. Yilmaz M, Wang F, Loghavi S, Bueso-Ramos C, Gumbs C, Little L, Song X, Zhang J, Kadia T, Borthakur G, Jabbour E, Pemmaraju N, Short N, Garcia-Manero G, Estrov Z, Kantarjian H, Futreal A, Takahashi K, Ravandi F. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?. Blood Cancer J 9(2):7, 2019. e-Pub 2019. PMID: 30651532.
108. Manshouri T, Verstovsek S, Harris DM, Veletic I, Zhang X, Post SM, Bueso-Ramos CE, Estrov Z. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes. PLoS One 14(9):e0222912, 2019. e-Pub 2019. PMID: 31569199.
109. Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption. Hum Pathol 82:215-231, 2018. e-Pub 2018. PMID: 30086334.
110. Williams P, Basu S, Garcia-Manero G, Hourigan CS, Oetjen KA, Cortes JE, Ravandi F, Jabbour EJ, Al-Hamal Z, Konopleva M, Ning J, Xiao L, Hidalgo Lopez J, Kornblau SM, Andreeff M, Flores W, Bueso-Ramos C, Blando J, Galera P, Calvo KR, Al-Atrash G, Allison JP, Kantarjian HM, Sharma P, Daver NG. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer 125(9):1470-1481. e-Pub 2018. PMID: 30500073.
111. Bose P, Nazha A, Komrokji RS, Patel KP, Pierce SA, Al-Ali N, Sochacki A, Shaver A, Ma W, Su X, Daver NG, DiNardo CD, Garcia-Manero G, Loghavi S, Bueso-Ramos C, Kantarjian HM, Sekeres MA, Savona MR, Maciejewski JP, Verstovsek S. Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable. Blood 132(19):2100-2103, 2018. e-Pub 2018. PMID: 30242087.
112. Hidalgo-Lopez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value. Cancer 124(19):3849-3855, 2018. e-Pub 2018. PMID: 30321462.
113. Abaza Y, Hidalgo-Lopez JE, Verstovsek S, Jabbour E, Ravandi F, Borthakur G, Estrov Z, Alvarado Y, Burger J, Schneider H, Soltysiak KA, Wei Y, Kantarjian HM, Bueso-Ramos CE, Garcia-Manero G. Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation. Leuk Res 73:78-85, 2018. e-Pub 2018. PMID: 30245189.
114. Masarova L, Verstovsek S, Hidalgo-Lopez JE, Pemmaraju N, Bose P, Estrov Z, Jabbour EJ, Ravandi-Kashani F, Takahashi K, Cortes JE, Ning J, Ohanian M, Alvarado Y, Zhou L, Pierce S, Gergis R, Patel KP, Luthra R, Kadia TM, DiNardo CD, Borthakur G, Bhalla K, Garcia-Manero G, Bueso-Ramos CE, Kantarjian HM, Daver N. A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis. Blood 132(16):1664-1674, 2018. e-Pub 2018. PMID: 30185431.
115. Wei Y, Zheng H, Bao N, Jiang S, Bueso-Ramos CE, Khoury J, Class C, Lu Y, Lin K, Yang H, Ganan-Gomez I, Starczynowski DT, Do KA, Colla S, Garcia-Manero G. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. Blood Adv 2(19):2491-2504, 2018. e-Pub 2018. PMID: 30275007.
116. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Correction: Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(76):34449, 2018. e-Pub 2018. PMID: 30344953.
117. Sakhdari A, Bueso-Ramos C, Garcia-Manero G, Medeiros LJ, Kanagal-Shamanna R. Myelodysplastic syndromes with EZH2 Mutations frequently show multilineage dysplasia, chromosome 7 alterations and concomitant mutations in ASXL1, RUNX1 and TET2. Clinical Lymphoma Myeloma & Leukemia 18(Supplement 1):S260-S260, 2018. e-Pub 2018.
118. Jabbar KJ, Yin CC, Bueso-Ramos CE, Luthra R, Medeiros LJ, Zuo Z. Higher body mass index is associated with better survival in patients with myelodysplastic syndromes. Leukemia Research 71:63-66, 2018. e-Pub 2018. PMID: 30015105.
119. Takahashi K, Wang F, Morita K, Yan Y, Hu P, Zhao P, Zhar AA, Wu CJ, Gumbs C, Little L, Tippen S, Thornton R, Coyle M, Mendoza M, Thompson E, Zhang J, DiNardo CD, Jain N, Ravandi F, Cortes JE, Garcia-Manero G, Kornblau S, Andreeff M, Jabbour E, Bueso-Ramos C, Takaori-Kondo A, Konopleva M, Patel K, Kantarjian H, Futreal PA. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun 9(1):2670, 2018. e-Pub 2018. PMID: 29991687.
120. Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, Kadia TM, Jabbour E, Bueso-Ramos CE, O'Brien SM, Konopleva M, Jain NB, Daver NG, Shpall EJ, Champlin RE, Simkins A, Garcia-Manero G, Keating MJ, Huang X, Cortes JE, Pierce SA, Ravandi F, Freireich EJ. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer 124(12):2534-2540, 2018. e-Pub 2018. PMID: 29645075.
121. Morita K, Kantarjian HM, Wang F, Yan Y, Bueso-Ramos C, Sasaki K, Issa GC, Wang S, Jorgensen J, Song X, Zhang J, Tippen S, Thornton R, Coyle M, Little L, Gumbs C, Pemmaraju N, Daver N, DiNardo CD, Konopleva M, Andreeff M, Ravandi F, Cortes JE, Kadia T, Jabbour E, Garcia-Manero G, Patel KP, Futreal PA, Takahashi K. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. J Clin Oncol 36(18):1788-1797, 2018. e-Pub 2018. PMID: 29702001.
122. Kurt H, Bueso-Ramos CE, Khoury JD, Routbort MJ, Kanagal-Shamanna R, Patel UV, Jorgensen JL, Wang SA, Ravandi F, DiNardo C, Luthra R, Medeiros LJ, Patel KP. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms. Am J Surg Pathol 42(5):569-577, 2018. e-Pub 2018. PMID: 29635257.
123. Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol 31(5):690-704, 2018. e-Pub 2018. PMID: 29327708.
124. Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res 28(4):432-447, 2018. e-Pub 2018. PMID: 29567676.
125. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Sun W, Cortes J, Kantarjian HM, Verstovsek S. Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis. J Hematol Oncol 11(1):42, 2018. e-Pub 2018. PMID: 29544547.
126. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol 97(3):425-434, 2018. e-Pub 2018. PMID: 29285580.
127. Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Gañan-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget 9(11):9714-9727, 2018. e-Pub 2018. PMID: 29515765.
128. Assi R, Kantarjian HM, Garcia-Manero G, Cortes JE, Pemmaraju N, Wang X, Nogueras-Gonzalez G, Jabbour E, Bose P, Kadia T, Dinardo CD, Patel K, Bueso-Ramos C, Zhou L, Pierce S, Gergis R, Tuttle C, Borthakur G, Estrov Z, Luthra R, Hidalgo-Lopez J, Verstovsek S, Daver N. A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Am J Hematol 93(2):277-285, 2018. e-Pub 2018. PMID: 29134664.
129. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(13):10987-10994, 2018. e-Pub 2018. PMID: 29541391.
130. Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED. T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group. Am J Clin Pathol 149(2):164-171, 2018. e-Pub 2018. PMID: 29365010.
131. Montes-Moreno S, Routbort MJ, Lohman EJ, Barkoh BA, Kanagal-Shamanna R, Bueso-Ramos CE, Singh RR, Medeiros LJ, Luthra R, Patel KP. Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era. PLoS One 13(9):e0204218, 2018. e-Pub 2018. PMID: 30222780.
132. Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol 44(12):1075-1079, 2017. e-Pub 2017. PMID: 28885734.
133. Kanagal-Shamanna R, Loghavi S, DiNardo CD, Medeiros LJ, Garcia-Manero G, Jabbour E, Routbort MJ, Luthra R, Bueso-Ramos CE, Khoury JD. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation. Haematologica 102(10):1661-1670, 2017. e-Pub 2017. PMID: 28659335.
134. Agbay, RC, Medeiros, LJ, Khoury, J, Salem, A, Bueso-Ramos, CE, Loghavi, S. Characteristics and clinical implications of reactive germinal centers in the bone marrow. Human Pathology 68:7-21, 2017. e-Pub 2017. PMID: 28428103.
135. Maiti A, Short NJ, Verstovsek S, Powers CA, Fullmer CA, Reyes SR, Bueso-Ramos CE. Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis. Leuk Lymphoma 58(10):1-3, 2017. e-Pub 2017. PMID: 28264600.
136. Kvasnicka HM, Orazi A, Thiele J, Barosi G, Bueso-Ramos CE, Vannucchi AM, Hasserjian RP, Kiladjian JJ, Gianelli U, Silver R, Mughal TI, Barbui T. European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia. Am J Hematol 92(10):1062-1067, 2017. e-Pub 2017. PMID: 28685840.
137. Kelly AD, Kroeger H, Yamazaki J, Taby R, Neumann F, Yu S, Lee JT, Patel B, Li Y, He R, Liang S, Lu Y, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Jelinek J, Issa JP. A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome. Leukemia 31(10):2011-2019, 2017. e-Pub 2017. PMID: 28074068.
138. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica 102(9):1511-1518, 2017. e-Pub 2017. PMID: 28473622.
139. Jabbour E, Guastad Daver N, Short NJ, Huang X, Chen HC, Maiti A, Ravandi F, Cortes J, Abi Aad S, Garcia-Manero G, Estrov Z, Kadia T, O'Brien S, Dabaja B, Bueso-Ramos C, Strati P, Bivins C, Pierce S, Kantarjian H. Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia. Am J Hematol 92(9):924-928, 2017. e-Pub 2017. PMID: 28556489.
140. Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Mod Pathol 30(9):1213-1222, 2017. e-Pub 2017. PMID: 28548124.
141. Jabbour E, Short NJ, Montalban-Bravo G, Huang X, Bueso-Ramos C, Qiao W, Yang H, Zhao C, Kadia T, Borthakur G, Pemmaraju N, Sasaki K, Estrov Z, Cortes J, Ravandi F, Alvarado Y, Komrokji R, Sekeres MA, Steensma DP, DeZern A, Roboz G, Kantarjian H, Garcia-Manero G. Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN. Blood 130(13):1514-1522, 2017. e-Pub 2017. PMID: 28774880.
142. Tang G, Bueso-Ramos CE, Li S, Medeiros LJ, Wang SA. Acquired 11q23/MLL rearrangement of unknown clinical significance. Int J Clin Exp Pathol 10(8):9045-9051, 2017. e-Pub 2017.
143. Jain, P, Milgrom, SA, Patel, KP, Nastoupil, L, Fayad, LE, Wang, L, Pinnix, CC, Dabaja, BS, Smith, GL, Yu, J, Hu, S, Bueso-Ramos, CE, Kanagal Shamanna, R, Medeiros, LJ, Oki, Y, Fowler, N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. British Journal of Haematology 178(3):403-412, 2017. e-Pub 2017. PMID: 28382648.
144. Kanagal-Shamanna R, Hidalgo Lopez JE, Milton DR, Kim HR, Zhao C, Zuo Z, Janania Martinez M, Stingo F, Lee J, Luthra R, Jabbour EJ, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE. Validation of the 2016 revisions to the WHO classification in lower-risk myelodysplastic syndrome. Am J Hematol 92(8):E168-E171, 2017. e-Pub 2017. PMID: 28456995.
145. Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos CE, Arber DA, Verstovsek S, Orazi A. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica 102(8):1352-1360, 2017. e-Pub 2017. PMID: 28495918.
146. Khouri MR, Jabbour EJ, Gulbis AM, Turturro F, Ledesma C, Korbling M, Samuels BI, Ahmed S, Alousi AM, Ciurea SO, Marin D, Patel KK, Popat UR, Bueso-Ramos CE, Bassett RL, Khouri IF. Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation. Biol Blood Marrow Transplant 23(8):1405-1410, 2017. e-Pub 2017. PMID: 28495642.
147. Marchesini M, Ogoti Y, Fiorini E, Aktas Samur A, Nezi L, D'Anca M, Storti P, Samur MK, Ganan-Gomez I, Fulciniti MT, Mistry N, Jiang S, Bao N, Marchica V, Neri A, Bueso-Ramos C, Wu CJ, Zhang L, Liang H, Peng X, Giuliani N, Draetta G, Clise-Dwyer K, Kantarjian H, Munshi N, Orlowski R, Garcia-Manero G, DePinho RA, Colla S. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell 32(1):88-100.e6, 2017. e-Pub 2017. PMID: 28669490.
148. Battula VL, Le PM, Sun JC, Nguyen K, Yuan B, Zhou X, Sonnylal S, McQueen T, Ruvolo V, Michel KA, Ling X, Jacamo R, Shpall E, Wang Z, Rao A, Al-Atrash G, Konopleva M, Davis RE, Harrington MA, Cahill CW, Bueso-Ramos C, Andreeff M. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight 2(13). e-Pub 2017. PMID: 28679949.
149. Daher M, Hidalgo Lopez JE, Randhawa JK, Jabbar KJ, Wei Y, Pemmaraju N, Borthakur G, Kadia T, Konopleva M, Kantarjian HM, Hearn K, Estrov Z, Reyes S, Bueso-Ramos CE, Garcia-Manero G. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. Am J Hematol 92(7):674-682, 2017. e-Pub 2017. PMID: 28370157.
150. Hidalgo-López JE, Kanagal-Shamanna R, Quesada AE, Thakral B, Hu Z, Mitsuhashi T, Yabe M, Garcia-Manero G, Bueso-Ramos CE. Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints. Clin Lymphoma Myeloma Leuk 17S:S16-S25, 2017. e-Pub 2017. PMID: 28760297.
151. Alfonso A, Montalban-Bravo G, Takahashi K, Jabbour EJ, Kadia T, Ravandi F, Cortes J, Estrov Z, Borthakur G, Pemmaraju N, Konopleva M, Bueso-Ramos C, Pierce S, Kantarjian H, Garcia-Manero G. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. Am J Hematol 92(7):599-606, 2017. e-Pub 2017. PMID: 28370097.
152. Takahashi K, Wang F, Kantarjian H, Song X, Patel K, Neelapu S, Gumbs C, Little L, Tippen S, Thornton R, DiNardo CD, Ravandi F, Bueso-Ramos C, Zhang J, Wu X, Garcia-Manero G, Futreal PA. Copy number alterations detected as clonal hematopoiesis of indeterminate potential. Blood Adv 1(15):1031-1036, 2017. e-Pub 2017. PMID: 29296745.
153. Hidalgo-López JE, Kanagal-Shamanna R, Medeiros LJ, Estrov Z, Yin CC, Verstovsek S, Konoplev S, Jorgensen JL, Mohammad MM, Miranda RN, Zhao C, Lee J, Zuo Z, Bueso-Ramos CE. Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation. J Natl Compr Canc Netw 15(6):790-796, 2017. e-Pub 2017. PMID: 28596259.
154. Strati P, Bose P, Lyle L, Gaw K, Zhou L, Pierce SA, Huynh-Lu J, Hirsch-Ginsberg CF, Bueso-Mendoza DE, Bueso-Ramos CE, Verstovsek S. Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions. Ann Hematol 96(5):733-738, 2017. e-Pub 2017. PMID: 28247057.
155. Montalban-Bravo G, Benton CB, Wang SA, Ravandi F, Kadia T, Cortes J, Daver N, Takahashi K, DiNardo C, Jabbour E, Borthakur G, Konopleva M, Pierce S, Bueso-Ramos C, Patel K, Kornblau S, Kantarjian H, Young KH, Garcia-Manero G, Andreeff M. Greater than one TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood 129(18):2584-2587, 2017. e-Pub 2017. PMID: 28246192.
156. Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. Int J Hematol 105(4):536-539, 2017. e-Pub 2017. PMID: 27830539.
157. Jabbour E, Strati P, Cabrero M, O'Brien S, Ravandi F, Bueso-Ramos C, Wei Q, Hu J, Abi Aad S, Short NJ, Dinardo C, Daver N, Kadia T, Wierda W, Wei Y, Colla S, Borthakur G, Cortes J, Estrov Z, Kantarjian H, Garcia-Manero G. Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents. Am J Hematol 92(4):351-358, 2017. e-Pub 2017. PMID: 28076892.
158. Konoplev S, Lu X, Konopleva M, Jain N, Ouyang J, Goswami M, Roberts KG, Valentine M, Mullighan CG, Bueso-Ramos C, Zweidler-McKay PA, Jorgensen JL, Wang SA. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience. Am J Clin Pathol 147(4):357-363, 2017. e-Pub 2017. PMID: 28340183.
159. Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP. Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study. Am J Clin Pathol 147(4):411-419, 2017. e-Pub 2017. PMID: 28375434.
160. Jabbour E, Faderl S, Sasaki K, Kadia T, Daver N, Pemmaraju N, Patel K, Khoury JD, Bueso-Ramos C, Bohannan Z, Ravandi F, Borthakur G, Verstovsek S, Miller D, Maduike R, Hosing C, Kantarjian HM, Garcia-Manero G. Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents. Cancer 123(4):629-637, 2017. e-Pub 2017. PMID: 27741352.
161. Montalban-Bravo G, Huang X, Jabbour E, Borthakur G, DiNardo CD, Pemmaraju N, Cortes J, Verstovsek S, Kadia T, Daver N, Wierda W, Alvarado Y, Konopleva M, Ravandi F, Estrov Z, Jain N, Alfonso A, Brandt M, Sneed T, Chen HC, Yang H, Bueso-Ramos C, Pierce S, Estey E, Bohannan Z, Kantarjian HM, Garcia-Manero G. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials. Leukemia 31(2):318-324, 2017. e-Pub 2017. PMID: 27795561.
162. Wang XJ, L Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Mod Pathol 30(2):194-203, 2017. e-Pub 2017. PMID: 27739436.
163. Yabe M, Medeiros LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, Young KH, Miranda RN. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review. Ann Diagn Pathol 26:16-22, 2017. e-Pub 2017. PMID: 28038706.
164. Yabe M, Medeiros LJ, Daneshbod Y, Davalou M, Bueso-Ramos CE, Moran EL, Young KH, Miranda RN. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor–α inhibitor therapy and literature review. Ann Diagn Pathol 26:16-22, 2017. e-Pub 2017. PMID: 28038706.
165. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol 41(1):82-93, 2017. e-Pub 2017. PMID: 27755009.
166. Takahashi K, Wang F, Kantarjian H, Doss D, Khanna K, Thompson E, Zhao L, Patel K, Neelapu S, Gumbs C, Bueso-Ramos C, DiNardo CD, Colla S, Ravandi F, Zhang J, Huang X, Wu X, Samaniego F, Garcia-Manero G, Futreal PA. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol 18(1):100-111, 2017. e-Pub 2017. PMID: 27923552.
167. Tang, G, Bueso-Ramos, CE, Li, S, Medeiros, LJ, Wang, S. Acquired 11q23/MLL rearrangement of unknown clinical significance. International journal of clinical and experimental pathology 10(8):9048-9051, 2017. e-Pub 2017.
168. Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol 6:30, 2017. e-Pub 2017. PMID: 29152412.
169. Short NJ, Kantarjian HM, Sasaki K, Cortes JE, Ravandi F, Thomas DA, Garcia-Manero G, Khouri I, Kebriaei P, Champlin RE, Pierce S, Issa GC, Konopleva M, Kadia TM, Bueso-Ramos C, Khoury JD, Jain N, O'Brien SM, Jabbour E. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer 122(24):3812-3820, 2016. e-Pub 2016. PMID: 27508525.
170. Verstovsek, S, Manshouri, T, Pilling, D, Bueso-Ramos, CE, Newberry, KJ, Prijic, S, Knez, L, Bozinovic, K, Harris, D, Spaeth, E, Post, SM, Multani, AS, Rampal, R, Ahn, J, Levine, RL, Creighton, CJ, Kantarjian, HM, Estrov, Z. Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis. Journal of Experimental Medicine 213(9):1723-1740, 2016. e-Pub 2016. PMID: 27481130.
171. Zhou Y, Kanagal-Shamanna R, Zuo Z, Tang G, Medeiors LJ, Bueso-Ramos CE. Advances in B-lymphoblastic leukemia: Cytogenetic and genomic lesions. Annals of Diagnostic Pathology 16(S1092-9134):30019-30023, 2016. e-Pub 2016. PMID: 27130145.
172. Wang, S, Tam, W, Tsai, AG, Arber, DA, Hasserjian, RP, Geyer, JT, George, T, Czuchlewski, DR, Foucar, K, Rogers, HJ, Hsi, ED, Rea, BB, Bagg, A, Dal Cin, P, Zhao, C, Kelley, TW, Verstovsek, S, Bueso-Ramos, CE, Orazi, A. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Modern Pathology 29(8):854-864, 2016. e-Pub 2016. PMID: 27174585.
173. Hoehn D, Cortes JE, Medeiros LJ, Jabbour EJ, Hidalgo JE, Kanagal-Shamanna R, Bueso-Ramos CE. Multiparameter analysis of off-target effects of Dasatinib on bone homeostasis in patients with newly diagnosed chronic myelogenous leukemia. Clinical Lymphoma, Myeloma & Leukemia(16 Suppl):S86-92, 2016. e-Pub 2016. PMID: 27521332.
174. Hidalgo Lopez, JE, Yabe, M, Carballo-Zarate, AA, Wang, S, Jorgensen, JL, Ahmed, S, Lee, J, Li, S, Schlette, EJ, McDonnell, TJ, Miranda, R, Medeiros, LJ, Bueso-Ramos, CE, Yin, CC. Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma. JNCCN Journal of the National Comprehensive Cancer Network 14(8):939-944, 2016. e-Pub 2016. PMID: 27496109.
175. Huh, YO, Tang, G, Talwalkar, S, Khoury, J, Ohanian, M, Bueso-Ramos, CE, Abruzzo, L. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Cancer Genetics 209(7-8):313-320, 2016. e-Pub 2016. PMID: 27318442.
176. Wang W, Cortes JE, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127(22):2742-2750, 2016. e-Pub 2016. PMID: 27006386.
177. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7(25):38122-38132. e-Pub 2016. PMID: 27203548.
178. Cabrero M, Wei Y, Yang H, Ganan-Gomez I, Bohannan Z, Colla S, Marchesini M, Bravo GM, Takahashi K, Bueso-Ramos C, Garcia-Manero G. Down-regulation of EZH2 expression in myelodysplastic syndromes. Leuk Res 44:1-7, 2016. e-Pub 2016. PMID: 26970171.
179. Aye LL, Loghavi S, Young KH, Siddiqi I, Yin CC, Routbort MJ, Liang M, Eilerman K, Medeiros LJ, Brynes RK, Bueso-Ramos C. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characerization of 7 cases. Annals of Diagnostic Pathology 21:53-58, 2016. e-Pub 2016. PMID: 27040932.
180. Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol 50:109-17, 2016. e-Pub 2016. PMID: 26997444.
181. Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan A, Zou D, Luthra R, Weber DM, O'Malley DP, Jorgensen JL, Khoury JD, Bueso-Ramos CE, Orlowski RZ, Medeiros LJ, Young KH. Crystal-storing histiocytosis: a clinicopathological study of 13 cases. Histopathology 68(4):482-91, 2016. e-Pub 2016. PMID: 26118455.
182. Takahashi K, Patel K, Bueso-Ramos C, Zhang J Gumbs C, Jabbour E, Kadia T, Andreff M, Konopleva M, DiNardo C, Daver N, Cortes J, Estrov Z, Futreal A, Kantarjian H, Garcia-Manero G. Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents. Oncotarget 7(12):14172-14187, 2016. e-Pub 2016. PMID: 26871476.
183. Loghavi S, Bueso-Ramos CE, Kanagal-Shamanna R, Young Ok C, Salim AA, Routbort MJ, Mehrotra M, Verstovsek S, Medeiros LJ, Luthra R, Patel KP. Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features. Am J Clin Pathol 145(3):418-27, 2016. e-Pub 2016. PMID: 27124925.
184. DiNardo CD, Garcia-Manero G, Pierce S, Nazha A, Bueso-Ramos C, Jabbour E, Ravandi F, Cortes J, Kantarjian H. Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Am J Hematol 91(2):227-32, 2016. e-Pub 2016. PMID: 26799610.
185. Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, Lee J, Zhao C, Stingo F, Zuo Z, Routbort MJ, Singh RR, Fox P, Ravandi F, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Oncotarget 7(12):14251-14258, 2016. e-Pub 2016. PMID: 26883102.
186. Vitale C, Jabbour E, Lu X, Yabe M, Kanagal-Shamanna R, Daver N, Pemmaraju N, Ce B, Takahashi K. Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia. Am J Hematol 91(4):E274-276. e-Pub 2016. PMID: 26798971.
187. Kongtim P, Popat U, Jimenez A, Gaballa S, El Fakih R, Rondon G, Chen J, Bueso-Ramos C, Borthakur G, Pemmaraju N, Garcia-Manero G, Kantarjian H, Alousi A, Hosing C, Anderlini P, Khouri IF, Kebriaei P, Andersson BS, Oran B, Rezvani K, Marin D, Shpall EJ, Champlin RE, Ciurea SO. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia. Biol Blood Marrow Transplant 22(1):47-53, 2016. e-Pub 2016. PMID: 26343946.
188. Huang, L, Wang, S, Konoplev, SN, Bueso-Ramos, CE, Thakral, B, Miranda, R, Jabbour, EJ, Medeiros, LJ, Kanagal Shamanna, R. Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities. Medicine (United States) 95(41), 2016. e-Pub 2016. PMID: 27741105.
189. Tang Z, Tang G, Wang SA, Lu X, Young KH, Bueso-Ramos CE, Alvarado Y, Medeiros LJ, Khoury JD. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review. Mol Cytogenet 9:23, 2016. e-Pub 2016. PMID: 26925167.
190. Yabe, M, Medeiros, LJ, Tang, G, Wang, S, Ahmed, S, Nieto, Y, Hu, S, Bhagat, G, Oki, Y, Patel, KP, Routbort, MJ, Luthra, R, Fanale, MA, Bueso-Ramos, CE, Jorgensen, JL, Vega Vazquez, F, Chen, W, Hoehn, D, Konoplev, SN, Milton, D, Wistuba, II, Li, S, You, MJ, Young, KH, Miranda, R. Prognostic factors of hepatosplenic T-cell lymphoma clinicopathologic study of 28 cases. American Journal of Surgical Pathology 40(5):676-688, 2016. e-Pub 2016. PMID: 26872013.
191. Yang H, Maddipoti S, Quesada A, Bohannan Z, Cabrero Calvo M, Colla S, Wei Y, Estecio M, Wierda W, Bueso-Ramos C, Garcia-Manero G. Analysis of Class I and II Histone Deacetylase Gene Expression in Human Leukemia. Leuk Lymphoma 56(12):3426-33, 2015. e-Pub 2015. PMID: 25944469.
192. Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC. IGK with conserved IG?V/IG?J repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration. Oncotarget 6(36):39062-72, 2015. e-Pub 2015. PMID: 26429876.
193. Ohanian M, Bueso-Ramos C, Ok CY, Lin P, Patel K, Alattar ML, Khoury JD, Rozovski U, Estrov Z, Huh YO, Cortes J, Abruzzo LV. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation. Cancer Genet 208(11):571-4, 2015. e-Pub 2015. PMID: 26382622.
194. Gallardo M, Lee HJ, Zhang X, Bueso-Ramos C, Pageon LR, McArthur M, Multani A, Nazha A, Manshouri T, Parker-Thornburg J, Rapado I, Quintas-Cardama A, Kornblau SM, Martinez-Lopez J, Post SM. hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies. Cancer Cell 28(4):486-99, 2015. e-Pub 2015. PMID: 26412324.
195. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol 171(1):91-9, 2015. e-Pub 2015. PMID: 26123119.
196. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 Double Hit Lymphoma (DHL): A Tumor Associated with an Aggressive Clinical Course and Poor Prognosis. Histopathology. e-Pub 2015. PMID: 26426741.
197. Badar T, Shetty A, Bueso-Ramos C, Cortes J, Konopleva M, Borthakur G, Pierce S, Huang X, Chen HC, Kadia T, Daver N, Dinardo C, O'Brien S, Garcia-Manero G, Kantarjian H, Ravandi F. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome. Am J Hematol 90(9):769-73, 2015. e-Pub 2015. PMID: 26017166.
198. Shen, Q, Ouyang, J, Tang, G, Jabbour, EJ, Garcia-Manero, G, Routbort, MJ, Konoplev, SN, Bueso-Ramos, CE, Medeiros, LJ, Jorgensen, JL, Wang, S. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response. European Journal of Haematology 95(2):168-176, 2015. e-Pub 2015. PMID: 25354960.
199. Konopleva M, Thall PF, Yi CA, Borthakur G, Coveler A, Bueso-Ramos C, Benito J, Konoplev S, Gu Y, Ravandi F, Jabbour E, Faderl S, Thomas D, Cortes J, Kadia T, Kornblau S, Daver N, Pemmaraju N, Nguyen HQ, Feliu J, Lu H, Wei C, Wilson WR, Melink TJ, Gutheil JC, Andreeff M, Estey EH, Kantarjian H. Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia. Haematologica 100(7):927-34, 2015. e-Pub 2015. PMID: 25682597.
200. Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Cardó-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini R. Targeting interleukin-11 receptor in leukemia and lymphoma: A functional ligand-directed study and hematopathology analysis of patient-derived specimens. Clin Cancer Res 21(13):3041-51, 2015. e-Pub 2015. PMID: 25779950.
201. Tang G, Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, DiNardo C, Medeiros LJ. Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant. Am J Clin Pathol 144(1):78-86, 2015. e-Pub 2015. PMID: 26071464.
202. Bueso Ramos CE, Medeiros LJ, Vega-Vazquez F. Introduction to the 2013 Workshop of the Society for Hematopathology/European Association for Haematopathology. Am J Clin Pathol 144(1):4-5, 2015. e-Pub 2015. PMID: 26071457.
203. Yabe M, Tang G, Garcia-Manero G, Loghavi S, Lu X, Miranda RN, Medeiros LJ, Kantarjian HM, Bueso-Ramos CE, Khoury JD. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features. Clin Lymphoma Myeloma Leuk 15 Suppl:S85-90, 2015. e-Pub 2015. PMID: 26297286.
204. Colla S, Ong DS, Ogoti Y, Marchesini M, Mistry NA, Clise-Dwyer K, Ang SA, Storti P, Viale A, Giuliani N, Ruisaard K, Ganan Gomez I, Bristow CA, Estecio M, Weksberg DC, Ho YW, Hu B, Genovese G, Pettazzoni P, Multani AS, Jiang S, Hua S, Ryan MC, Carugo A, Nezi L, Wei Y, Yang H, D'Anca M, Zhang L, Gaddis S, Gong T, Horner JW, Heffernan TP, Jones P, Cooper LJ, Liang H, Kantarjian H, Wang YA, Chin L, Bueso-Ramos C, Garcia-Manero G, DePinho RA. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome. Cancer Cell 27(5):644-57, 2015. e-Pub 2015. PMID: 25965571.
205. Rozovski U, Grgurevic S, Bueso-Ramos C, Harris DM, Li P, Liu Z, Wu JY, Jain P, Wierda W, Burger J, O'Brien S, Jain N, Ferrajoli A, Keating MJ, Estrov Z. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells. Mol Cancer Res 13(5):944-53, 2015. e-Pub 2015. PMID: 25733697.
206. Estécio MR, Maddipoti S, Bueso-Ramos C, DiNardo CD, Yang H, Wei Y, Kondo K, Fang Z, Stevenson W, Chang KS, Pierce SA, Bohannan Z, Borthakur G, Kantarjian H, Garcia-Manero G. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. Br J Haematol 169(3):344-51, 2015. e-Pub 2015. PMID: 25612675.
207. Zuo Z, Maiti S, Hu S, Loghavi S, Calin GA, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Cooper LJ, Bueso-Ramos CE. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetially normal myelodysplastic syndromes. Mod Pathol 28(3):373-82, 2015. e-Pub 2015. PMID: 25216221.
208. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8(1):32, 2015. e-Pub 2015. PMID: 25888368.
209. DiNardo, C, Daver, N, Jabbour, EJ, Kadia, TM, Borthakur, G, Konopleva, M, Pemmaraju, N, Yang, H, Pierce, S, Wierda, WG, Bueso-Ramos, CE, Patel, KP, Cortes, JE, Ravandi-Kashani, F, Kantarjian, HM, Garcia-Manero, G. Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia. The Lancet Haematology 2(1):e12-e20, 2015. e-Pub 2015. PMID: 26687423.
210. Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis. Pediatr Hematol Oncol 32(8):1-13, 2015. e-Pub 2015. PMID: 26558423.
211. Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. J Natl Cancer Inst 108(2), 2015. e-Pub 2015. PMID: 26568194.
212. Yin CC, Jain N, Mehrotra M, Zhagn J, Protopopov A, Zuo Z, Pemmaraju N, DiNardo C, Hirsch-Ginsberg C, Wang SA, Medeiros LJ, Chin L, Patel KP, Ravandi F, Futreal A, Bueso-Ramos CE. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw 13(1):19-22, 2015. e-Pub 2015. PMID: 25583766.
213. DiNardo CD, Tang G, Pemmaraju N, Wang SA, Pike A, Garcia-Manero G, Cortes J, Bueso-Ramos C, Kantarjian HM. Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation. Clin Lymphoma Myeloma Leuk 15(1):47-51, 2015. e-Pub 2015. PMID: 25081372.
214. Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, Muzzafar T, Medeiros LJ, Wang SA, Bueso-Ramos CE. MLL gene amplification in acute myeloid leukemia and myelodysplasti syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol 46(1):S0046-8177(14)00374-8, 2015. e-Pub 2015. PMID: 25387813.
215. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated+15 in bone marrow; Disease-associated or a benign finding?. Leuk Res 39(1):S0145-2126, 2015. e-Pub 2015. PMID: 25435027.
216. Hasserjian, RP, Campigotto, F, Klepeis, V, Fu, B, Wang, S, Bueso-Ramos, CE, Cascio, MJ, Rogers, HJ, Hsi, ED, Soderquist, C, Bagg, A, Yan, J, Ochs, R, Orazi, A, Moore, F, Mahmoud, A, George, T, Foucar, K, Odem, J, Booth, C, Morice, W, DeAngelo, DJ, Steensma, DP, Stone, RM, Neuberg, D, Arber, DA. De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults. American journal of hematology 89(11):E193-E199, 2014. e-Pub 2014. PMID: 25042343.
217. Loghavi, S, Zuo, Z, Ravandi-Kashani, F, Kantarjian, HM, Bueso-Ramos, CE, Zhang, L, Singh, RR, Patel, KP, Medeiros, LJ, Stingo, F, Routbort, MJ, Cortes, JE, Luthra, R, Khoury, J. Clinical features of de Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations. Journal of Hematology and Oncology 7(1), 2014. e-Pub 2014. PMID: 25281355.
218. Li P, Harris D, Liu Z, Rozovski U, Ferrajoli A, Wang Y, Bueso-ramos C, Hazan-Halevy I, Grgurevic S, Wierda W, Burger J, O'Brien S, Daderl S, Keating M, Estrov Z. STAT3-Activated GM-CSFRalpha Translocates to the Nucleus and Protects CLL Cells from Apoptosis. Mol Cancer Res 12(9):1267-1282, 2014. e-Pub 2014. PMID: 24836891.
219. Wu, W, Grimm, K, Hummel, J, Weiss, LM, Patel, KP, Bueso-Ramos, CE, O’Malley, DP. Follicular lymphoma in situ with coincident low-grade B cell lymphoma. Journal of Hematopathology 7(3):95-101, 2014. e-Pub 2014.
220. Wang, S, Medeiros, LJ, Xu-Monette, Z, Zhang, S, O'Malley, DP, Orazi, A, Zuo, Z, Bueso-Ramos, CE, Yin, CC, Liu, Z, Miranda, R, Young, KH. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Annals of Diagnostic Pathology 18(4):203-209, 2014. e-Pub 2014. PMID: 24852241.
221. Wang S, Medeiros LJ, Xu-Monette ZY, Zhang S, O'Malley DP, Orazi A, Zuo Z, Bueso-Ramos CE, Yin CC, Liu Z, Miranda RN, Young KH. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diagn Pathol 18(4):203-209, 2014. e-Pub 2014.
222. Yang H, Bueso-Ramos C, DiNardo C, Estecio MR, Davanlou M, Geng QR, Fang Z, Nguyen M, Pierce S, Wei Y, Parmar S, Cortes J, Kantarjian H, Garcia-Manero G. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia 28(6):1280-8, 2014. e-Pub 2014. PMID: 24270737.
223. Ok CY, Yin CC, Yabe M, Bueso-ramos CE, Miranda RN, Medeiros LJ, Konoplev SN. Lymphoma with features intermediate between aggressive T-large granular lyphocyctic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?. Clin Lymphoma Myeloma Leuk 14(3):e95-e100, 2014. e-Pub 2014. PMID: 24524924.
224. Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica 99(5):821-9, 2014. e-Pub 2014. PMID: 24463215.
225. Daver N, Naqvi K, Jabbour E, Kadia T, DiNardo C, Cardenas-Turanzas M, Pierce S, Nguyen KT, Bueso-Ramos C, Kantarjian H, Garcia-Manero G. Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes. Am J Hematol 89(5):509-16, 2014. e-Pub 2014. PMID: 24458781.
226. Ok, CY, Li, L, Xu-Monette, Z, Visco, C, Tzankov, A, Manyam, GC, Montes-Moreno, S, Dybaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Chen, J, Richards, KL, Hsi, ED, Choi, WW, Van Krieken, JH, Huh, J, Ai, W, Ponzoni, M, Ferreri, AJ, Farnen, JP, Møller, MB, Bueso-Ramos, CE, Miranda, R, Winter, JN, Piris, MA, Medeiros, LJ, Young, KH. Prevalence and clinical implications of Epstein-Barr virus infection in de Novo diffuse large B-cell lymphoma in western countries. Clinical Cancer Research 20(9):2338-2349, 2014. e-Pub 2014. PMID: 24583797.
227. Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123(17):2645-51, 2014. e-Pub 2014. PMID: 24627528.
228. i G, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Adanez Mdel C, Garcia-Manero G. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-kB activation and enhances erythroid differentiation arrest. PLoS one 9(4):e93404, 2014. e-Pub 2014. PMID: 24690917.
229. DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC, Pierce S, Jabbour E, Cortes JE, Kantarjian HM, Garcia-Manero G, Verstovsek S. Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia 28(4):958-61, 2014. e-Pub 2014. PMID: 24492324.
230. Jacamo R, Chen Y, Wang Z, Ma W, Zhang M, Spaeth EL, Wang Y, Battula VL, Mak PY, Schallmoser K, Ruvolo P, Schober WD, Shpall EJ, Nguyen MH, Strunk D, Bueso-Ramos CE, Konoplev S, Davis RE, Konopleva M, Andreeff M. Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-kB mediates chemoresistance. Blood 123(17):2691-2702, 2014. e-Pub 2014. PMID: 24599548.
231. Arana Yi C, Jeyakumar G, Medina P, Cortes J, Pierce S, Bueso-Ramos C, Kantarjian H, Verstovsek S. Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers. Leuk Res 38(1):91-4, 2014. e-Pub 2014. PMID: 24284333.
232. Hoehn, D, Lu, G, Konoplev, SN, Zhou, Y, Bueso-Ramos, CE, Zuo, Z, Hsu, B, Medeiros, LJ, Yin, CC. t(15;17)(q24.1;q21.2)/PML-RARA in blast phase of chronic myelogenous leukemia. Journal of Hematopathology 6(4):187-193, 2013. e-Pub 2013.
233. Alayed KM, Medeiros LJ, Phan D, Ojiaku C, Patel J, Yap JP, McCord Y, Woods JS, Konoplev S, Bueso-Ramos CE, Reyes SR. Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3. Arch Pathol Lab Med 137(11):1669-73, 2013. e-Pub 2013. PMID: 24168508.
234. Chakhachiro ZI, Zuo Z, Aladily TN, Kantarjian HM, Cortes JE, Alayed K, Nguyen MH, Medeiros LJ, Bueso-Ramos C. CD105 (Endoglin) is highly overexpressed in a subset of cases of acute myeloid leukemias. AJCP 140(3), 2013. e-Pub 2013. PMID: 23955456.
235. Lu G, Schulz RA, Bueso-Ramos CE, Cortes JE, Iris Wang X, Medeiros LJ, Yin CC. Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemia. J Clin Pathol 66(9):826-9, 2013. e-Pub 2013. PMID: 23703854.
236. Alayed K, Medeiros LJ, Schultz RA, Cortes J, Lu G, Bueso-Ramos CE, Konoplev S. Value of oligonucleotide-based array comparative genomic hybridization for diagnosis of acute promyelocytic leukemia in a patient negative for t(15;17)(q24.1;q21.2)/promyelocytic leukemia-retinoic acid receptor, alpha by conventional cytogenetics and fluorescence in situ hybridization. Clin Lymphoma Myeloma Leuk 13(4):507-10, 2013. e-Pub 2013. PMID: 23770155.
237. Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, Lin P, Bueso-Ramos CE, Manning JT, Patel K, Thomazy V, Brynes RK, Goswami M, Fayad LE, Miranda RN. Classical hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol 37(8):1290-7, 2013. e-Pub 2013. PMID: 23774171.
238. Xu-Monette ZY, Møller MB, Tzankov A, Montes-Moreno S, Hu W, Manyam GC, Fan L, Visco C, Dybkær K, Chiu A, Tam W, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Winter JN, Wu L, Zhao X, Go RS, Wang SA, Bueso-Ramos CE, Li Y, Piris MA, Medeiros LJ, Young KH. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy. Blood, 2013. e-Pub 2013. PMID: 23982177.
239. Takahashi K, Pemmaraju N, Strati P, Nogueras-Gonzalez G, Ning J, Bueso-Ramos C, Luthra R, Pierce S, Cortes J, Kantarjian H, Garcia-Manero G. Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia. Blood. e-Pub 2013. PMID: 23896412.
240. Battula VL, Chen Y, Cabreira Mda G, Ruvolo V, Wang Z, Ma W, Konoplev S, Shpall E, Lyons K, Strunk D, Bueso-Ramos C, Davis RE, Konopleva M, Andreeff M. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood 122(3):357-66, 2013. e-Pub 2013. PMID: 23741006.
241. Heinrichs, S, Conover, LF, Bueso-Ramos, CE, Kilpivaara, O, Stevenson, KE, Neuberg, D, Loh, M, Wu, WS, Rodig, SJ, Garcia-Manero, G, Kantarjian, HM, Look, AT. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. eLife 2013(2), 2013. e-Pub 2013. PMID: 23878725.
242. Greaves WO, Verma S, Bisrat T, Strati P, Rahimi H, Paladugu AV, Luthra R, Patel KP, Medeiros LJ, Yao H, Pierce S, Bueso-Ramos CE, Verstovsek S. TP53 mutation is rare in primary myelofibrosis. Leuk Lymphoma 54(7):1552, 2013. e-Pub 2013. PMID: 23121011.
243. S* H, Conover L, Bueso-Ramos C, Kilpivaara O. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife, 2013. e-Pub 2013.
244. Chakhachiro ZI, Saliba RM, Okoroji GJ, Korbling M, Alousi AM, Betul O, Anderlini P, Ciurea SO, Popat U, Champlin R, Samuels BI, Medeiros LJ, Bueso-Ramos C, Khouri IF. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission. Cancer. e-Pub 2013. PMID: 23775587.
245. Jain P, Lin P, Bueso-Ramos C, Verstovsek S, Pemmaraju N. Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS. Eur J Haematol. e-Pub 2013. PMID: 23772772.
246. Wei Y, Dimicoli S, Bueso-Ramos C, Chen R, Yang H, Neuberg D, Pierce S, Jia Y, Zheng H, Wang H, Wang X, Nguyen M, Wang SA, Ebert B, Bejar R, Levine R, Abdel-Wahab O, Kleppe M, Ganan-Gomez I, Kantarjian H, Garcia-Manero G. Toll-like receptor alterations in myelodysplastic syndrome. Leukemia. e-Pub 2013. PMID: 23765228.
247. Takahashi K, Jabbour E, Wang X, Luthra R, Bueso-Ramos C, Patel K, Pierce S, Yang H, Wei Y, Daver N, Faderl S, Ravandi F, Estrov Z, Cortes J, Kantarjian H, Garcia-Manero G. Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. Leukemia. e-Pub 2013. PMID: 23774633.
248. Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: A diagnostic challenge. Clin Lymphoma Myeloma Leuk. e-Pub 2013. PMID: 23800601.
249. Zhou Y, Fan X, Routbort M, Cameron Yin C, Singh R, Bueso-Ramos C, Thomas DA, Milton DR, Medeiros LJ, Lin P. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol. e-Pub 2013. PMID: 23702731.
250. Fu B, Ok CY, Goswami M, Xei W, Jaso JM, Muzzafar T, Bueso-Ramos C, Verstovsek S, Garcia-Manero G, Medeiros LJ, Wang SA. The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. Ann Hematol. e-Pub 2013. PMID: 23660629.
251. Al-Kali A, Quintás-Cardama A, Luthra R, Bueso-Ramos C, Pierce S, Kadia T, Borthakur G, Estrov Z, Jabbour E, Faderl S, Ravandi F, Cortes J, Tefferi A, Kantarjian H, Garcia-Manero G. Prognostic impact of RAS mutations in patients with myelodysplastic syndrome. Am J Hematol 88(5):365-9, 2013. e-Pub 2013. PMID: 23512829.
252. Kanagal-Shamanna R, Lehman NL, O'Donnell JP, Lim MS, Schultz DS, Chitale DA, Bueso-Ramos CE, Medeiros LJ, Inamdar KV. Differential expression of aurora-A kinase in T-cell lymphomas. Mod Pathol 26(5):640-7, 2013. e-Pub 2013. PMID: 23411487.
253. Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Ganan-Gomez I, Ebert B, Levine R, Kantarjian H, Garcia-Manero G. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia. e-Pub 2013. PMID: 23538751.
254. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PM, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol 88(3):219-24, 2013. e-Pub 2013. PMID: 23440662.
255. Nazha A, Estrov Z, Cortes J, Bueso-Ramos CE, Kantarjian H, Verstovsek S. Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis. Leuk Lymphoma. e-Pub 2013. PMID: 23343175.
256. Patel KP, Khokhar FA, Muzzafar T, James You M, Bueso-Ramos CE, Ravandi F, Pierce S, Medeiros LJ. TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation. Mod Pathol 26(2):195-203, 2013. e-Pub 2013. PMID: 22936064.
257. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PP, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol. e-Pub 2013. PMID: 23335446.
258. Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ, Yin CC. Extranodal NK/T-cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 37(1):14-23, 2013. e-Pub 2013. PMID: 23232851.
259. Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma 54(1):138-44, 2013. e-Pub 2013. PMID: 22691121.
260. Hoeller S, Zhou Y, Kanagal-Shamanna R, Xu-Monette ZY, Hoehn D, Bihl M, Swerdlow SH, Rosenwald A, Ott G, Said J, Dunphy CH, Bueso-Ramos CE, Lin P, Wang M, Miranda RN, Tzankov A, Medeiros LJ, Young KH. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study. Hum Pathol 44(1):110-21, 2013. e-Pub 2013. PMID: 22944294.
261. Nazha A, Bueso-Ramos C, Estey E, Faderl S, O'Brien S, Fernandez MH, Nguyen M, Koller C, Freireich E, Beran M, Pierce S, Keating M, Cortes J, Kantarjian H, Ravandi F. The addition of all-trans retinoic acid to chemotherapy may not improve the outcome of patient with NPM1 mutated acute myeloid leukemia. Front Oncol 3:218, 2013. e-Pub 2013. PMID: 24032106.
262. Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q). Cancer Genet 206(1-2):42-6, 2013. e-Pub 2013. PMID: 23357231.
263. Dimicoli S, Wei Y, Bueso-Ramos C, Yang H, Dinardo C, Jia Y, Zheng H, Fang Z, Nguyen M, Pierce S, Chen R, Wang H, Wu C, Garcia-Manero G. Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromes. PLoS One 8(8):e71120, 2013. e-Pub 2013. PMID: 23976989.
264. Hoehn D, Medeiros LJ, Kantarjian HM, Cortes JE, Wang X, Bueso-Ramos CE. Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemia. Hum Pathol 43(12):2354-9, 2012. e-Pub 2012. PMID: 22939577.
265. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol 35(5):462-7, 2012. e-Pub 2012. PMID: 21654313.
266. Tong WG, Quintás-Cardama A, Kadia T, Borthakur G, Jabbour E, Ravandi F, Faderl S, Wierda W, Pierce S, Shan J, Bueso-Ramos C, Kantarjian H, Garcia-Manero G. Predicting survival of patients with hypocellular myelodysplastic syndrome: Development of a disease-specific prognostic score system. Cancer 118(18):4462-70, 2012. e-Pub 2012. PMID: 22252728.
267. Lee DW, Futami M, Carroll M, Feng Y, Wang Z, Fernandez M, Whichard Z, Chen Y, Kornblau S, Shpall EJ, Bueso-Ramos CE, Corey SJ. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155. Oncogene 31(37):4085-94, 2012. e-Pub 2012. PMID: 22249254.
268. Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Møller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the international DLBCL rituximab-CHOP consortium program study. Leukemia 26(9):2103-13, 2012. e-Pub 2012. PMID: 22437443.
269. Zhou Y, You MJ, Young KH, Lin P, Lu G, Medeiros LJ, Bueso-Ramos CE. Advances in the molecular pathobiology of B-lymphoblastic leukemia. Hum Pathol 43(9):1347-62, 2012. e-Pub 2012. PMID: 22575265.
270. Kanagal-Shamanna R, Zhao W, Vadhan-Raj S, Nguyen MH, Fernandez MH, Medeiros LJ, Bueso-Ramos CE. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11. Int J Environ Res Public Health 9(8):2788-800, 2012. e-Pub 2012. PMID: 23066397.
271. Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol 138(1):146-52, 2012. e-Pub 2012. PMID: 22706870.
272. Verma S, Greaves WO, Ravandi F, Reddy N, Bueso-Ramos CE, O'Brien S, Thomas DA, Kantarjian H, Medeiros LJ, Luthra R, Patel KP. Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay. Am J Clin Pathol 138(1):153-6, 2012. e-Pub 2012. PMID: 22706871.
273. Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G, Vadhan-Raj S, Hoehn D, Medeiros LJ, Yin CC. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 118(11):2879-88, 2012. e-Pub 2012. PMID: 22038701.
274. Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y, Kantarjian HM, Bueso-Ramos C, Medeiros LJ, Wang SA. B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?. Haematologica 97(6):919-25, 2012. e-Pub 2012. PMID: 22207681.
275. Vadhan-Raj S, Fayad LE, Fanale MA, Pro B, Rodriguez A, Hagemeister FB, Bueso-Ramos CE, Zhou X, McLaughlin PW, Fowler N, Shah J, Orlowski RZ, Samaniego F, Wang M, Cortes JE, Younes A, Kwak LW, Sarlis NJ, Romaguera JE. A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Ann Oncol 23(6):1640-5, 2012. e-Pub 2012. PMID: 22015451.
276. Xu-Monette ZY, Medeiros LJ, Li Y, Orlowski RZ, Andreeff M, Bueso-Ramos CE, Greiner TC, McDonnell TJ, Young KH. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood 119(16):3668-83, 2012. e-Pub 2012. PMID: 22275381.
277. Papathomas TG, Venizelos I, Dunphy CH, Said JW, Wang ML, Campo E, Swerdlow SH, Chan JC, Bueso-Ramos CE, Weisenburger DD, Medeiros LJ, Young KH. Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications. Hum Pathol 43(4):467-80, 2012. e-Pub 2012. PMID: 22221705.
278. Zuo Z, Medeiros LJ, Chen Z, Liu D, Bueso-Ramos CE, Luthra R, Wang SA. Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML. PLoS One 7(7):e41485, 2012. e-Pub 2012. PMID: 22844482.
279. Lamothe B, Lai Y, Hur L, Orozco NM, Wang J, Campos AD, Xie M, Schneider MD, Lockworth CR, Jakacky J, Tran D, Ho M, Dawud S, Dong C, Lin HK, Hu P, Estrov Z, Bueso-Ramos CE, Darnay BG. Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice. PLoS One 7(12):e51228, 2012. e-Pub 2012. PMID: 23251462.
280. Ok CY, Medeiros LJ, Hu Y, Bueso-Ramos CE, Wang SA. Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies. Leuk Res 35(12):1605-10, 2011. e-Pub 2011. PMID: 21596435.
281. Badoux X, Bueso-Ramos C, Harris D, Li P, Liu Z, Burger J, O'Brien S, Ferrajoli A, Keating MJ, Estrov Z. Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3. Hum Pathol 42(12):1989-2000, 2011. e-Pub 2011. PMID: 21733558.
282. Naqvi K, Jabbour E, Bueso-Ramos C, Pierce S, Borthakur G, Estrov Z, Ravandi F, Faderl S, Kantarjian H, Garcia-Manero G. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood 118(17):4690-3, 2011. e-Pub 2011. PMID: 21868570.
283. Faderl S, Bueso-Ramos C, Liu Z, Pal A, Bornmann W, Ciurea DV, Harris D, Hazan-Halevy I, Kantarjian HM, Estrov Z. Kit inhibitor APcK110 extends survival in an AML xenograft mouse model. Invest New Drugs 29(5):1094-7, 2011. e-Pub 2011. PMID: 20517635.
284. Khouri IF, Bassett R, Poindexter N, O'Brien S, Bueso-Ramos CE, Hsu Y, Ferrajoli A, Keating MJ, Champlin R, Fernandez-Vina M. Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: Long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome. Cancer 117(20):4679-88, 2011. e-Pub 2011. PMID: 21455998.
285. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467-77, 2011. e-Pub 2011. PMID: 21647195.
286. Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, Shimizu M, Garcia-Manero G, Bueso-Ramos CE. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 118(2):413-5, 2011. e-Pub 2011. PMID: 21602527.
287. Vigil CE, Wang SA, Cortes JE, Bueso-Ramos C, Verstovsek S, Shinder R, Chen SS, Katz RL, Khanna A, Esmaeli B, Manning JT, You MJ, Miranda RN. Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. J Clin Oncol 29(17):e514-6, 2011. e-Pub 2011. PMID: 21464405.
288. Kidd S, Bueso-Ramos C, Jagan S, Paganessi LA, Boggio LN, Fung HC, Gregory SA, Christopherson KW. In Vivo expansion of the megakaryocyte progenitor cell population in adult CD26 deficient mice. Exp Hematol 39(5):580-590.e1, 2011. e-Pub 2011. PMID: 21291952.
289. Alseraye FM, Zuo Z, Bueso-Ramos C, Wang S, Medeiros LJ, Lu G. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation. Int J Clin Exp Pathol 4(4):371-7, 2011. e-Pub 2011. PMID: 21577323.
290. Greaves WO, Bueso-Ramos C, Fayad L. Classical hodgkin's lymphoma associated with langerhans cell histiocytosis: Multiagent chemotherapy resulted in histologic resolution of both the classical hodgkin's lymphoma and langerhans cell proliferation components. J Clin Oncol 29(4):e76-8, 2011. e-Pub 2011. PMID: 21041711.
291. Karjalainen K, Jaalouk DE, Bueso-Ramos CE, Zurita AJ, Kuniyasu A, Eckhardt BL, Marini FC, Lichtiger B, O'Brien S, Kantarjian HM, Cortes JE, Koivunen E, Arap W, Pasqualini R. Targeting neuropilin-1 in human leukemia and lymphoma. Blood 117(3):920-7, 2011. e-Pub 2011. PMID: 21063027.
292. Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ. Constitutive BR3 receptor signaling in diffuse large B-cell lymphomas stabilizes NF-{kappa}B-inducing kinase, while activating both canonical and alternative NF-{kappa}B pathways. Blood 117(1):200-10, 2011. e-Pub 2011. PMID: 20889926.
293. Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, Li P, Ravoori M, Abruzzo L, Han L, Singh S, Sun M, Kundra V, Kurzrock R, Estrov Z. Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One 6(6):e21250, 2011. e-Pub 2011. PMID: 21731684.
294. Sun J, Medeiros LJ, Lin P, Lu G, Bueso-Ramos CE, You MJ. Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression. Pathology 43(1):54-7, 2011. e-Pub 2011. PMID: 21240066.
295. Benito J, Shi Y, Szymanska B, Carol H, Boehm I, Lu H, Konoplev S, Fang W, Zweidler-McKay PA, Campana D, Borthakur G, Bueso-Ramos C, Shpall E, Thomas DA, Jordan CT, Kantarjian H, Wilson WR, Lock R, Andreeff M, Konopleva M. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS One 6(8):e23108, 2011. e-Pub 2011. PMID: 21853076.
296. Santos FP, Bueso-Ramos CE, Ravandi F. Acute erythroleukemia: diagnosis and management. Expert Rev Hematol 3(6):705-18, 2010. e-Pub 2010. PMID: 21091147.
297. Yin CC, Medeiros LJ, Bueso-Ramos CE. Recent advances in the diagnosis and classification of myeloid neoplasms - comments on the 2008 WHO classification. Int J Lab Hematol 32(5):461-76, 2010. e-Pub 2010. PMID: 20626469.
298. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med 153(6):358-67, 2010. e-Pub 2010. PMID: 20855800.
299. Konoplev SN, Fritsche HA, O'Brien S, Wierda WG, Keating MJ, Gornet TG, St Romain S, Wang X, Inamdar K, Johnson MR, Medeiros LJ, Bueso-Ramos CE. High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia. Am J Clin Pathol 134(3):472-7, 2010. e-Pub 2010. PMID: 20716805.
300. Thomas DA, O'Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Ravandi F, Verstovsek S, Jorgensen JL, Bueso-Ramos C, Andreeff M, Pierce S, Garris R, Keating MJ, Cortes J, Kantarjian HM. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. J Clin Oncol 28(24):3880-9, 2010. e-Pub 2010. PMID: 20660823.
301. Kasyan A, Medeiros LJ, Zuo Z, Santos FP, Ravandi-Kashani F, Miranda R, Vadhan-Raj S, Koeppen H, Bueso-Ramos CE. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Mod Pathol 23(8):1113-26, 2010. e-Pub 2010. PMID: 20473273.
302. Pham LV, Tamayo AT, Li C, Bueso-Ramos C, Ford RJ. An epigenetic chromatin-remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas. Blood. e-Pub 2010. PMID: 20664054.
303. Ciurea SO, de Lima M, Giralt S, Saliba R, Bueso-Ramos C, Andersson BS, Hosing CM, Verstovsek S, Champlin RE, Popat U. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation. Biol Blood Marrow Transplant 16(4):555-9, 2010. e-Pub 2010. PMID: 20005966.
304. Dimov ND, Medeiros LJ, Ravandi F, Bueso-Ramos CE. Acute promyelocytic leukemia at time of relapse commonly demonstrates cytogenetic evidence of clonal evolution and variability in blast immunophenotypic features. Am J Clin Pathol 133(3):484-90, 2010. e-Pub 2010. PMID: 20154288.
305. Liang M, Han X, Vadhan-Raj S, Nguyen M, Zhang YH, Fernandez M, Drakos E, Konoplev SN, Yin CC, Miranda RN, McDonnell TJ, Medeiros LJ, Bueso-Ramos CE. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Mod Pathol 23(3):381-91, 2010. e-Pub 2010. PMID: 20062013.
306. Tarrand JJ, Keating MJ, Tsimberidou AM, O'Brien S, LaSala RP, Han XY, Bueso-Ramos CE. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer 116(4):880-7, 2010. e-Pub 2010. PMID: 20052729.
307. Jones D, Yao H, Romans A, Dando C, Pierce S, Borthakur G, Hamilton A, Bueso-Ramos C, Ravandi F, Garcia-Manero G, Kantarjian H. Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias. Genes Chromosomes Cancer 49(2):182-91, 2010. e-Pub 2010. PMID: 19908318.
308. Abdel-Wahab O, Manshouri T, Patel J, Harris K, Yao J, Hedvat C, Heguy A, Bueso-Ramos C, Kantarjian H, Levine RL, Verstovsek S. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res 70(2):447-52, 2010. e-Pub 2010. PMID: 20068184.
309. Dimov ND, Medeiros LJ, Kantarjian HM, Cortes JE, Chang KS, Bueso-Ramos CE, Ravandi F. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients. Cancer 116(2):369-76, 2010. e-Pub 2010. PMID: 19950129.
310. Khokhar FA, Payne WD, Talwalkar SS, Jorgensen JL, Bueso-Ramos CE, Medeiros LJ, Vega F. Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol 41(1):79-87, 2010. e-Pub 2010. PMID: 19740519.
311. Cui W, Bueso-Ramos CE, Yin CC, Sun J, Chen S, Muddasani R, Lu G. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia, and a wide spectrum of disease progression. J Biomed Biotechnol 2010:365318, 2010. e-Pub 2010. PMID: 21331167.
312. Chen W, Konoplev S, Medeiros LJ, Koeppen H, Leventaki V, Vadhan-Raj S, Jones D, Kantarjian HM, Falini B, Bueso-Ramos CE. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer 115(23):5481-9, 2009. e-Pub 2009. PMID: 19672946.
313. Kantarjian H, O'Brien S, Ravandi F, Borthakur G, Faderl S, Bueso-Ramos C, Abruzzo L, Pierce S, Shan J, Issa JP, Garcia-Manero G. The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?. Cancer 115(22):5202-9, 2009. e-Pub 2009. PMID: 19691096.
314. Quintás-Cardama A, Kantarjian HM, Manshouri T, Thomas D, Cortes J, Ravandi F, Garcia-Manero G, Ferrajoli A, Bueso-Ramos C, Verstovsek S. Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients With myelofibrosis. J Clin Oncol 27(28):4760-6, 2009. e-Pub 2009. PMID: 19720904.
315. Santos FP, Faderl S, Garcia-Manero G, Koller C, Beran M, O'Brien S, Pierce S, Freireich EJ, Huang X, Borthakur G, Bueso-Ramos C, de Lima M, Keating M, Cortes J, Kantarjian H, Ravandi F. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia, 2009. e-Pub 2009. PMID: 19741728.
316. Heinrichs S, Kulkarni RV, Bueso-Ramos CE, Levine RL, Loh ML, Li C, Neuberg D, Kornblau SM, Issa JP, Gilliland DG, Garcia-Manero G, Kantarjian HM, Estey EH, Look AT. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 23(9):1605-13, 2009. e-Pub 2009. PMID: 19387468.
317. McKenna M, Arnold C, Catherwood MA, Humphreys MW, Cuthbert RJ, Bueso-Ramos C, McManus DT. Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report. J Clin Pathol 62(8):757-9, 2009. e-Pub 2009. PMID: 19638550.
318. Konoplev S, Huang X, Drabkin HA, Koeppen H, Jones D, Kantarjian HM, Garcia-Manero G, Chen W, Medeiros LJ, Bueso-Ramos CE. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis. Cancer, 2009. e-Pub 2009. PMID: 19637342.
319. Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, Mullighan CG, Chen L, Bergstraesser E, Bueso-Ramos CE, Emanuel PD, Hasle H, Issa JP, van den Heuvel-Eibrink MM, Locatelli F, Stary J, Trebo M, Wlodarski M, Zecca M, Shannon KM, Niemeyer CM. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood. e-Pub 2009. PMID: 19571318.
320. Nussenzveig RH, Cortes J, Sever M, Quintás-Cardama A, Ault P, Manshouri T, Bueso-Ramos C, Prchal JT, Kantarjian H, Verstovsek S. Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001. Int J Hematol 90(1):58-63. e-Pub 2009. PMID: 19484334.
321. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4(10):e7405, 2009. e-Pub 2009. PMID: 19823581.
322. Verstovsek S, Tefferi A, Kantarjian H, Manshouri T, Luthra R, Pardanani A, Quintás-Cardama A, Ravandi F, Ault P, Bueso-Ramos C, Cortes JE. Alemtuzumab therapy for hypereosinophilic syndrome and chronic eosinophilic leukemia. Clin Cancer Res 15(1):368-73, 2009. e-Pub 2009. PMID: 19118067.
323. Yang H, Kadia T, Xiao L, Bueso-Ramos CE, Hoshino K, Thomas DA, O'Brien S, Jabbour E, Pierce S, Rosner GL, Kantarjian HM, Garcia-Manero G. Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood 113(9):1892-8. e-Pub 2008. PMID: 19109226.
324. Ye D, Garcia-Manero G, Kantarjian HM, Xiao L, Vadhan-Raj S, Fernandez MH, Nguyen MH, Medeiros LJ, Bueso-Ramos CE. Analysis of aurora kinase a expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia. J Hematop 2(1):2-8. e-Pub 2008. PMID: 19669217.
325. Yin CC, Jones D, Cortes JE, Kantarjian H, Merzianu M, Medeiros LJ, Bueso-Ramos CE. Type b core binding factor beta/smooth muscle myosin heavy chain fusion transcript in myeloid blast phase of chronic myeloid leukemia: correlation with nuclear and cytoplasmic localization of the fusion protein. Clinical Leukemia 2(4):257-260, 2008. e-Pub 2008.
326. Inamdar KV, O'Brien S, Sen S, Keating M, Nguyen MH, Wang X, Fernandez M, Thomazy V, Medeiros LJ, Bueso-Ramos CE. Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Mod Pathol 21(12):1428-35. e-Pub 2008. PMID: 18931650.
327. Jones D, Luthra R, Cortes J, Thomas D, O'Brien S, Bueso-Ramos C, Hai S, Ravandi F, de Lima M, Kantarjian H, Jorgensen JL. BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias. Blood 112(13):5190-2. e-Pub 2008. PMID: 18809762.
328. Johnson MR, Verstovsek S, Jorgensen LJ, Manshouri T, Luthra R, Jones DM, Bueso-Ramos CE, Medeiros LJ, Huh YO. Utility of the World Health Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Mod Pathol 22(1):50-7. e-Pub 2008. PMID: 19116630.
329. Tam CS, Nussenzveig RM, Popat U, Bueso-Ramos CE, Thomas DA, Cortes JA, Champlin RE, Ciurea SE, Manshouri T, Pierce SM, Kantarjian HM, Verstovsek S. The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms. Blood 112(5):1628-37, 2008. e-Pub 2008. PMID: 18566326.
330. Kroeger H, Jelinek J, Estécio MR, He R, Kondo K, Chung W, Zhang L, Shen L, Kantarjian HM, Bueso-Ramos CE, Issa JP. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 112(4):1366-73, 2008. e-Pub 2008. PMID: 18523155.
331. Yanada M, Borthakur G, Ravandi F, Bueso-Ramos C, Kantarjian H, Estey E. Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia. Haematologica 93(8):1263-5, 2008. e-Pub 2008. PMID: 18519513.
332. Borthakur, G, Alvarado, Y, Ravandi-Kashani, F, Cortes, JE, Estrov, Z, Faderl, SH, Ivy, SP, Bueso-Ramos, CE, Bekele, BN, Giles, FJ. Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies. Cancer 113(2):360-366, 2008. e-Pub 2008. PMID: 18473351.
333. Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 22(6):1295-8, 2008. e-Pub 2008. PMID: 18059483.
334. Anderlini P, Swanston N, Rashid A, Bueso-Ramos C, Macapinlac HA, Champlin RE. Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement. Biol Blood Marrow Transplant 14(4):478-80, 2008. e-Pub 2008. PMID: 18342791.
335. Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda WG, Faderl S, Koller C, Morris G, Rosner G, Loboda A, Fantin VR, Randolph SS, Hardwick JS, Reilly JF, Chen C, Ricker JL, Secrist JP, Richon VM, Frankel SR, Kantarjian HM. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood 111(3):1060-6, 2008. e-Pub 2008. PMID: 17962510.
336. McDonnell TJ, Chari NS, Cho-Vega JH, Troncoso P, Wang X, Bueso-Ramos CE, Coombes K, Brisbay S, Lopez R, Prendergast G, Logothetis C, Do KA. Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer. BMC Med Genomics 1:1, 2008. e-Pub 2008. PMID: 18237448.
337. Sun X, Zhang W, Ramdas L, Stivers DN, Jones DM, Kantarjian HM, Estey EH, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE. Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping. Mod Pathol 20(8):811-20, 2007. e-Pub 2007. PMID: 17571080.
338. Ostronoff F, Bueso-Ramos C, Cortes J, Giralt S. Normal hematopoietic function and multiple bone marrow clonal abnormalities in a patient with acute myeloid leukemia after two mismatched stem-cell transplants with graft failure and autologous reconstitution. Am J Hematol 82(8):744-7, 2007. e-Pub 2007. PMID: 17506066.
339. Zhao W, Bueso-Ramos CD, Verstovsek S, Barkoh BA, Khitamy AA, Jones D. Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease. Leukemia 21(7):1574-1576, 2007. e-Pub 2007. PMID: 17410189.
340. Aribi A, Bueso-Ramos C, Estey E, Estrov Z, O'Brien S, Giles F, Faderl S, Thomas D, Kebriaei P, Garcia-Manero G, Pierce S, Cortes J, Kantarjian H, Ravandi F. Biphenotypic acute leukaemia: a case series. Br J Haematol 138(2):213-6, 2007. e-Pub 2007. PMID: 17593028.
341. Khouri IF, Saliba RM, Admirand J, O'Brien S, Lee MS, Korbling M, Samuels BI, Giralt S, Lima de M, Keating MJ, Champlin RE, Bueso-Ramos C. Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia. Br J Haematol 137(4):355-63, 2007. e-Pub 2007. PMID: 17456058.
342. Han X, Bueso-Ramos CE. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias. Am J Clin Pathol 127(4):528-44, 2007. e-Pub 2007. PMID: 17369128.
343. Bhardwaj A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, Aggarwal BB. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109(6):2293-302, 2007. e-Pub 2007. PMID: 17164350.
344. Kantarjian HM, O'Brien S, Huang X, Garcia-Manero G, Ravandi F, Cortes J, Shan J, Davisson J, Bueso-Ramos CE, Issa JP. Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience. Cancer, 2007. e-Pub 2007. PMID: 17315156.
345. Han X, Garcia-Manero G, McDonnell TJ, Lozano G, Medeiros LJ, Xiao L, Rosner G, Nguyen M, Fernandez M, Valentin-Vega YA, Barboza J, Jones DM, Rassidakis GZ, Kantarjian HM, Bueso-Ramos CE. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target. Mod Pathol 20(1):54-62, 2007. e-Pub 2007. PMID: 17143258.
346. Kilic G, Boruban MC, Bueco-Ramos C, Konoplev SN. Granulocytic sarcoma involving the uterus and right fallopian tube with negative endometrial biopsy. Eur J Gynaecol Oncol 28(4):270-2, 2007. e-Pub 2007. PMID: 17713090.
347. Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, Ferrajoli A, Wierda W, Shan J, Davis J, Giles F, Saba HI, Issa JP. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 109(1):52-7, 2007. e-Pub 2007. PMID: 16882708.
348. Jiang L, Admirand JH, Moran C, Ford RJ, Bueso-Ramos CE. Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. Ann Diagn Pathol 10(6):357-62, 2006. e-Pub 2006. PMID: 17126255.
349. Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Wierda WG, Ravandi F, Koller C, Xiao L, Faderl S, Estrov Z, Cortes J, O'brien S, Estey E, Bueso-Ramos C, Fiorentino J, Jabbour E, Issa JP. Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood 108(10):3271-9, 2006. e-Pub 2006. PMID: 16882711.
350. Zhao W, Claxton DF, Medeiros LJ, Lu D, Vadhan-Raj S, Kantarjian HM, Nguyen MH, Bueso-Ramos CE. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22). Am J Surg Pathol 30(11):1436-44, 2006. e-Pub 2006. PMID: 17063086.
351. Talwalkar SS, Valbuena JR, Abruzzo LV, Admirand JH, Konoplev SN, Bueso-Ramos CE, Medeiros LJ. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol 19(11):1402-8, 2006. e-Pub 2006. PMID: 16917511.
352. Johnson MR, Del Carpio-Jayo D, Lin P, Giralt S, Anderlini P, Champlin RE, Khouri IF, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation. Ann Diagn Pathol 10(5):263-8, 2006. e-Pub 2006. PMID: 16979517.
353. Tsimberidou AM, O'Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, Lerner S, Bueso-Ramos CE, Keating MJ. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. Cancer 107(6):1294-302, 2006. e-Pub 2006. PMID: 16902984.
354. Chen W, Rassidakis GZ, Li J, Routbort M, Jones D, Kantarjian H, Medeiros LJ, Bueso-Ramos CE. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei). Blood 108(5):1783-4, 2006. e-Pub 2006. PMID: 16926303.
355. Sanchez-Gonzalez B, Yang H, Bueso-Ramos C, Hoshino K, Quintas-Cardama A, Richon VM, Garcia-Manero G. Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor. Blood 108(4):1174-82, 2006. e-Pub 2006. PMID: 16675713.
356. Tsimberidou AM, Keating MJ, Bueso-Ramos CE, Kurzrock R. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 47(5):827-36, 2006. e-Pub 2006. PMID: 16753866.
357. Merzianu M, Jiang L, Lin P, Wang X, Weber DM, Vadhan-Raj S, Nguyen MH, Medeiros LJ, Bueso-Ramos CE. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and does not correlate with p65 NF-kappaB activation. Mod Pathol, 2006. e-Pub 2006. PMID: 16636680.
358. Chaves J, Huen A, Bueso-Ramos C, Safdar A, Vadhan-Raj S. Aerosolized ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma. Clin Infect Dis 42(8):e72-5, 2006. e-Pub 2006. PMID: 16575720.
359. Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 106(7):1569-80, 2006. e-Pub 2006. PMID: 16502413.
360. Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G. Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center. Blood 107(3):880-4, 2006. e-Pub 2006. PMID: 16123215.
361. See HT, Thomas DA, Bueso-Ramos C, Kavanagh J. Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer. Int J Gynecol Cancer 16 Suppl 1:236-40, 2006. e-Pub 2006. PMID: 16515597.
362. Jelinek J, Oki Y, Gharibyan V, Bueso-Ramos C, Prchal JT, Verstovsek S, Beran M, Estey E, Kantarjian HM, Issa JP. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia-chromosome negative CML and megakaryocytic leukemia . Blood 106(10):3370-3, 2005. e-Pub 2005. PMID: 16037387.
363. Okcu MF, Wang RY, Bueso-Ramos C, Schober W, Weidner D, Andrassy R, Blakely M, Russell H, Ozkan A, Kuttesch J, Andreeff M, Chan KW, Ater J. Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow. Pediatr Blood Cancer 45(6):787-95, 2005. e-Pub 2005. PMID: 15929127.
364. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11(20):7490-8, 2005. e-Pub 2005. PMID: 16243823.
365. Konoplev S, Medeiros LJ, Bueso-Ramos CE, Jorgensen JL, Lin P. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Am J Clin Pathol 124(3):414-20, 2005. e-Pub 2005. PMID: 16191510.
366. Kantarjian HM, Bueso-Ramos CE, Talpaz M, O'Brien S, Giles F, Faderl S, Wierda W, Rios MB, Shan J, Cortes J. Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapy. Cancer 104(4):777-80, 2005. e-Pub 2005. PMID: 15971197.
367. Giles F, O'Brien S, Cortes J, Verstovsek S, Bueso-Ramos C, Shan J, Pierce S, Garcia-Manero G, Keating M, Kantarjian H. Outcome of patients with acute myelogenous leukemia after second salvage therapy. Cancer 104(3):547-54, 2005. e-Pub 2005. PMID: 15973664.
368. Kantarjian HM, Bueso-Ramos CE, Talpaz M, O'Brien S, Giles F, Rios MB, Shan J, Cortes J. The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy. Leuk Lymphoma 46(7):993-7, 2005. e-Pub 2005. PMID: 16019549.
369. Bueso-Ramos C, Xu Y, McDonnell TJ, Brisbay S, Pierce S, Kantarjian H, Rosner G, Garcia-Manero G. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol 23(17):3932-9, 2005. e-Pub 2005. PMID: 15851765.
370. Vadhan-Raj S, Cohen V, Bueso-Ramos C. Thrombopoietic growth factors and cytokines. Curr Hematol Rep 4(2):137-44, 2005. e-Pub 2005. PMID: 15720963.
371. Jiang L, Jones D, Medeiros LJ, Orduz YR, Bueso-Ramos CE. Peripheral T-cell lymphoma with a "follicular" pattern and the perifollicular sinus phenotype. Am J Clin Pathol 123(3):448-55, 2005. e-Pub 2005. PMID: 15716242.
372. Vadhan, S, Bueso-Ramos, CE, Hangoc, G, Christopherson, K, Collard, M, Broxmeyer, HE. Expansion of bone marrow progenitors and mobilization of multilineage progenitor cells associated with one-per-cycle administration of the long-acting growth factors pegfilgrastim and darbepoetin alfa with chemotherapy. Journal of Supportive Oncology 3(2 SUPPL. 1):22-23, 2005. e-Pub 2005.
373. Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol 123(2):200-5, 2005. e-Pub 2005. PMID: 15842043.
374. Patel HS, Kantarjian HM, Bueso-Ramos CE, Medeiros LJ, Haidar MA. Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia. Genes Chromosomes Cancer 42(1):87-94, 2005. e-Pub 2005. PMID: 15495192.
375. Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R. Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. Ann Oncol 16(1):139-45, 2005. e-Pub 2005. PMID: 15598951.
376. Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101(12):2788-801, 2004. e-Pub 2004. PMID: 15481055.
377. Ottaviani G, Bueso-Ramos CE, Seilstad K, Medeiros LJ, Manning JT, Jones D. The role of the perifollicular sinus in determining the complex immunoarchitecture of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 28(12):1632-40, 2004. e-Pub 2004. PMID: 15577684.
378. Anderlini P, Valbuena JR, Champlin RE, Bueso-Ramos CE. Epstein-barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation. Bone Marrow Transplant 34(10):919-21, 2004. e-Pub 2004. PMID: 15361906.
379. Oyarzo MP, Lin P, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros LJ. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol 122(3):348-58, 2004. e-Pub 2004. PMID: 15362364.
380. Bueso-Ramos CE, Ferrajoli A, Medeiros LJ, Keating MJ, Estrov Z. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. Hematology 9(4):279-86, 2004. e-Pub 2004. PMID: 15621735.
381. Bueso-Ramos CE, Cortes J, Talpaz M, O'Brien S, Giles F, Rios MB, Medeiros LJ, Kantarjian H. Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia. Cancer 101(2):332-6, 2004. e-Pub 2004. PMID: 15241831.
382. Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, Glassman AB, Bueso-Ramos C, Huh YO. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol 121(3):402-7, 2004. e-Pub 2004. PMID: 15023045.
383. Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, Estrov Z, Smith TL, Nguyen MH, Aggarwal BB. Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia. Hum Pathol 35(2):246-53, 2004. e-Pub 2004. PMID: 14991544.
384. Thomas DA, O'Brien S, Bueso-Ramos C, Faderl S, Keating MJ, Giles FJ, Cortes J, Kantarjian HM. Rituximab in relapsed or refractory hairy cell leukemia. Blood 102(12):3906-11, 2003. e-Pub 2003. PMID: 12816862.
385. Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia. J Clin Oncol 21(16):3158-67, 2003. e-Pub 2003. PMID: 12915607.
386. Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 120(2):246-53, 2003. e-Pub 2003. PMID: 12931555.
387. Lin P, Bueso-Ramos C, Wilson CS, Mansoor A, Medeiros LJ. Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients. Am J Surg Pathol 27(8):1104-13, 2003. e-Pub 2003. PMID: 12883242.
388. Sun X, Medeiros LJ, Lu D, Rassidakis GZ, Bueso-Ramos C. Dysplasia and high proliferation rate are common in acute myeloid leukemia with inv(16)(p13q22). Am J Clin Pathol 120(2):236-45, 2003. e-Pub 2003. PMID: 12931554.
389. Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73(1):12-7, 2003. e-Pub 2003. PMID: 12701114.
390. Nunez CA, Zipf TF, Roberts WM, Medeiros LJ, Hayes K, Bueso-Ramos CE. Molecular monitoring of cerebrospinal fluid can predict clinical relapse in acute lymphoblastic leukemia with eosinophilia. Arch Pathol Lab Med 127(5):601-5, 2003. e-Pub 2003. PMID: 12708906.
391. Schlette E, Medeiros LJ, Beran M, Bueso-Ramos CE. Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up. Arch Pathol Lab Med 127(4):488-91, 2003. e-Pub 2003. PMID: 12683882.
392. Tsimberidou AM, Medina J, Earl M, Sierra M, Shriki JE, Bueso-Ramos C, Giralt S, Beran M, Giles FJ, Garcia-Manero G. Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia. Bone Marrow Transplant 31(5):413-4, 2003. e-Pub 2003. PMID: 12634736.
393. Manna SK, Bueso-Ramos C, Alvarado F, Aggarwal BB. Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents. Cancer Lett 190(2):171-82, 2003. e-Pub 2003. PMID: 12565172.
394. DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T, Prendergast GC. Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer. J Cell Biochem 88(3):635-42, 2003. e-Pub 2003. PMID: 12532338.
395. Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62(17):4945-54, 2002. e-Pub 2002. PMID: 12208745.
396. Onciu M, Schlette E, Bueso-Ramos C, Medeiros LJ. Leukemic mantle cell lymphoma with cells resembling prolymphocytes. Am J Clin Pathol 118(2):305-6; author reply 306, 2002. e-Pub 2002. PMID: 12162692.
397. Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Lancet 359(9324):2145-52, 2002. e-Pub 2002. PMID: 12090979.
398. Garcia-Manero G, Bueso-Ramos C, Daniel J, Williamson J, Kantarjian HM, Issa JP. DNA methylation patterns at relapse in adult acute lymphocytic leukemia. Clin Cancer Res 8(6):1897-903, 2002. e-Pub 2002. PMID: 12060634.
399. Vega F, Medeiros LJ, Lang WH, Mansoor A, Bueso-Ramos C, Jones D. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours. Br J Haematol 117(3):569-76, 2002. e-Pub 2002. PMID: 12028024.
400. Dabaja BS, Ha CS, Thomas DA, Wilder RB, Gopal R, Cortes J, Bueso-Ramos C, Hess MA, Cox JD, Kantarjian HM. The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer 94(10):2738-44, 2002. e-Pub 2002. PMID: 12173345.
401. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 94(9):2401-8, 2002. e-Pub 2002. PMID: 12015765.
402. Onciu M, Bueso-Ramos C, Medeiros LJ, Ball G, Smith T, Lai R. Acute lymphoblastic leukemia in elderly patients the Philadelphia chromosome may not be a significant adverse prognostic factor. Am J Clin Pathol 117(5):716-20, 2002. e-Pub 2002. PMID: 12090419.
403. Onciu M, Lai R, Vega F, Bueso-Ramos C, Medeiros LJ. Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets. Am J Clin Pathol 117(2):252-8, 2002. e-Pub 2002. PMID: 11863221.
404. Coombes KR, Zhang L, Bueso-Ramos C, Brisbay S, Logothetis C, Roth J, Keating MJ, McDonnell TJ. TAD: a web interface and database for tissue microarrays. Appl Bioinformatics 1(3):155-8, 2002. e-Pub 2002. PMID: 15130842.
405. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20(52):7597-609, 2001. e-Pub 2001. PMID: 11753638.
406. Schlette E, Lai R, Onciu M, Doherty D, Bueso-Ramos C, Medeiros LJ. Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol 14(11):1133-40, 2001. e-Pub 2001. PMID: 11706075.
407. Mansoor A, Medeiros LJ, Weber DM, Alexanian R, Hayes K, Jones D, Lai R, Glassman A, Bueso-Ramos CE. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol 116(4):543-9, 2001. e-Pub 2001. PMID: 11601139.
408. Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, Abruzzo LV. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116(3):410-9, 2001. e-Pub 2001. PMID: 11554170.
409. Rosales CM, Lin P, Mansoor A, Bueso-Ramos C, Medeiros LJ. Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia associated with Hodgkin disease. A report of two cases. Am J Clin Pathol 116(1):34-40, 2001. e-Pub 2001. PMID: 11447749.
410. Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M. BCR rearrangement-negative chronic myelogenous leukemia revisited. J Clin Oncol 19(11):2915-26, 2001. e-Pub 2001. PMID: 11387365.
411. Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 115(4):571-81, 2001. e-Pub 2001. PMID: 11293906.
412. Mhawech P, Medeiros LJ, Bueso-Ramos C, Coffey DM, Gei AF, Shahab I. Natural killer-cell lymphoma involving the gynecologic tract. Arch Pathol Lab Med 124(10):1510-3, 2000. e-Pub 2000. PMID: 11035585.
413. Huh YO, Smith TL, Collins P, Bueso-Ramos C, Albitar M, Kantarjian HM, Pierce SA, Freireich EJ. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry. Leuk Lymphoma 37(3-4):319-31, 2000. e-Pub 2000. PMID: 10752983.
414. Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, Broxmeyer HE, Kudelka AP, Freedman RS, Edwards CL, Gershenson D, Jones D, Ashby M, Kavanagh JJ. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer. Ann Intern Med 132(5):364-8, 2000. e-Pub 2000. PMID: 10691586.
415. Hamoudi WH, Medeiros LJ, Townsend G, Glassman AB, Bueso-Ramos CE. Acute myelomonocytic leukemia with histologic features resembling sarcomatoid carcinoma in bone marrow. Arch Pathol Lab Med 124(2):315-8, 2000. e-Pub 2000. PMID: 10656748.
416. Lai, R, Hirsch-Ginsberg, CF, Bueso-Ramos, CE. Pathologic diagnosis of acute lymphocytic leukemia. Hematology/Oncology Clinics of North America 14(6):1209-1235, 2000. e-Pub 2000. PMID: 11147220.
417. Bueso-Ramos C, Medeiros LJ, Zipf T, Nunez C, Tubergen D. Tenupodia formation by blasts in bone marrow aspirate smears from a patient with acute monoblastic leukemia. Blood 94(11):3954-5, 1999. e-Pub 1999. PMID: 10627120.
418. Vadhan-Raj S, Currie LM, Bueso-Ramos C, Livesey SA, Connor J. Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO. Br J Haematol 104(2):403-11, 1999. e-Pub 1999. PMID: 10050726.
419. Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol 6(1):79-84, 1999. e-Pub 1999. PMID: 9874668.
420. Chang CY, Glassman AB, Bueso-Ramos CE. Applicability of direct in situ reverse transcription-polymerase chain reaction on bone marrow smears. Ann Clin Lab Sci 28(1):34-42, 1998. e-Pub 1998. PMID: 9512783.
421. Wilhelm M, Bueso-Ramos C, O'Brien S, Pierce S, Keating M, Talpaz M, Kantarjian HM. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia. Leukemia 12(1):65-70, 1998. e-Pub 1998. PMID: 9436922.
422. Vadhan-Raj S, Murray LJ, Bueso-Ramos C, Patel S, Reddy SP, Hoots WK, Johnston T, Papadopolous NE, Hittelman WN, Johnston DA, Yang TA, Paton VE, Cohen RL, Hellmann SD, Benjamin RS, Broxmeyer HE. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 126(9):673-81, 1997. e-Pub 1997. PMID: 9139552.
423. Haidar MA, El-Hajj H, Bueso-Ramos CE, Manshouri T, Glassman A, Keating MJ, Maher A. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance. Am J Hematol 54(3):189-95, 1997. e-Pub 1997. PMID: 9067496.
424. Copeland AR, Bueso-Ramos C, Liu FJ, Kornblau SM, Huh YO, Albitar M. Molecular study of hairy cell leukemia variant with biclonal paraproteinemia. Arch Pathol Lab Med 121(2):150-4, 1997. e-Pub 1997. PMID: 9126043.
425. Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat 37(2):179-88, 1996. e-Pub 1996. PMID: 8750585.
426. Cervantes-Vasquez M, Bueso-Ramos CE, Glassman AB, Marguz-Monter H. El ciclo celular y la oncogenia. Patologia 33:279-287, 1995. e-Pub 1995.
427. Bueso-Ramos, CE, Yang, Y, Manshouri, T, Feltz, L, Ayala, AG, Glassman, A, Albitar, M. Molecular abnormalities of MDM-2 in human sarcomas. International journal of oncology 7(5):1043-1048, 1995. e-Pub 1995. PMID: 21552929.
428. Bueso-Ramos CE, Yang Y, Manshouri T, Feltz L, Ayala A, Glassman AB, Albitar M. Molecular abnormalities of MDM-2 in human sarcomas. Int J Oncol 7:1043-48, 1995. e-Pub 1995.
429. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. The human MDM-2 oncogene is overexpressed in leukemias. Blood 82(9):2617-23, 1993. e-Pub 1993. PMID: 8219216.
430. Schwartz DA, Bueso-Ramos C, Siegel R. Disseminated herpes simplex infection in a twin: the role of the "stat" autopsy in immediate therapeutic intervention for survival of multiple birth neonates. J Perinat Med 20(4):281-7, 1992. e-Pub 1992. PMID: 1432552.
431. Siegel RJ, Bueso-Ramos C, Cohen C, Koss M. Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases. Mod Pathol 4(5):566-70, 1991. e-Pub 1991. PMID: 1722041.
432. Judd R, Bueso-Ramos C. Combined true thymic hyperplasia and lymphoid hyperplasia in Graves' disease. Pediatr Pathol 10(5):829-36, 1990. e-Pub 1990. PMID: 2235767.
433. Bueso-Ramos CE, Donahoe RM, Nicholson JK, Madden JJ, Falek A. Cytofluorometric analyses of human T cell CD2/CD4 inter-molecular interactions. J Immunol 140(5):1414-20, 1988. e-Pub 1988. PMID: 2964474.
434. Donahoe RM, Bueso-Ramos C, Falek A, McClure H, Nicholson JK. Comparative effects of morphine on leukocytic antigenic markers of monkeys and humans. J Neurosci Res 19(1):157-65, 1988. e-Pub 1988. PMID: 3343706.
435. Donahoe RM, Bueso-Ramos C, Donahoe F, Madden JJ, Falek A, Nicholson JK, Bokos P. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann N Y Acad Sci 496:711-21, 1987. e-Pub 1987. PMID: 3496836.
436. Bueso-Ramos CE, Castillo JC, Alvarado D. Cancer en Honduras: 1969-1979. Revis Med Hond 50:136-147, 1983. e-Pub 1983.

Invited Articles

1. Cotta CV, Konoplev S, Medeiros LJ, Bueso-Ramos CE. Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment. Ann Diagn Pathol 10(3):169-92, 2006. e-Pub 2006. PMID: 16730315.
2. Konoplev S, Bueso-Ramos CE. Advances in the pathologic diagnosis and biology of acute myeloid leukemia. Ann Diagn Pathol 10(1):39-65, 2006. e-Pub 2006. PMID: 16414545.
3. Han X, Bueso-Ramos CE. Advances in the pathological diagnosis and biology of acute lymphoblastic leukemia. Ann Diagn Pathol 9(4):239-57, 2005. e-Pub 2005. PMID: 16084461.
4. Ibrahim S, Medeiros LJ, Bueso-Ramos CE. Refractory anemia with excess blasts and del (5q). Pathol Case Rev 5:252-258, 2000. e-Pub 2000.
5. HL* S, Bueso-Ramos CE, Medeiros LJ, Abruzzo LV. Burkitt lymphoma in leukemic phase. Pathol Case Rev 5:267-273, 2000. e-Pub 2000.
6. D* L, Medeiros LJ, Bueso-Ramos CE. Acute myelomonocytic leukemia with abnormal bone marrow eosinophils and inv (16)(p13;q22). Pathol Case Rev 5:259-265, 2000. e-Pub 2000.
7. EJ* S, Bueso-Ramos CE, Medeiros LJ. B-cell prolymphocytic leukemia. Pathol Case Rev 5:274-280, 2000. e-Pub 2000.

Review Articles

1. Prakash S, Arber DA, Bueso-Ramos C, Hasserjian RP, Orazi A. Advances in myelodysplastic/myeloproliferative neoplasms. Virchows Arch 482(1):69-83, 2023. e-Pub 2023. PMID: 36469102.
2. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol 65:147-156, 2017. e-Pub 2017. PMID: 28551329.
3. Alikhan, M, Song, JY, Sohani, AR, Moroch, J, Plonquet, A, Duffield, AS, Borowitz, MJ, Jiang, L, Bueso-Ramos, CE, Inamdar, KV, Menon, M, Gurbuxani, S, Chan, E, Smith, SM, Nicolae, A, Jaffe, ES, Gaulard, P, Venkataraman, G. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3-/dim CD4+ population by flow cytometry. Modern Pathology 29(10):1173-1182, 2016. e-Pub 2016. PMID: 27312067.
4. Han, X, Medeiros, LJ, Zhang, YH, You, MJ, Andreeff, M, Konopleva, M, Bueso-Ramos, CE. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome. Clinical Lymphoma, Myeloma and Leukemia 16:S30-S38, 2016. e-Pub 2016. PMID: 27155969.
5. Gallardo M, Hornbaker MJ, Zhang X, Hu P, Bueso-Ramos C, Post SM. Aberrant hnRNP K expression: All roads lead to cancer. Cell Cycle 15(12):1552-7, 2016. e-Pub 2016. PMID: 27049467.
6. Vega F, Medeiros LJ, Bueso-Ramos CE, Arboleda P, Miranda RN. Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1. Am J Clin Pathol 144(3):377-92, 2015. e-Pub 2015. PMID: 26276769.
7. Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA. Therapy-Related Myeloid Neoplasms. Am J Clin Pathol 144(2):207-218, 2015. e-Pub 2015. PMID: 26185306.
8. Kanagal Shamanna, R, Bueso-Ramos, CE, Chen, SS, Abruzzo, L, De Lima, M, Sargent, RL, Medeiros, LJ, Lu, G. Donor-derived isolated del(20q) after hematopoietic stem cell transplantation. Journal of Hematopathology 6(1):25-32, 2013. e-Pub 2013.
9. Gustafson S, Medeiros LJ, Kalhor N, Bueso-Ramos CE. Anaplastic large cell lymphoma: another entity in the differential diagnosis of small round blue cell tumors. Ann Diagn Pathol 13(6):413-27, 2009. e-Pub 2009. PMID: 19917480.
10. Inamdar KV, Bueso-Ramos CE. Pathology of chronic lymphocytic leukemia: an update. Ann Diagn Pathol 11(5):363-89, 2007. e-Pub 2007. PMID: 17870025.
11. Garcia M, Konoplev S, Morosan C, Abruzzo LV, Bueso-Ramos CE, Medeiros LJ. MALT lymphoma involving the kidney: a report of 10 cases and review of the literature. Am J Clin Pathol 128(3):464-73, 2007. e-Pub 2007. PMID: 17709321.
12. Cotta CV, Bueso-Ramos CE. New insights into the pathobiology and treatment of chronic myelogenous leukemia. Ann Diagn Pathol 11(1):68-78, 2007. e-Pub 2007. PMID: 17240312.
13. Anderson CM, Bueso-Ramos CE, Wallner SA, Albitar M, Rosenzweig TE, Koller CA. Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature. Leuk Lymphoma 32(3-4):385-90, 1999. e-Pub 1999. PMID: 10037039.
14. Przepiorka D, Giralt S, Khouri I, Champlin R, Bueso-Ramos C. Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases. Am J Hematol 57(1):24-8, 1998. e-Pub 1998. PMID: 9423812.
15. Osborne BM, Bueso-Ramos C. Histologic grading of nodular sclerosing Hodgkin's disease: is it an independent prognostic factor?. Cancer Treat Res 85:29-40, 1996. e-Pub 1996. PMID: 9043773.
16. Bueso-Ramos CE, Manshouri T, Haidar MA, Huh YO, Keating MJ, Albitar M. Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis. Leuk Lymphoma 17(1-2):13-8, 1995. e-Pub 1995. PMID: 7773150.
17. Bueso-Ramos CE, Pugh WC, Butler JJ. Anaplastic large cell lymphoma presenting as a soft-tissue mass mimicking sarcoma. Mod Pathol 7(4):497-500, 1994. e-Pub 1994. PMID: 8066079.

Professional Educational Materials

1. Bueso-Ramos CE, Huh YO. Hairy Cell Leukemia Variant, 1997.
2. K* A, Bueso-Ramos CE, Huh Y. Adult T-cell leukemia associated with HIV-1 infection, 1995.
3. Bueso-Ramos CE, Sewell C. Mullerian adenosarcoma of the uterus, 1990.
4. Bueso-Ramos CE, Check I, Chan WC. Clinical and immunophenotypic characteristics of patients with large granular lymphocyte (LGL) proliferations, 1989.

Other Articles

1. Uryu, H, Saeki, K, Haeno, H, Kapadia, C, Furudate, D.M.D., Ph.D., K, Nangalia, J, Spencer Chapman, M, Zhang, L, Padilla, J, Zhao, L, Hsu, JI, Zhao, C, Chen, S, Tanaka, T, Li, Z, Ogata, S, Hanache, S, Yang, H, DiNardo, C, Daver, N, Pemmaraju, N, Jain, N, Ravandi-Kashani, F, Zhang, J, Song, X, Thompson, EJ, Tang, H, Little, L, Gumbs, C, Orlowski, R, Qazilbash, MH, Bhalla, K, Colla, S, Kantarjian, HM, Kanagal Shamanna, R, Bueso-Ramos, CE, Nakada, D, Al-Atrash, G, Molldrem, JJ, Futreal, A, Shpall, E, Goodell, MA, Garcia-Manero, G, Takahashi, K Author Correction. Nature Genetics 57(9):2339, 2025. PMID: 40789920.
2. Saul EE, Urrutia S, Yang H, Montalban-Bravo G, Tang G, Toruner G, Patel K, Luthra R, Wang SA, Chien K, Sasaki K, Atluri H, Goulart H, Thakral B, Garcia-Manero G, Kanagal-Shamanna R, Bueso-Ramos CE A case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia (AML) detected by Optical Genome Mapping (OGM). JNCCN 23(6):5, 2025.
3. Han, X, Bueso-Ramos, CE Erratum to "Advances in the Pathological Diagnosis and Biology of Acute Lymphoblastic Leukemia" [Ann Diagn Pathol 2005;9:239-57] (DOI:10.1016/j.anndiagpath.2005.07.001). Annals of Diagnostic Pathology 11(1):79, 2007.

Abstracts

1. Hein K, Routbort M, Luthra R, Roy-Chowdhuri S, Bueso-Ramos C, Yang R, Quesada A, Thakral B, Patel K, Medeiros LJ, Kanagal-Shamanna R. Landscape of Germline Mutations in Solid Tumor Patients with Antecedent or Subsequent Myeloid Neoplasms. Laboratory Investigation - 2023 Annual Meeting of USCAP 103(3 / Supplement S), 2023. e-Pub 2023.
2. Nguyen H, Sasaki K, Ravandi F, Luthra R, Patel KP, Loghavi S, Jelloul FZ, Routbort M, Kalia A, Montalban-Bravo G, chien KS, Hu P, Yilmaz M, Bueos-Ramos CE, Medeiros LJ, Garcia-Manero G, Kanagal-Shamanna R. Homologous Recombination DNA Repair Deficiency Score Is Independent Prognostic Variable in Myelodysplastic Syndrome/ Acute Myeloid Leukemia with Complex Karyotype. Blood - 2022 Annual Meeting of ASH 140(Supplement: 1):1353-1354, 2022. e-Pub 2022.
3. Urrutia S, Sasaki K, Kanagal-Shamanna R, Bataller A, Montalban-Bravo G, Ganan-Gomez I, Wei Y, Yang H, Chien KS, Hammond D, Bueso-Ramos CE, Pierce SA, Kantarjian H, Garcia-Manero G. Impact of Spliceosome Mutations on the Prognosis of Myelodysplastic Syndrome (MDS). Blood - 2022 Annual Meeting of ASH 140(Supplement: 1):6952-6954, 2022. e-Pub 2022.
4. Nwogbo O, Hu SM, Hao SY, Li SY, Xu J, Yin CC, Bueso-Ramos C, Tang GL, Medeiros LJ, Lin P. Prognostic Impact of 8q24/MYC Rearrangement in Myeloma in the Era of Novel Therapy. Laboratory Investigation-2022 Annual USCAP 102(Supplement 1):997-997, 2022. e-Pub 2022.
5. Qiu LQ, Garcia-Manero G, Montalban-Bravo G, Yang H, Tang ZY, Patel K, Loghavi S, Ok CY, Bueso-Ramos C, Medeiros LJ, Kanagal-Shamanna R. Somatic U2AF1 Mutations Involving Codons Q157 and S34 are Associated with Distinct Clinical and Molecular Characteristics but Similar Outcomes in Patients with Myelodysplastic Syndrome. Laboratory Investigation-2022 Annual USCAP 102(Supplement 1):1004-1005, 2022. e-Pub 2022.
6. Cantu M, Kanagal-Shamanna R, Bueso-Ramos C, Patel S, Geyer J, Tam W, Li P, George T, Nichols M, Rogers H, Liu YC, Aggarwal N, Kurzer J, Maracaja D, Hsi E, Zaiem F, Babu D, Fourcar K, Laczko D, Bagg A, Orazi A, Arber D, Hasserjian R, Weinberg O. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-related and De Novo Acute Myeloid Leukemia: A Multi-institutional Study by the Bone Marrow Pathology Group. Modern Pathology - USCAP 2022 102(Supplement 1):925-927, 2022. e-Pub 2022.
7. Evans M, Khoury J, DiNardo C, Garcia-Manero G, Yang H, Loghavi S, Montalban-Bravo G, Patel K, Quesada A, Konoplev S, Garces S, Toruner G, Bueso-Ramos C, Medeiros LJ, Kanagal-Shamanna R. Bone Marrow Pathologic Abnormalities in Myelodysplastic Syndrome (MDS) Patients with Underlying TERT/TERC Germline Alterations. Laboratory Investigation-2022 Annual USCAP 102(Supplement 1):945-946, 2022. e-Pub 2022.
8. Adema V, Kanagal R, Ma F, Yang H, Ganan-Gomez I, Santoni A, Thongon N, Montalban-Bravo G, Pellegrini M, Bueso-Ramos C, Maciejewski J, Visconte V, Carew J, Garcia-Manero G, Colla S. Single-Cell-Level Analysis of SF3B1-Mutant Myelodysplastic Syndrome with Ringed Sideroblasts. Leukemia Research 108(Supplement 2):S3-S4, 2021. e-Pub 2021.
9. Kanagal-Shamanna R, Evans A, Bueso-Ramos C, Garcia-Manero G, Medeiros LJ, Iqbal MA. Comprehensive Genomic Assessment using both NGS and CGH-SNP Analysis is Essential to Identify Clonal Abnormalities in Idiopathic Cytopenia(s) of Undetermined Significance. Laboratory Investigation-2021 Annual USCAP 101(Supplement 1):857-857, 2021. e-Pub 2021.
10. Wang XQ, Tang GL, Hu ZH, Wang W, Toruner G, Tang ZY, Bueso-Ramos C, Medeiros LJ, Hu SM. Acute Myeloid Leukemia and Myelodysplastic Syndrome with MYC Rearrangement. Laboratory Investigation-2021 Annual USCAP 101(Supplement 1):9-3-904, 2021. e-Pub 2021.
11. de Cap MR, Wu L, Pihan G, Patel S, Tam W, Bueso-Ramos C, Kanagal-Shamanna R, Raess P, Siddon A, Narayanan D, Morgan E, Pinkus G, Mason E, Hsi E, Rogers H, Toth L, Foucar K, Hurwitz S, Bagg A, Rets A, George T, Orazi A, Arber D, Hasserjian R, Weinberg O. Clinical and Genomic Findings of Myeloid Sarcoma with an Emphasis on NPM1 Mutations: A study from the Bone Marrow Pathology Group. Laboratory Investigation-2021 Annual USCAP 101(Supplement 1):884-885, 2021. e-Pub 2021.
12. Khanlari M, Lin P, Xu J, You MJ, Tang GL, Yin CC, Qiu LQ, Bueso-Ramos C, Medeiros LJ, Li SY. Blastoid B-cell Lymphoma Initially Presenting in Bone Marrow: A Diagnostic Challenge. Laboratory Investigation-2021 Annual USCAP 101(Supplement 1):865-866, 2021. e-Pub 2021.
13. Al-Ghamdi Y, Lake J, Bagg A, Thakral B, Wang S, Bueso-Ramos C, Rogers H, Hsi E, Gralewski J, Fourcar K, % G, Rets A, Hasserjian R, Weinbert O, Arbewr D, Padilla O, Orazi A, Tam W. Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group (BMPG) Study. Laboratory Investigation-2021 Annual USCAP 101(Supplement 1):799-800, 2021. e-Pub 2021.
14. Bravo GM, Kanagal-Shamanna R, Guerra V, Perez JMR, Hammond D, Paul S, Naqvi K, Sasaki K, Jabbour E, DiNardo CD, Takahashi K, Konopleva M, Pemmaraju N, Kadia TM, Ravandi F, Daver N, Borthakur G, Estrov ZE, Khoury JD, Loghavi S, Pierce SA, Bueso-Ramos CE Patel K, Kantarjian HM, Garcia-Manero G. Clinical Outcomes and Influence of Mutation Clonal Dominance in Oligomonocytic and Classical Chronic Myelomonocytic Leukemia. 62nd ASH Annual Meeting & Exposition, Dec. 2020 136(Supplement 1), 2020. e-Pub 2020.
15. Kanagal-Shamanna R, Bravo GM, Sasaki K, Bueso-Ramos CE, Jabbour E, Wei Y, Darbaniyan F, Routbort M, Pierce SA, Soltysiak KA, Patel K, Medeiros LJ, Kantarjian HM, Garcia-Manero G. Only Hotspot SF3B1 K700E Mutation Is an Independent Predictor of Overall Survival in Myelodysplastic Syndromes. 62nd ASH Annual Meeting & Exposition, Dec. 2020, 2020. e-Pub 2020.
16. Kanagal-Shamanna R, Adema V, Ma F, Santoni A, Yang H, Ganan-Gomez I, Thongon N, Montalban-Bravo G, Pellegrini M, Bueso-Ramos CE, Garcia-Manero G, Colla S. SF3B1-Mutant Myelodysplastic Syndrome with Ringed Sideroblasts (MDS-RS) at the Single-Cell Level. 62nd ASH Annual Meeting & Exposition, Dec. 2020 136(Supplement 1), 2020. e-Pub 2020.
17. Bravo GM, Kanagal-Shamanna R, Sasaki K, Masarova L, Naqvi K, Jabbour E, DiNardo CD, Takahashi K, Konopleva M, Pemmaraju N, Short NJ, Issa GC, Kadia TM, Ravandi F, Daver N, Borthakur G, Estrov ZE, Khoury JD, Loghavi S, Pierce SA, Bueso-Ramos CE, Patel K, Verstovsek S, Kantarjian HM, Bose P, Garcia-Manero G. Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia. 62nd ASH Annual Meeting & Exposition, Dec. 2020, 2020. e-Pub 2020.
18. Bravo GM, Darbaniyan F, Kanagal-Shamanna R, Ganan-Gomez I, Sasaki K, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien KS, Bueso-Ramos CE, Kantarjian HM, Garcia-Manero G. Transcriptomic Features and Deregulation of Genes Involved in Monopoiesis Influence Outcomes of Patients with Chronic Myelomonocytic Leukemia. 62nd ASH Annual Meeting & Exposition, Dec. 2020 136(Supplement 1), 2020. e-Pub 2020.
19. Bravo GM, Kanagal-Shamanna R, Darbaniyan F, Ganan-Gomez I, Sasaki K, Naqvi K, Wei Y, Yang H, Soltysiak KA, Chien KS, Bueso-Ramos CE, Kantarjian HM, Garcia-Manero G. Genomic and Transcriptomic Differences of Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) and Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS). 62nd ASH Annual Meeting & Exposition, Dec. 2020 136(Supplement 1), 2020. e-Pub 2020.
20. Khanlari M, Loghavi S, Popat U, Bueso-Ramos C, Medeiros LJ, Konoplev S. Delayed Resolution of Bone Marrow Morphological Changes of Myelofibrosis Following Successful Stem Cell Transplant and Molecular Clearance of Disease: A Cautionary Tale. Cliinical Lymphoma Myeloma & Leukemia 20(Supplement 1):S340-S341, 2020. e-Pub 2020.
21. Tashakori M, Khoury JD, Routbort MJ, Patel KP, Wang SA, Ok CY, Kanagal-Shamanna R, Luthra R, Hu SM, Lin P, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Exploring the Molecular Grey Zone of Myeloid Neoplasms: Concurrent SRSF2 and Classic MPN Driver Mutations. Clinical Lymphoma Myeloma & Leukemia 20(Supplement 1):S340-S340, 2020. e-Pub 2020.
22. Xie W, Tang GL, Wang ED, Kim Y, Shen Q, Zhou Y, Loghavi S, Wang S, Bueso-Ramos C, Medeiros LJ, Hu SM. t(11;16)(q23;p13) and t(2;11)(p21;q23) in Hematologic Neoplasms: Presumptive Evidence of Myelodysplasia Revisited. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1410-1410, 2020. e-Pub 2020.
23. Tashakori M, Khoury J, Routbort M, Patel K, Wang S, Ok CY, Kanagal-Shamanna R, Luthra R, Hu SM, Khanlari M, El Hussein S, Lin P, Bueso-Ramos C, Medeiros LJ, Loghavi S. Exploring the Molecular Grey Zone of Myeloid Neoplasms: Concurrent SRSF2 and Classic MPN Driver Mutations. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1395-1396, 2020. e-Pub 2020.
24. Sukswai N, Khoury J, Patel K, Routbort M, Luthra R, Bueso-Ramos C, Loghavi S, Medeiros LJ, Kanagal-Shamanna R. Characterization of Bone Marrow Morphologic and Genetic Features of Myeloid Neoplasms with Germline DDX41 Mutation in 10 Distinct Pedigrees. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1394-1394, 2020. e-Pub 2020.
25. Ok C, Trowell K, Parker K, Moser K, Weinberg O, Rogers H, Reichard K, George T, Hsi E, Bueso-Ramos C, Tam W, Orazi A, Bagg A, Arber D, Hasserjian R Wang S. Pathologic Spectrum of Chronic Myeloid Neoplasms Harboring Concomitant Mutations in Myeloproliferative Neoplasm Driver Genes and SF3B1. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1359-1360, 2020. e-Pub 2020.
26. Khanlari M, Loghavi S, Wang S, El Hussein S, Tashakori M, Bueso-Ramos C, Yin CC, Kanagal-Shamanna R, Khoury J, Medeiros LJ, Patel K, Popat U, Konoplev S. Importance of Bone Marrow Morphologic Features for Surveillance of Patients with Myelofibrosis Following Molecular Clearance after Stem Cell Transplant. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1322-1322, 2020. e-Pub 2020.
27. Kanagal-Shamanna R, Orazi A, Hasserjian R, Arber D, Reichard K, Hsi E, Bagg A, Rogers H, Geyer J, Devins K, Pozdnyakova O, George T, Dal Cin P, Wang S, Bueso-Ramos C. Myeloid Neoplasms with Isolated Isochromosome 17q Represent a Distinct Subset within Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with a Significantly Worse Outcome: A Multi-Institutional Collaborative Study from the Bone Marrow Pathology Group. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1317-1318, 2020. e-Pub 2020.
28. Fang H, Beird H, Hu SM, Bueso-Ramos C, Tang GL, Tang ZY, You MJ, Khoury J, Medeiros LJ, Wang W. T(6;14)(q25;q32) Involves BCL11B and is Highly Associated with Mixed Phenotype Acute Leukemia, T/Myeloid. Laboratory Investigation-109th Annual USCAP 100(Supplement 1):1280-1281, 2020. e-Pub 2020.
29. :purebrahimabadi R, Alaniz Z, Osterann LB, Luong HA Montoya RH, Ruvolo PP, Kornblau SM, Khoury JD, Bueso-Ramos CE, Andreeff M. p53 Mediated Bone Marrow Mesenchymal Stem Cell Expansion Supports Acute Myeloid Leukemia Development. BLOOD-61st Annual Meeting of the American-Society-of-Hematology (ASH) 134(Supplement 1), 2019. e-Pub 2019.
30. Wei Y, Zheng H, Bao N, Kanagal-Shamanna R, Class C, Yang H, Bravo GM, Ganan-Gomez I, Soltysiak K, Do KA, Colla S, Bueso-Ramos CE, Garcia-Manero G. KDM6B Overexpression and TET2 Deficiency Cooperatively Drive Development of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia-like Phenotype in Mice. BLOOD-61st Annual Meeting of the American-Society-of-Hematology (ASH) 134(Supplement 1), 2019. e-Pub 2019.
31. Montalban-Bravo G, Kanagal-Shamanna R, Sasakii K, Ravandi F, Cortes JE, Daver NG, Takahashi K, DiNardo CD, Jabbour E, Borthakur GM, aqvi K, Konopleva MY, Pierce SA, Bueso-Ramos CE, Patel KP, Kantarjian HM, Garcia-Manero G, Kadia TM. Outcomes of Patients with Acute Myeloid Leukemia with Myelodysplastic Are Dependent on Diagnostic Criteria and Therapy. BLOOD-61st Annual Meeting of the American-Society-of-Hematology (ASH) 134(Supplement 1), 2019. e-Pub 2019.
32. Pemmaraju N, Carter BZ, Kantarjian HM, Cortes JE, Bose P, Kadia TM, Garcia-Manero G, Bueso-Ramos CE, DiNardo CD, Bledsoe S, Daver NG, Popat U, Konopleva MY, Ohanian M, Pierce SA, Zhou LS, Estrov Z, Borthakur GM, Mak PY, Jain N, Jabbour E, Verstovsek S. Final Results of Phase 2 Clinical Trial of LCL161, a Novel Oral SMAC Mimetic/IAP Antagonist, for Patients with Intermediate to High Risk Myelofibrosis. BLOOD-61st Annual Meeting of the American-Society-of-Hematology (ASH) 134(Supplement 1), 2019. e-Pub 2019.
33. Morita K, Wang F, Jahn K, Kuipers J, Yan YZ, Matthews J, Little L, Gumbs C, Chen SJ Zhang JH, Song XZ, Thompson E, Patel K, Bueso-Ramos C, DiNardo C, Ravandi F, Jabbour E, Andreeff M, Cortes J, Konopleva M, Bhalla K, Garcia-Manero G, Kantarjian H, Beerenwinkel N, Navin N, Futreal PA, Takahashi K. Deconvolution of Clonal Heterogeneity in Acute Myeloid Leukemia using Single-Cell DNA Sequencing. Clinical Lymphoma Myeloma & Leukemia 129(Supplement 1):S234-S234, 2019. e-Pub 2019.
34. Moriat K, Wang F, Jahn K, Yan YZ, Durruthy-Durruthy R, Parikh A, Matthews J, Little L, Gumbs C, Zhang JH, Song XZ, Thompson E, Patel K, Bueso-Ramos C, DiNardo C, Ravandi F, Jabbour E, Andreeff M, Cortes J, Konopleva M, Garcia-Manero G, Kantarjian H, Eastburn DJ, Futreal PA, Beerenwinkel N, Takahashi K. The single-cell atlas of driver mutations in acute myeloid leukemia. Cancer Research-AACR 2019 79(13), 2019. e-Pub 2019.
35. Gallardo M, Malaney P, Aitken MJL, Zhang X, Link TM, Shah V, Alybayev S, Wu MH, Pageon LR, Ma H, Jacamo R, Yu L, Xu-Monette ZY, Steinman H, Lee HJ, Sarbassov D, Rapado I, Barton MC, Martinez-Lopez J, Bueso-Ramos C, Young KH, Post SM. Uncovering the role of hnRNP K, an RNA-binding protein, in B-cell lymphomas. J Natl Cancer Inst. e-Pub 2019. PMID: 31077320.
36. Luedke C, Hu SM, Zhao Y, Pan ZG, Song JM, Bueso-Ramos C, Medeiros LJ, Wang E. Two Distinct Pathways for the Development of Plasmablastic Lymphoma in the Setting of Chronic Lymphocytic Leukemia: Richter Transformation-Like Clonal Evolution and Epstein-Barr Virus Associated De Novo B-Cell Neoplasm. Laboratory Investigation-108th Annual USCAP 99(Supplement 1), 2019. e-Pub 2019.
37. Shou T, Tang GI, Loghavi S, Kurt H, Bueso-Ramos C, Medeiros LJ, Hu SM. Significance of idic(X)(q13) in Myeloid Neoplasms. Laboratory Investigation-108th Annual USCAP 99(Supplement 1), 2019. e-Pub 2019.
38. Sakhdari A, Tang ZY, Bueso-Ramos C, Tang GI, Medeiros LJ, Huh Y. Homogeneously Staining Region (hsr) on Chromosome 11 Is Highly Specific for KMT2A Amplification in Acute Myeloid Leukemia (AML) and Myelodysplastic syndromes (MDS). Laboratory Investigation-108th Annual USCAP 99(Supplement 1), 2019. e-Pub 2019.
39. Rogers H, Geyer J, Thakral B, Wang S, Wool G, Li KD, Davis A, Bueso-Ramos C, Arber D, George T, Bagg A, Hasserfian R, Orazi A, Hsi E. Molecular profile is useful to predict clinical outcome in myeloproliferative neoplasm, unclassifiable: Bone marrow pathology group study. Laboratory Investigation-108th Annual USCAP 99(Supplement 1), 2019. e-Pub 2019.
40. Morita K, Wang F, Yan YQ, Burks J, Gumbs C, Latasha L, Tippen S, Thornton R, Coyle M, Zhang JH, Song XZ, DiNardo C, Jabbour E, Andreeff M, ortes J, Konopleva M, Patel K, Garcia-Manero G, Kantarjian H, Bueso-Ramos C, Futreal PA Takahashi K. The landscape of genotype-phenotype correlation in AML. Clinical Lymphoma Myeloma & Leukemia 18(Supplement 1):S209-S210, 2018. e-Pub 2018.
41. Myers K, Furutani E, Siegele B, Fleming M, Eighetany MT, Arsenault V, Alter B, Boulad F, Bueso-Ramos C, Burroughs L, Castillo P, Connelly J, Davies S, Desierto M, DiNardo C, Hanif I, Ho R, Karras N, Keel S, Manalang M, McReynolds L, Nakano T, Nalepa G, Norkin M, Oberley M, Orgel E, Pastore Y, Rosenthal J, Walkovich K, Shimamura A. MDS and AML in Shwachman Diamond Syndrome: Clinical Features and Outcomes. Pediatric Blood & Cancer 65(Supplement 1), 2018. e-Pub 2018.
42. Angelova E, Luthra R, Patel K, Quesada AE, Khoury J, Zuo Z, Yin CC, Medeiros LJ, Bueso-Ramos C, Kanagal-Shamanna R. Lack of typical clinicomorphologic features associated with Acute Myeloid Leukemia with variant (Non-Type A) CBFB-MYH11 fusion transcript presents diagnostic challenges. Modern Pathology/USCAP 31(Supplement 2):496-496, 2018. e-Pub 2018.
43. Ruiz-Cordero R, Hidalgo-Lopez JE, Bueso-Ramos C, Routbort M, Kanagal-Shamanna R, Zuo Z, Yin CC, Loghavi S, Ok CY, Jorgensen J, Wang S, Tang GL, Luthra R, Medeiros LJ, Patel K. Distinct genetic features of myelodysplastic syndromes as defined in the revised 2016 World Health Organization classification. Modern Pathology/USCAP 31(Supplement 2):549-549, 2018. e-Pub 2018.
44. Rahman H, Khoury J, Bueso-Ramos C, McDonnell T, Salem A, Wang S, Muzzafar T, Tetzlaff M, Bell D, Khogeer H, Angelova E, Li SY, Tang GL, Hu SM, Patel K, Routbort M, Luthra R, Lin P, Medeiros LJ, Loghavi S. Aberrant cytokeratin expression in acute myeloid leukemia is associated with complex karyotype and TP53 alterations. Modern Pathology/USCAP 31(Supplement 2):546-546, 2018. e-Pub 2018.
45. Quesada AE, Routbort M, Luthra R, Patel K, Hidalgo-Lopez JE, Bueso-Ramos C, Medeiros LJ, Kanagal-Shamanna R. RUNX1 mutations in myelodysplastic syndrome. Modern Pathology/USCAP 31(Supplement 2):545-546, 2018. e-Pub 2018.
46. Quesada AE, Dinardo C, Routbort M, Bueso-Ramos C, Kanagal-Shamanna R, Zuo Z Yin CC, Loghavi S, Ok CY, Wang S, Benton C, Kantarjian HM, Luthra R, Medeiros LJ, Patel K. DDX41 mutations in myeloid neoplasms are associated with male predominance, TP53 mutation and a high risk of progression to AML. Modern Pathology/USCAP 31(Supplement 2):545-545, 2018. e-Pub 2018.
47. Liu JL, Medeiros LJ, Huang WT, McDonnell T, Miranda R, Bueso-Ramos C, Schlette E, Lin P, Li SY. MYC-rearrangement and MYC/BCL2 double expression but not Cell-of-Origin predict prognosis in de novo Diffuse Large B-Cell lymphoma treated with R-CHOP. Modern Pathology/USCAP 31(Supplement 2):534-534, 2018. e-Pub 2018.
48. Kanagal-Shamanna R, Hidalgo-Lopez JE, Patel K, Luthra R, Routbort M, Quesada AE, Zhao C, Lee J, Medeiros LJ, Bueso-Ramos C. Myelodysplastic syndrome with RSF2/U2AF1 mutations shows ring siderblastic phenotype similar to SF3B1 mutation but has adverse clinicopathologic features. Modern Pathology/USCAP 31(Supplement 2):526-527, 2018. e-Pub 2018.
49. Hidalgo-Lopez JE, Quesada AE, Gong ZM, Wang W, Kanagal-Shamanna R, Hu SM, Yin CC, Cortes J, Bassett RL, Medeiros LJ, Kantarjian HM, Bueso-Ramos C. Indications for bone marrow biopsy at time of first assessment in patients with chronic myeloid leukemia in the the era of tyrosine kinase inhibitor therapy. Modern Pathology/USCAP 31(Supplement 2):521-521, 2018. e-Pub 2018.
50. Thakral B, Muzzafar T, Badar I, Wang S, Mirnda R, Lin P, Khoury J, Routbort M, Kanagal-Shamanna R, Loghavi S, Ok CY, Yin CC, Zuo Z, Verstovsek S, Benton C, Luthra R, Bueso-Ramos C, Medeiros LJ, Patel K. Clinicopathologic and molecular characteristics of myeloid neoplasms with non-canonical MPL mutations. Modern Pathology/USCAP 31(Supplement 2):559-560, 2018. e-Pub 2018.
51. Takahashi, Wang K, Morita F, al KE. Genomic landscape of adult mixed phenotype acute leukemia (MPAL). Clinical Cancer Research-2nd AACR Conference on Hematologic Malignancies-Translating Discoveries to Novel Therapies 23(24):43-43 Supplement, 2017. e-Pub 2017.
52. Takahashi, Wang K, Patel F, al KE. Genetic aberrations in adult acute lymphoblastic leukemia and their impact on clinical outcome. Haematologica-22nd Congress of the European-Hematology Association 102(Supplement 2):342-342, 2017. e-Pub 2017.
53. Manshouri, Estrov T, Pilling Z, al DE. Engraftment of primary myelofibrosis bone marrow-derived CD14+monocytes in NOD-SCID-g mice. Haematologica-22nd Congress of the European-Hematology Association 102(Supplement 2):275-276, 2017. e-Pub 2017.
54. Morita, Wang K, Patel F, al KE. Montalban-Bravo, G.; Alfonso, A.; Patel, K.; et al. Haematologica-22nd Congress of the European-Hematology Association 102(Supplement 2):211-211, 2017. e-Pub 2017.
55. Montalban-Bravo, Alfonso G, Patel A, al KE. Impact of the mutational profile at the time of diagnosis in response outcomes in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia treated with hypomethylating agents. Haematologica/21st Congress of the European Hematology Association 102(Supplement 2):184-184, 2017. e-Pub 2017.
56. Garcia-Manero, Daver G, Montalban-Bravo N, al GE. An update of a phase II study of nivolumab (NIVO) or ipilimumab (IPI) with azacitidine in pts with previously treated or untreated myelodysplastic syndromes (MDS). Haematologica/21st Congress of the European Hematology Association 102(Supplement 2):183-183, 2017. e-Pub 2017.
57. Bose, Nazha P, Komrokji A, al RE. Mutational landscape of myelodysplastic syndrome/myeloproliferative neoplasm - unclassifiable. Haematologica/21st Congress of the European Hematology Association 102(Supplement 2):118-118, 2017. e-Pub 2017.
58. Montalban-Bravo, Bose G, Alvarado P, al YE. Updated results from phase 2 study of guadecitabine for patients with untreated int-2/high risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Haematologica-22nd Congress of the European-Hematology Association 102(Supplement 2):99-99, 2017. e-Pub 2017.
59. Montalban-Bravo, Benton G, Kadia C, al TE. Number of TP53 abnormalities and their clinical relevance in patients with acute myeloid leukemia and myelodysplastic syndromes. Haematologica-22nd Congress of the European-Hematology Association 102(Supplement 2):48-48, 2017. e-Pub 2017.
60. Takahashi, Wang K, Patel F, al KE. Prognostic impact of somatic mutation clearance in patients with acute myeloid leukemia. Haematologica- 22nd Congress of the European-Hematology Association 102(Supplement 2):43-44, 2017. e-Pub 2017.
61. Takahashi, Wang K, Patel F, al KE. Distinct patterns of somatic mutation clearance and association with clinical outcome in patients with AML. Journal of Clinical Oncology-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 35(Supplement 15), 2017. e-Pub 2017.
62. Pierola, Montalban-Bravo AA, Takahashi G, al KE. Impact of the type of first cancer therapy in therapy related myelodysplastic syndromes outcomes. Journal of Clinical Oncology-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 35(Supplement 15), 2017. e-Pub 2017.
63. Morita, Wang K, Patel F, al KE. Genomic landscape of adult mixed phenotype acute leukemia (MPAL). Journal of Clinical Oncology-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 35(Supplement 15), 2017. e-Pub 2017.
64. Montalban-Bravo, Pierola G, Takahashi AA, al KE. Clinical relevance of mutations in patients with myelodysplastic syndromes and myelodysplastic/myeloprolife neoplasms with normal karyotype. Journal of Clinical Oncology-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 35(Supplement 15), 2017. e-Pub 2017.
65. Takahashi, Wang K, Patel F, al KE. Persistence of preleukemic clonal hematopoiesis after chemotherapy is associated with poor prognosis in patients with high risk MDS and AML. Leukemia Research-14th International Symposium on Myelodysplastic Syndromes (MDS) 55(Supplement 1):S17-S18, 2017. e-Pub 2017.
66. Pierola, A Alfonso; Guillermo A, M B; Takahashi M, al KE. Impact of the type of first-cancer therapy in therapy-related myelodysplastic syndromes outcomes. Leukemia Research-14th International Symposium on Myelodysplastic Syndromes (MDS) 55(Supplement 1):S165-S166, 2017. e-Pub 2017.
67. Montalban-Bravo, Pierola G, A Alfonso; Takahashi A, al KE. Prognostic impact of mutations in patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms with normal karyotype. Leukemia Research-14th International Symposium on Myelodysplastic Syndromes (MDS) 55(Supplement 1):S40-S40, 2017. e-Pub 2017.
68. Kurt, Bueso-Ramos H, Khoury CE, al JE. Characterization of IDH1 p.R132H Mutant Clones Using Mutation Specific Antibody in Myeloid Neoplasms. LABORATORY INVESTIGATION/106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 97(Supplement 1):358A-358A, 2017. e-Pub 2017.
69. Garces, Medeiros S, L Jeffrey; Salem L, al AE. Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma with Prominent Proliferation Centers in Bone Marrow Is Associated with High Tumor Burden and TP53 Deletion. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 97(Supplement 1):349A-350A, 2017. e-Pub 2017.
70. Hidalgo, Shamanna J, Mohammad RK, et al MM. Morphologic and Molecular Characteristics of De Novo AML with JAK2V617F Mutation. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):353A-353A, 2017. e-Pub 2017.
71. Lopez, Hidalgo; Wang JE, Medeiros S, L Jeffrey; et al L. Clinical Significance of Cytogenetic Abnormalities in Polycythemia Vera. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):353A-353A, 2017. e-Pub 2017.
72. Kanagal-Shamanna, Loghavi R, Medeiros S, L Jeffrey; et al L. Familial Platelet Disorder with Propensity to Myeloid Malignancy (FPDMM) Associated with Germline RUNX1 Mutation Shows Characteristic Morphologic Features. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):356A-356A, 2017. e-Pub 2017.
73. Kurt, Bueso-Ramos H, Khoury CE, al JE. Characterization of IDH1 p.R132H Mutant Clones Using Mutation Specific Antibody in Myeloid Neoplasms. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):358A-358A, 2017. e-Pub 2017.
74. Loghavi, Zuo S, Gur Z, al DE. Differential Proteomic Signatures in Chronic Myelomonocytic Leukemia Subsets Identified by Reverse Phase Protein Array Analysis. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):361A-361A, 2017. e-Pub 2017.
75. Lopez-Hidalgo, Carballo-Zarate JE, Medeiros AA, L J; et al L. Blast Phase of Polycythemia Vera. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):361A-361A, 2017. e-Pub 2017.
76. Quesada, Huang AE, P; Luthra RS, al RE. Genetic Landscape of Non-R882 DNMT3A Mutations Is Distinct from DNMT3A R882 Mutations. MODERN PATHOLOGY-106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 30(Supplement 2):371A-371A, 2017. e-Pub 2017.
77. Garces, Medeiros S, L Jeffrey; Salem L, al AE. Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma with Prominent Proliferation Centers in Bone Marrow Is Associated with High Tumor Burden and TP53 Deletion. LABORATORY INVESTIGATION/106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 97(Supplement 1):353A-353A, 2017. e-Pub 2017.
78. Hidalgo, Shamanna J, Mohammad RK, et al MM. Morphologic and Molecular Characteristics of De Novo AML with JAK2V617F Mutation. LABORATORY INVESTIGATION/106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 97(Supplement 1):353A-353A, 2017. e-Pub 2017.
79. Lopez, Hidalgo; Wang JE, Medeiros S, L Jeffrey; et al L. Clinical Significance of Cytogenetic Abnormalities in Polycythemia Vera. LABORATORY INVESTIGATION/106th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) 97(Supplement 1):353A-353A, 2017. e-Pub 2017.
80. Daver N, Cortes J, Ravandi F, Basu S, Garcia-Manero G, Jabbour E, Pemmaraju N, Hendrickson S, Pierce S, Ning J, Gonzales G, Konopleva M, Andreeff M, Borthakur G, Bueso-Ramos C, Glando J, Allison J, Kantarjian H, Sharma P. Phase IB/II study of nivolumab in combination with 5-azacytidine (AZA) in patients (pts) with relapsed acute myeloid leukemia (AML). Haematologica/21st Congress of the European Hematology Association 101(Supplement 1):42-43, 2016. e-Pub 2016.
81. Takahashi K, Wang F, Kantarjian H, Denaha D, Khanna K, Thompson E, Patel K, Neelapu S, Gumbs C, Bueso-Ramos C, DiNardo C, Colla S, Ravandi F, Xingzhi S, Zhang J, Wu X, Samaniego F, Garcia-Manero G, Futreal A. Clonal origin of therapy-related myeloid neoplasms. Haematologica/21st Congress of the European Hematology Association 101(Supplement 1):159-159, 2016. e-Pub 2016.
82. Ohanian M, Rozovski U, Kantarjian HM, Loghavi S, Zuang Z, Abruzzo L, Huh YO, Garcia-Manero G, Ravandi F, Andreeff M, Kornblau S, Borthakur G, Nguyen M, Hu P, Medeiros J, Nogueras-Gonzalez GM, Huang X, Estrov Z, Bueso-Ramos CE, Cortes JE. MYC Protein Expression is Prognostic in Acute Myeloid Leukemia. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
83. Maiti A, Verstovsek S, Powers CA, Fullmer CP, Reyes SR, Bueso-Ramos CE, Short NJ. Quality and cost comparison of powered versus manual bone marrow biopsy devices at a large U.S. cancer center. 2016 ASCO Annual Meeting, 2016. e-Pub 2016.
84. Gallardo M, Hornbaker MJ, Lee HJ, Zhang X, Bueso-Ramos C, Pageon LR, McArthur M, Multani A, Manshouri T, Parker-Thornburg J, Hu P, Rapado I, Quintas-Cardama A, Kornblau SM, Martinez-Lopez J, Post SM. HNRNP K: An Oncogene and Tumor Suppressor, Two Discrete Paths to AML Through On Gene. Haematologica/21st Congress of the European Hematology Association 101(Supplement 1):11-12, 2016. e-Pub 2016.
85. Borthakur G, Tallman MS, Ofran Y, Foran J, Uy GL, DiPersio JF, Nagler A, Rowe JM, Showel MM, Altman JK, Peled A, Abraham M, Pereg Y, Vainstein A, Oberkovitz G, Aharon A, Bueso-Ramos C, Cortes JE, Andreeff M. Clinical Response in Relapsed/Refractory AML Patients Correlates with Leukemic Blast Mobilization and Differentiation induced by BL-8040, A Potent CXCR4 Antagonist: Results of a phase IIA Study. Haematologica/21st Congress of the European Hematology Association 101(Supplement 1):43-43, 2016. e-Pub 2016.
86. Rogers HJ, Hsi ED, Tang GL, Wang S, Bueso-Ramos CE, Lubin D, Morrissette JJD, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP. Most Myeloid Neoplasms with Deletion of Chromosome 16q Are Distinct from Acute Myeloid Leukemia with inv(16)(p13.1q22). Laboratory Investigation 96(Supplement 1):373A-373A, 2016. e-Pub 2016.
87. Yabe M, Medeiros LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, Routbort M, Young KH, Miranda R. Hepatosplenic T-cell Lymphoma Arising in Patients with Immunosuppression: A Clinicopathologic, Immunophenotypic and Cytogenetic Study of 7 Cases and a Review of 67 Cases in the Literature. Laboratory Investigation 96:386A, Supplement 1, 2016. e-Pub 2016.
88. Wang S, Tam W, Tsai A, Arber DA, Hasserjian RP, Geyer J, George TI, Czuchiewski D, Foucar K, Rogers HJ, Hsi ED, Rea B, Bagg A, Dal Cin P, Kelley TW, Verstovsek S, Bueso-Ramos CE, Orazi A. Targeted Next Generation Sequencing (NGS) of Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS) and of Idiopathic Hypereosinophilic Syndrome (HES). Laboratory Investigation/105th Annual Meeting of the USCAP 96(Supplement 1):382A-382A, 2016. e-Pub 2016.
89. Wang W, Cortes J, Tang GL, Khoury JD, Wang S, Bueso-Ramos CE, DiGuiseppe JA, Chen Z, Kantarjian H, Medeiros LJ, Hu S. Risk Stratification of Additional Chromosomal Changes in Chronic Myelogenous Leukemia in Era of Tyrosine Kinase Inhibitor Therapy. Laboratory Investigation 96(Supplement 1):382A-383A, 2016. e-Pub 2016.
90. Soderquist C, Ewalt MD, Czuchlewski D, Geyer J, Rogers HJ, Babushok D, Hexner E, Orazi A, Hsi ED, Wang S, Bueso-Ramos CE, Arber DA, Bagg A. Myeloproliferative Neoplasms with Concurrent BCR-ABL1 Translocation and JAK2 V617F Mutation. Mod Pathol 29:377A, Supplement 2, 2016. e-Pub 2016.
91. Quesada A, Luthra R, Patel KP, Singh RR, Routbort MJ, Loghavi S, Khoury JD, Medeiros LJ, Bueso-Ramos CE, Kanagal-Shamanna R. De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features. Laboratory Investigation 96:371A, Supplement 1, 2016. e-Pub 2016.
92. Loghavi S, Zuo Z, Doss DJ, Thompson EJ, Zhao C, Lee J, Kanagal-Shamanna R, Medeiors LJ, Bueso-Ramos CE. Bone Marrow and Extramedullary Lesions in Patients with Myeloproliferative Neoplasms Exhibit similar miRNA Profies. Mod Pathol 29:360A, 2016. e-Pub 2016.
93. Jain P, Patel KP, Futreal A, Gumbs C, Hu S, Ramos CB, Wang M, Romaguera J, Fayad LE, Orlowski RZ, Medeiros J, Fowler N. Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS). Blood 126(23):2700. e-Pub 2015.
94. Shah M, Pilecki V, Redis R, Fabris L, Ciccone M, Ivan C, Berindan-Neago I, Fodde R, Bueso-Ramos CE, Gagea M, Manero GG, Calin G. Long Non-Coding RNA Induces De Novo Myelodysplastic Syndrome through Epigenetic Regulation. Blood 126(23):1640. e-Pub 2015.
95. Borthakur G, Ofran Y, Nagler A, Rowe JM, Foran JM, Uy GL, DiPersio JF, Altman JK, Frankfurt O, Tallman MS, Peled A, Pereg Y, Vainstein A, Aharon A, AlRawi A, McQueen T, Pemmaraju N, Bueso-Ramos CE, Cortes JE, Andreeff M. The Peptidic CXCR4 Antagonist, BL-8040, Significantly Reduces Bone Marrow Immature Leukemia Progenitors By Inducing Differentiation, Apoptosis and Mobilization: Results of the Dose Escalation Clinical Trial in Acute Myeloid Leukemia. Blood 126(23):2546. e-Pub 2015.
96. Battula VL, Le PM, Sun J, Mu H, McQueen T, Shpall EJ, Konopleva M, Bueso-Ramos CE, Harrington M, Palisch CW, Andreeff M. Acute Myeloid Leukemia (AML) Cells Alter the Bone Marrow Microenvironment By Inducing Osteogenic and Suppressing Adipogenic Differentiation of MSCs through BMP-RUNX2-CTGF Mediated Mechanisms. Blood 126(23):2403. e-Pub 2015.
97. Takahashi K, Kantarjian HM, Patel K, Bueso-Ramos* CE, Kadia T, Jabbour E, DiNardo C, Daver N, Pierce S, Futreal A, Garcia-Manero G. TP53 Mutated MDS Patients Respond Equally to Hypomethylating Agents but Have Significantly Shorter Response Duration Compared to Patients with Wild Type TP53. Blood 126(23):1681. e-Pub 2015.
98. Gallardo M, Lee HJ, Zhang X, Bueso-Ramos CE, Pageon L, McArthur M, Multani A, Nazha A, Manshouri T, Parker-Thornburg J, Hu P, Qi Y, Su X, Rapado I, Quintás-Cardama A, Kornblau SM, Martinez-López J, Post SM. hnRNP K Is a Novel Haploinsufficient Tumor Suppressor at the 9q21.32 Locus That Defines a Subset of AML. Blood 126(23):439. e-Pub 2015.
99. Kongtim P, Popat UR, Jimenez AM, Gabella S, El Fakih RO, Rondon G, Chen J, Bueso-Ramos CE, Borthakur G, Pemmaraju N, Garcia-Manero G, Kantarjian HM, Alousi AM, Hosing CM, Anderlini P, Khouri IF, Kebriaei P, Andersson BS, Oran B, Rezvani K, Marin D, Shpall EJ, Champlin RE, Ciurea SO. Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Survival for Patients with Chronic Myelomonocytic Leukemia. Blood 126(23):4347. e-Pub 2015.
100. Marchesini M, Ogoti Y, Ganan-Gomez I, Wei Y, Bueso-Ramos CE, Garcia-Manero G, DePinho RA, Colla S. Telomere Dysfunction-Induced DNA Damage Drives Hematopoietic Stem Cell Fate. Blood 126(23):1156. e-Pub 2015.
101. Chamseddine AN, Wei Y, Cabrero M, Ganan-Gomez I, Colla S, Takahashi K, Yang H, Estecio MR, Bohannan ZS, Pierce S, Bueso-Ramos CE, Kantarjian HM, Jabbour E, Garcia-Manero G. PDE4 Differential Expression Is a Potential Prognostic Factor and a Therapeutic Target in Myelodysplastic Syndromes. Blood 126(23):5227. e-Pub 2015.
102. Wei Y, Jia Y, Zheng H, Yang H, Bohannan ZS, Lee J, Zhao C, Bueso-Ramos CE, Chamseddine AN, Garcia-Manero G. Pharmacological Inhibition of Histone Demethylase JMJD3 Reduces Leukemia Cell Survival and Represses Production of the Cytokine CCL2 in MDS/AML. Blood 126(23):5219. e-Pub 2015.
103. Takahashi K, Vitale C, Bueso-Ramos C, Wang F, Kim E, Zhang J, Gumbs C, Routbort M, MD PhD* MD, 2, Estrov Z, MD1, Jain N, MD1, Garcia-Manero G, MD1, Kantarjian HM, MD1, Burger JA, MD PhD1 MD, Ferrajoli A, MD1, Keating M, MBBS1, Futreal A, Wierda W. IKZF3 p.L162R Is a Recurrent Hotspot Mutation in Chronic Lymphocytic Leukemia (CLL). Blood 126(23):4136 - 4136. e-Pub 2015.
104. Gañán-Gómez I, Ogoti Y, Marchesini M, Wei Y, Yang H, Jiang S, E Bueso-Ramos NBC, Garcia-Manero G, Colla S. Effect of Azacytidine on the Hematopoietic Stem and Progenitor Cell Compartments of MDS Mouse Models: Unveiling the Mechanisms of Remission and Relapse. Blood 126(23):2852 - 2852. e-Pub 2015.
105. Loghavi S, Kanagal-Shamanna R, Ok CY, Almohammedsalim A, Bueso-Ramos CE, Routbort M, Mehrotra M, Verstovsek S, Kantarjian H, Medeiros LJ, Lughra R, Patel K. Myeloproliferative Neoplasms with Calreticulin Mutations Exhibit Distinctive Megakaryocytic Features and Increased Vascular Proliferation. Mod Pathol/USCAP 28(Sup 2):361A, 2015. e-Pub 2015.
106. Rich A, Ai D, Wang W, You MJ, Yin CC, Bueso-Ramos CE, Medeiros LJ, Hu S. Pediatric Chronic Myelogenous Leukemia in Tyrosine Kinase Inhibitor Era. Mod Pathol/USCAP 28(Sup 2):373A, 2015. e-Pub 2015.
107. Yabe M, Medeiros LJ, Tang G, Wang S, Konoplev SN, Bhagat G, Jabbar K, Bueso-Ramos CE, Loghavi S, Hoehn D, lu G, Li S, Young K, Miranda R. Evaluation of Myelodysplastic Features and Correlation with Cytogenetic Findings in Hepatosplenic T-Cell Lymphoma: Analysis of 28 Patients. Mod Pathol/USCAP 28(Sup 2):389A, 2015. e-Pub 2015.
108. Loghavi S, Al-Ibraheemi A, Zuo Z, Wang S, Garcia-Manero G, Kantarjian H, Yin CC, Miranda R, Medeiros LJ, Bueso-Ramos E, Khoury J. De Novo Myelodysplastic Syndromes with Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression. Mod Pathol/USCAP 28(Sup 2):361A, 2015. e-Pub 2015.
109. Wang W, Ai D, Tang G, Liu H, Bueso-Ramos CE, Medeiros LJ, Hu S. Balanced 11q23/MLL Rearrangement in Chronic Myelogenous Leukemia. Mod Pathol/USCAP 28(Sup 2):384A, 2015. e-Pub 2015.
110. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Kamalanabhaiah S, Kantarjian H, Verstovsek S. CD34+ Hematopoietic Progenitors and Bone Marrow Angiogenesis in Patients with Myelofibrosis Following Therapy. Mod Pathol/USCAP 28(Sup 2):357A, 2015. e-Pub 2015.
111. Kanagal-Shamanna R, Bueso-Ramos C, Singh R, Routbort M, Miranda R, Lu G, Ravandi F, Dinardo C, Kantarjian H, Medeiros LJ, Patel K, Luthra R. Next-Generation Sequencing of Sporadic Acute Myeloid Leukemia Demonstrates GATA2 Mutation To Be a Secondary Event Frequently Associated With Other Driver Mutations. Mod Pathol/USCAP 28(Sup 2):354A, 2015. e-Pub 2015.
112. Yabe M, Medeiros LJ, Tang G, Wang S, Bhagat G, Kanagal-Shamanna R, Bueso-Ramos CE, Jorgensen JL, Chen W, Hoehn D, Lu G, Li S, Young K, Miranda R. Prognostic Factors of Hepatosplenic T-Cell Lymphoma (HSTCL): A clinicopathologic, Immunophenotypic, and Cytogenetic Analysis of 28 Patients. Mod Pathol/USCAP 28(Sup 2):389A, 2015. e-Pub 2015.
113. Kim HR, Garcia-Manero G, Bueso-Ramos CE, Kantarjian HM, Maiti S, Cooper LJ, L Jeffrey Medeiros L, Zuo Z. Comparison of Risk Models for Patients with Lower Risk Myelodysplastic Syndromes. Blood 124(56th ASH Annual Meeting & Exposition):1919, 2014. e-Pub 2014.
114. Randhawa JK, Jabbar KJ, Kadia T, Borthakur G, Pemmaraju N, Daver N, Kantarjian HM, Cortes JE, Hearn K, Bueso-Ramos CE, Garcia-Manero G. Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κB Activation. Blood 124(56th ASH Annual Meeting & Exposition):1930, 2014. e-Pub 2014.
115. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Sun W, Cortes JE, Kantarjian HM, Verstovsek S. Ruxolitinib-Induced Modulation of Bone Marrow Microenvironment in Patients with Myelofibrosis Is Associated with Inflammatory Cytokine Levels. Blood 124(56th ASH Annual Meeting & Exposition):3182, 2014. e-Pub 2014.
116. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Kamalanabhaiah S, Cortes JE, Kantarjian H, Verstovsek S. Changes in Activated Bone Marrow Macrophages and Mast Cells in Patients with Myelofibrosis Following Ruxolitinib Therapy. Blood 124(56th ASH Annual Meeting & Exposition):3184, 2014. e-Pub 2014.
117. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Kamalanabhaiah S, Cortes JE, Kantarjian HM, Verstovsek S. Ruxolitinib Therapy Effectively Modulates CD34+ Hematopoietic Progenitors and Bone Marrow Angiogenesis in Patients with Myelofibrosis. Blood 124(56th ASH Annual Meeting & Exposition):4578, 2014. e-Pub 2014.
118. Estecio MR, Maddipoti S, DiNardo CD, Yang H, Stevenson WS, Bueso-Ramos CE, Pierce SR, Wei Y, Garcia-Manero G. Association Between RUNX3 Hypermethylation and Acute Myeloid Leukemia Inv(16) Subtype. Blood 124(56th ASH Annual Meeting & Exposition):3548, 2014. e-Pub 2014.
119. Rozovski U, Grgurevic S, Bueso-Ramos CE, Harris DM, Li P, Liu Z, JI Yuan Wu JI, Wierda W, Burger JA, O'Brien S, Jain N, Ferrajoli A, Keating M, Estrov Z. STAT3-Driven, Aberrantly Expressed Lipoprotein Lipase Mediates Free Fatty Acid Metabolism in Chronic Lymphocytic Leukemia Cells. Blood 124(56th ASH Annual Meeting & Exposition):3304, 2014. e-Pub 2014.
120. Gallardo M, Lee HJ, Bueso-Ramos CE, Zhang X, Pageon LR, Multani A, Rapado I, Quintás-Cardama A, Kornblau SM, Martinez-Lopez J, Post SM. hnRNP K: A Tumor Suppressor or Oncogene?. Blood 124(56th ASH Annual Meeting & Exposition):259, 2014. e-Pub 2014.
121. Colla S, Ong D, Ogoti Y, Marchesini M, Mistry N, Clise-Dwyer K, Storti P, Viale A, Wei Y, Giuliani N, Yang H, D'Anca M, Estecio MR, Liang H, Kantarjian HM, Wang AY, Chin L, Bueso-Ramos CE, Garcia-Manero G, DePinho R. A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome. Blood 124(56th ASH Annual Meeting & Exposition):523, 2014. e-Pub 2014.
122. Borthakur G, Nagler A, Ofran Y, Rowe JM, Altman JK, Frankfurt O, Tallman MS, Avivi I, Peled A, Pereg Y, Foley-Comer A, Russovsky L, Aharon A, McQueen T, Pemmaraju N, Bueso-Ramos CE, Cortes JE, Andreeff M. BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial. Blood 124(56th ASH Annual Meeting & Exposition):950, 2014. e-Pub 2014.
123. Randhawa JK, Jabbar KJ, Kadia T, Borthakur G, Pemmaraju N, Daver N, Kantarjian HM, Cortes JE, Hearn K, Bueso-Ramos CE, Garcia-Manero G. Phase II Study of Targeted Subcutaneous (SC) Bortezomib for Patients with Low- or Intermediate-1 (Int-1)-Risk Myelodysplastic Syndrome (MDS) with Evidence of NF-κB Activation. Blood 124(56th ASH Annual Meeting & Exposition):1930, 2014. e-Pub 2014.
124. Kanagal-Shamanna R, Schlette E, Lin P, Patel KP, Wang SA, Medeiros LJ, Miranda RN, Bueso-Ramos CE. Lymphoplasmacyti lymphoma/Waldenstrom macroglobulinemia, MYD88 mutation positive in bone marrow and concurrent lymph node. 17th Meeting of the European Asso for Haematopathology 2014, 2014. e-Pub 2014.
125. Kvasnicka HM, Thiele J, Bueso-Ramos CE, Hasserjian RP, Gianelli U, Van der Walt J, Molina TJ, Orazi A. Criteria for Therapy Response and Progression in Patients with Myelofibrosis Based on Bone Marrow Features. The International European LeukemiaNet Consensus Project. Mod Pathol/USCAP 103rd Annual Meeting 27(Supplement 2s):357A, 2014. e-Pub 2014.
126. Alikhan M, Hu Z, Moroch J, Plonquet A, Jiang L, Gurbuxani S, Anastasi J, Bueso-Ramos C, Inamdar K, Menon MP, Nicolae A, Jaffe ES, Gaulard P, Venkataraman G. Follicular T Cell Lymphomas Frequently Display an aberrant CD3-/CD4+ Population by Flow Cytometry: An Important Clue to the Diagnosis of a Hodgkin Lymphoma Mimic. Mod Pathol/USCAP103rd Annual Meeting 27(Supplement 2s):333A, 2014. e-Pub 2014.
127. Zhang L, Yang Y, Li W, Miranda RN, Dave S, Han X, Huang X, Jin P, Medeiros LJ, Bueso-Ramos CE, You MJ. Expression of MicroRNA-150 Is Significantly Decreased in T-Acute Lymphoblastic Leukemia (T-ALL) and Inhibits T-ALL Cell Growth. Mod Pathol/USCAP 103rd Annual Meeting 27(Supplement 2s):388A, 2014. e-Pub 2014.
128. Loghavi S, Bueso-Ramos CE, Maiti SM, Hu S, Calin GA, Garcia-Manero G, Kantarjian HM, Medeiros J, Cooper L, Zuo Z. Diagnostic and Prognostic Utility of Plasma microRNA Signatures in Patients with Myelodysplasti Syndromes. Mod Pathol/USCAP 103rd Annual Meeting 27(Supplement 2s):359A, 2014. e-Pub 2014.
129. Levantaki V, DiNardo C, Eng C, Bueso-Ramos C, Konoplev S. Cellular (40%) bone marrow with dysmegakaryopoiesis, slight reticulin fibrosis and thrombocytopenia; history of familial platelet disorder and heterozygous RUNX1 mutation, 2013. e-Pub 2013.
130. Kvasnicka H, Thiele J, Bueso-Ramos CE, Hou K, Cortes JE, Kantarjian HM, and Verstovsek S. Exploratory analysis of the effect of ruxolitinib on bone marrow morphology in patients with myelofibrosis. Journal of Clinical Oncology, 2013 ASCO Annual Meeting, 2013. e-Pub 2013.
131. Zhang L, Aladily TN, Chakhachiro Z, Yao H, Su X, Routbort M, Wang SA, Luthra R, Miranda R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. RAS mutation is a poor prognostic factor in patients with chronic myelomonocytic leukemia (1544). USCAP, 2013. e-Pub 2013.
132. Wang XI, Patel K, Lin P, Zuo Z, Bueso-Ramos CE, Luthra R, Medeiros LJ, Yin CC. Clinicopathologic and molecular genetic features of de novo myeloid sarcoma (1527). USCAP, 2013. e-Pub 2013.
133. Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Lui Y, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Hsi ED. Complex karyotype but not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome with inv(3)(q21q26.2)/t(q21:q26.2): a bone marrow pathology group study (1498). USCAP, 2013. e-Pub 2013.
134. Hoehn D, Medeiros LJ, Pemmaraju N, Sireci A, Bhagat G, Cortes JE, and Bueso-Ramos CE. Dasatinib therapy affects bone homeostasis in patients with chronic myelogenous leukemia in chronic phase independently of molecular response: Poster. Blood 120:1682, 2012. e-Pub 2012.
135. Dimicoli S, Wei Y, Chen R, Bueso-Ramos CE, Pierce SA, Yang H, Jia Y, Zheng H, Fang Z, Ganan-Gomez I, Nguyen M, Fernandez M, Kantarjian HM, and Garcia-Manero G. Toll-like receptor (TLR) signaling adaptor protein MYD88 in myelodysplastic syndromes (MDS): Oral session. Blood 120:556, 2012. e-Pub 2012.
136. Nazha A, Bueso-Ramos CE, Faderl S, Estey EH, O'Brien SM, Farnandez M, Nguyen M, Koller C, Freireich E, Beran M, Pierce S, Cortes JE, Kantarjian HM, Ravandi AF. Addition of all-trans retinoic acid (ATRA) to the combination of fludarabine, cytarabine, idarubicin, with or without GCSF in older, higher risk patients with AML and high-risk MDS does not improve the outcome in those with NPM1 mutation: Poster. Blood 120:2616, 2012. e-Pub 2012.
137. Yang H, Bueso-Ramos CE, Parmar S, Wei Y, Fang Z, Nguyen M, Fernandez M, Pierce SA, Geng Q, Kantarjian HM, Cortes JE, and Garcia-Manero G. Induction of PD-1 and PD-1 ligand expression by hypomethylating agents (HMA) in myelodysplastic syndromes and acute myelogenous leukemia suggest a role for T-cell function in clinical resistance to Hmas: Poster. Blood 120:3810, 2012. e-Pub 2012.
138. Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JD, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, and Hsi ED. Clinicopathologic characterization of acute myeloid leukemia and myelodysplastic syndrome with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals that complex karyotype but not blast percentage is associated with poor survival; A bone marrow pathology group study: Poster. Blood 120:3847, 2012. e-Pub 2012.
139. Wei Y, Chen R, Dimicoli S, Bueso-Ramos CE, Neuberg DS, Pierce SA, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Fernandez M, Wang SA, Kantarjian HM, and Garcia-Manero G. Deregulation of TLR2-JMJD3 innate immunity signaling, including a rare TLR2 SNP as a potential somatic mutation, in myelodysplastic syndromes (MDS): Poster. Blood 120:1700, 2012. e-Pub 2012.
140. Vadhan-Raj S, Zhou X, Bueso-Ramos CE, Patel S, Benjamin RS, and Ngyuen M. Interleukin-6, hepcidin, and other biomarkers in anemia of chronic disease (ACD) and chemotherapy-induced anemia (CIA): Potential therapeutic targets: Poster. Blood 120:2086, 2012. e-Pub 2012.
141. Wei Y, Bueso-Ramos CE, Yang H, Jia Y, Zheng H, Colla S, Nguyen M, Fernandez M, Kantarjian HM, and Garcia-Manero G. Serum amyloid protein A 1 (hSAA1) is overexpressed in myelodysplastic syndromes and potentially mediates toll-like receptor 2 innate immunity signaling in CD34+ hematopoietic stem cells: Poster. Blood 120:1703, 2012. e-Pub 2012.
142. Yang H, Bueso-Ramos CE, Pierce SA, Wei Y, Fang Z, Nguyen M, Fernadez M, Cardenas-Turanzas M, Kantarjian HM, and Garcia-Manero G. Upregulation of focal adhesion kinase, a potential therapeutic target, in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS): Poster. Blood 120:2827, 2012. e-Pub 2012.
143. Yang H, Bueso-Ramos CE, Pierce SA, Wei Y, Fang Z, Nguyen M, Fernadez M, Cardenas-Turanzas M, Kantarjian HM, and Garcia-Manero G. Expression profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in myelodysplastic syndromes (MDS): Level of MMP-9 is associated with improved prognosis in MDS patients: Poster. Blood 120:3845, 2012. e-Pub 2012.
144. Zhou Y, Kanagal-Shamanna R, Hoeller S, Tzankov A, Hoehn D, Swerdlow SH, Rosenwald A, Xu-Monette ZY, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Young KH. Molecular characteristics of composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: Poster session II (1613). USCAP, 2012. e-Pub 2012.
145. Chen SS, Tarrand JJ, Prieto V, Lin P, Fernandez MH, Hasan T, Medeiros LJ, Bueso-Ramos CE. Merkel cell polyomavirus (MCPvV) detected in plasma of post-bone marrow transplant patients by SYBR green-based real-time PCR and melting curve analysis: Poster session VI (1617). USCAP, 2012. e-Pub 2012.
146. Hoehn D, Pemmaraju N, Cortes JE, Wang X, Kanagal-Shamanna R, Dellasala SE, Nazha A, Kantarjian HM, Medeiros LJ, Bueso-Ramos CE. Dasatinib affects bone homeostasis, independent of molecular response, in patients with chronic myelogenous leukemia (CML): Poster session V (1424). USCAP, 2012. e-Pub 2012.
147. Greaves WO, Verma S, Bisrat T, Rahimi H, Paladugu A, Yao H, Patel KP, Luthra R, L Jeffrey Medeiros L, Verstovsek S, Bueso-Ramos CE. TP53 mutation is rare in primary myelofibrosis by high resolution melting curve analysis and sanger sequencing: Poster session V (1415). USCAP, 2012. e-Pub 2012.
148. Leventaki V, Bourbon E, Qu C, Liu Y, Kunkalla K, Nguyen M, Bueso-Ramos CE, Singh RR, Agarwal NK, Vega F. Diffuse large B-cell lymphoma cells promote paracrine activation of NF-kB pathway in tumor-associated stromal cells: Poster session IV (1471). USCAP, 2012. e-Pub 2012.
149. Chakhachiro Z, Zuo Z, Kantarjian H, Cortes J, AlAyed K, Nguyen M, Vadhan-Raj S, Medeiros JL, Bueso-Ramos CE. Endoglin (CD105) is strongly overexpressed in AML with t(15;17)/PML-RARA and is significantly associated with IDH2 mutation, but is not expressed in bone marrow endothelial cells: Poster session III (1373). USCAP, 2012. e-Pub 2012.
150. Zhou Y, Routbort M, Young KH, Wang S, Hoehn D, Tang G, Bueso-Ramos CE, Yin CC, Miranda RN, Medeiros LJ, Lin P. Negative TdT expression predicts adverse treatment outcome in T-lymphoblastic leukemia/lymphoma in adults: Platform session, section C (1614). USCAP, 2012. e-Pub 2012.
151. Zhou Y, Luthra R, Ravandi F, Kantarjian H, Jorgensen JL, Bueso-Ramos CE, Medeiros LJ, Konoplev S. Re-evaluation of risk factors for relapse in APL patients treated with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) frontline chemotherapy: Poster session III (1612). USCAP, 2012. e-Pub 2012.
152. Patel K, Khokhar FA, Muzzafar T, You MJ, Ravandi F, Bueso-Ramos C, Medeiros LJ. Acute myeloid leukemia with minimal differentiation: TdT expression is associated with better overall survival following stem cell transplantation: Poster session III (1511). USCAP, 2012. e-Pub 2012.
153. Hu S, Ruvolo V, Lu H, Kantarjian HM, Wheeler D, Muzny DM, Medeiros LJ, Bueso-Ramos C, Konopleva M, Andreeff M, Konoplev S. HIF1α expression is associated with NPM1 mutation, but not IDH1 or IDH2 mutations in acute myeloid leukemia with normal karyotype: Poster session III (1431). USCAP, 2012. e-Pub 2012.
154. Kanagal-Shamanna R, Weber DM, Orlowski RZ, Lin P, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Young KH. Clinicopathologic and molecular features of crystal (immunoglobulin) storing histiocytosis associated with lymphoplasmacytic neoplasms: Poster session II (1449). USCAP, 2012. e-Pub 2012.
155. Hu S, Ruvolo V, Lu H, Kantarjian HM, Wheeler D, Muzny DM, Medeiros LJ, Bueso-Ramos C, Konopleva M, Andreeff M, Konoplev S. HIF1α expression is associated with NPM1 mutation, but not IDH1 or IDH2 mutations in acute myeloid leukemia with normal karyotype: Poster session III (1431). USCAP, 2012. e-Pub 2012.
156. Greaves WO, Verma S, Bisrat T, Rahimi H, Paladugu A, Bueso-Ramos CE, Patel KP, Luthra R, Yao H, Verstovsek S. TP53 mutation is rare in primary myelofibrosis. Blood 118(21):5241, 2011. e-Pub 2011.
157. Chakhachiro ZI, Saliba RM, Okoroji GJ, Korbling M, Alousi AM, Hosing CM, De Lima M, Anderlini P, Popat U, Samuels BI, Medeiros LJ, Bueso-Ramos CE, Champlin R, Khouri IF. 12-year experience with high-dose rituximab-containing autologous stem cell transplantation for SOX11-positive mantle cell lymphoma patients in first remission: Emerging lymphoma-free survival plateau after 3 years. Blood 118(21):4138, 2011. e-Pub 2011.
158. Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, d'Amore ESG, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Kahl BS, Winter JN, Wang HY, Dunphy CH, Hsi ED, Zhao FX, Go RS, Choi WWL, Zhou F, Czader M, Zhao X, JHJM VK, Huang Q, Ai W, Etzell JE, Ponzoni M, Ferreri AJM, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Young KH. The t(14;18)(q32;q21) characterizes a subset of patients with diffuse large B-cell lymphoma of germinal center origin with poor outcome: Report from the international DLBCL rituximab-CHOP consortium program study. Blood 118(21):949, 2011. e-Pub 2011.
159. Shamanna RK, Miranda RN, Yin CC, Bueso-Ramos CE, Muddasani R, Medeiros LJ, Lu G. Clinicopathologic study of isolated del(20q) in de novo myelodysplastic syndrome: A group with favorable prognosis and no evidence of common oncogenic mutations. Modern Pathology 24(Supplement 1s):304a, 2011. e-Pub 2011.
160. Hoehn D, Medeiros LJ, Bueso-Ramos CE. Short term imatinib therapy promotes bone formation in patients with chronic myelogenous leukemia (CML) independent of cytogenetic response. Modern Pathology 24:301a, 2011. e-Pub 2011.
161. Shamannna RK, Yin CC, Lu G, Nguyen M, Hoehn D, Garcia-Manero G, Vadhan-Raj S, Medeiros LJ, Bueso-Ramos CE. Myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with isolated isochromosome 17q [i(17q)]: An aggressive entity with prominent multilineage dysplasia and wild type NPM1. Modern Pathology 24:304a, 2011. e-Pub 2011.
162. Khouri IF, Bassett R, Cano P, O'Brien S, Hsu Y, Bueso-Ramos CE, Harrell R, Okoroji GJ, de Padua Silva L, Ferrajoli A, Champlin R, McMannis J, Fernandez-Vina M. Human-leukocyte-histocompatibility antigens predict response to rituximab and donor lymphocyte infusion (DLI) after non-myeloablative allogeneic stem transplantation (NST) for chronic lymphocytic leukemia (CLL). Blood 116(21):2548, 2010. e-Pub 2010.
163. Heider KH, Ostermann E, Lamche H, Kuepcue Z, Jacobi A, Konopitzky R, Hirt U, Reichardt V, and Borges E. Novel fc-engineered antibodies to CD37 with pro-apoptotic and enhanced ADCC activity:Oral session. Blood, 2010. e-Pub 2010.
164. Benito J, Shi Y, Szymanska B, Carol H, Bohem I, Lu H, Konoplev S, Fang W, Kornblau SM, Zweidler-McKay P, Wilson W, Campana D, Borthakur G, Bueso-Ramos CE, Kantarjian HM, Shpall EJ, Thomas DA, Jordan CT, Lock RB, Andreef M, Konopleva M. Targeting the leukemia-associated hypoxic microenvironment with hypoxia-activated prodrug PR-104. Blood 116(21):868, 2010. e-Pub 2010.
165. Naqvi K, Garcia-Manero G, Bueso-Ramos CE, Pierce S, Kadia T, Borthakur G, Estrov Z, Ravandi F, Faderl S, Kantarjian HM, Jabbour E. Discrepancy in diagnosis of myelodysplastic syndrome (MDS) between referral and tertiary care centers: Experience at MD anderson cancer center (MDACC). Blood 116(21):1870, 2010. e-Pub 2010.
166. Heinrichs S, Conover L, Bueso-Ramos CE, Kilpivaara O, Levine R, Stevenson K, Neuberg D, Bejar R, Ebert BL, Garcia-Manero G, Kantarjian HM, Look AT. MYBL2 Is a candidate tumor suppressor gene in MDS. Blood 116(21):1865, 2010. e-Pub 2010.
167. Al-Kali A, Luthra R, Bueso-Ramos CE, Pierce S, Kadia T, Borthakur G, Estrov Z, Jabbour E, Faderl S, Ravandi F, Cortes J, Kantarjian HM, Garcia-Manero G. Impact of RAS mutations In myelodysplastic syndrome (MDS). Blood 116(21):2926, 2010. e-Pub 2010.
168. Vadhan-Raj S, Hagemeister F, Fayad LE, Zhou X, ORoark SS, Ames K, Rodriguez MA, Fanale MA, Pro B, Johnson MM, McLaughlin P, Bueso-Ramos CE, Younes A, Kwak L, Romaguera JE. Randomized, double-blind, placebo-controlled, dose and schedule-finding study of AMG 531 in chemotherapy-induced thrombocytopenia (CIT): Results of a phase I/II study. Blood 116(21):1544, 2010. e-Pub 2010.
169. Cui W, Chen S, Sun J, Bueso-Ramos CE, Lu G. Trisomy 14 as the sole abnormality is associated with heterogeneous groups of myeloid malignancy and a wide spectrum of disease progression. Mod Pathol 23:292a, 2010. e-Pub 2010.
170. Khokhar FA, Muzzafar T, Bueso-Ramos CE, Medeiros LJ. Acute myeloid leukemia, not otherwise specified, with minimal differentiation: TDT+ and TDT- subsets have distinctive features. Mod Pathol 23:306a, 2010. e-Pub 2010.
171. Gurevich I, Zhao C, Yin CC, Han X, Lin P, Gao X, Nguyen MH, Pan E, Medeiros LJ, Bueso-Ramos C, You MJ. Aberrant nuclear and loss of PTEN expression in acute myeloid leukemia. Mod Pathol 23:299a, 2010. e-Pub 2010.
172. Alseraye FM, Zuo Z, Bueso-Ramos CE, Medeiros LJ, Barakat FH, Lu G. Trisomy 11 as a sole abnormality in acute myeloid leukemia and myelodysplastic syndrome has unfavorable prognosis but no association with mutations of kit and RAS genes. Mod Pathol 23:284a, 2010. e-Pub 2010.
173. Alseraye FM, Cortes J, Medeiros LJ, Nguyen M, Bueso-Ramos C. IREM-1 (CD300f) is expressed by normal cells and leukemic blasts and is a potential target for immunotherapy: An analysis of 53 cases. Mod Pathol 23:284a, 2010. e-Pub 2010.
174. Gonzalez-Longoria A, Kolhe R, Ramalingam P, Medeiros LJ, Bueso-Ramos CE. Expression of C-rel in high-grade B-cell lymphomas with MYC rearrangement: Impact on survival. Mod Pathol 23:297a, 2010. e-Pub 2010.
175. de Paula HM, Calin G, Medeiros LJ, Fernandez M, Garcia-Manero G, Bueso-Ramos CE. MicroRNA fingerprints in patients with myelodysplastic syndrome identify miR-let7a and miR-16 as potential diagnostic markers. Mod Pathol 23:292a, 2010. e-Pub 2010.
176. Bunning JT, Kantarjian HM, Medeiros LJ, Nguyen M, Konoplev S, Bueso-Ramos C. Mechanisms of chemotherapy-resistance in elderly AML patients: An immunohistochemical and molecular study with therapeutic and prognostic implications. Mod Pathol 23:288a, 2010. e-Pub 2010.
177. Faderl S, Bueso-Ramos C, Liu Z, Pal A, Bornmann W, Harris D, Hazan-Halevy I, Kantarjian HM, and Estrov Z. APcK 110, a novel inhibitor of kit, extends survival of NOD-SCID mice in an AML xenograft model: Poster. Blood 114(1045), 2009. e-Pub 2009.
178. Beltran B, Quinones P, Morales D, Capellino A, Miranda R, Bueso-Ramos CE, Sotomayor EM, and Castillo J. Clinical outcome and survival of EBV-positive diffuse large B-cell lymphoma. Blood 114:5005, 2009. e-Pub 2009.
179. Lee D, Bueso-Ramos CE, Carroll M, Whichard Z, Feng Y, Stein P, Jensen SA, Kornblau S, and Corey SJ. SHIP1 is a novel tumor suppressor in late-stage myelodysplastic syndromes and is silenced by mir-210 and mir-155: Poster. Blood 114:3824, 2009. e-Pub 2009.
180. Castoro R, Raynal N, Huang X, Bueso-Ramos CE, Garcia-Manero G, Kantarjian HM, and Issa JP. DNA methylation and gene expression analysis in a phase II randomized study of decitabine vs. decitabine plus valproic acid in MDS and AML: Poster. Blood 114:3808, 2009. e-Pub 2009.
181. Konopleva M, Benito J, Shi YX, Konoplev S, Kornblau SM, Frolova O, Zweidler-McKay PA, Qiu Y, Wilson WR, Campana D, Jacamo R, Lu H, Fang W, Borthakur G, Bueso-Ramos CE, Kantarjian HM, Thomas DA, and Andreeff M. Therapeutic targeting of the hypoxic microenvironment in acute lymphocytic leukemia. Blood 114:2040, 2009. e-Pub 2009.
182. Abdel-Wahab O, Manshouri T, Patel J, Harris K, Yao JJ, Hedvat CV, Heguy A, Bueso-Ramos C, Kantarjian HM, Levine RL, and Verstovsek S. TET2 and ASXL1 mutations in leukemic transformation of chronic myeloproliferative neoplasms: Poster session. Blood 114:2894, 2009. e-Pub 2009.
183. Wei Y, Chen R, Bueso-Ramos CE, Wang H, Song X, Wang J, Yao H, Nguyen M, Fernandez M, Yang H, and Garcia-Manero G. Genome-wide chip-seq analysis of histone methylation reveals modulators of NF-B signaling and the histone demethylase JMJD3 as implicated in disease progression in myelodysplastic syndrome (MDS): Oral session. Blood 114:2040, 2009. e-Pub 2009.
184. Khouri I, Bassett R, Cano P, O'Brien S, Hsu Y, Bueso-Ramos CE, Harrell R, Okoroji GJ, Silva L, Ferrajoli A, Champlin R, McMannis J, and Fernandez-Vina M. Human-leukocyte-histocompatibility antigens predict response to rituximab and donor lymphocyte infusion (DLI) after non-myeloablative allogeneic stem transplantation (NST) for chronic lymphocytic leukemia (CLL): Poster. Blood 116:2548, 2009. e-Pub 2009.
185. Badoux XC, Ramos CB, Harris D, Li P, Liu Z, Burger J, O'Brien S, Ferrajoli A, Keating M, Estrov AZ. Cross-talk between CLL cells and endothelial cells in the bone marrow microenvironment: Role of signal transducer and activator of transcription (stat)-3: Poster. Blood 114:1242, 2009. e-Pub 2009.
186. Vadhan-Raj S, Fayad L, Fanale M, Pro B, Rodriguez A, Hagemeister F, Ames K, Bueso-Ramos CE, Zhou X, McLaughlin P, Fowler N, Shah J, Samaniego F, Younes A, Kwak L, and Romaguera J. Randomized clinical trial of rasburicase administered as a standard fixed five days dosing vs a single dose followed by as needed dosing in adult patients with hematologic malignancies at risk for developing tumor lysis syndrome: Oral session. Blood 114:105, 2009. e-Pub 2009.
187. Dimov ND, Bueso-Ramos C, Medeiros LJ. Acute promyelocytic leukemia at time of relapse: Clinicopathologic findings and results of ancillary testing. Mod Pathol 22((Supplement 1s)):260a, 2009. e-Pub 2009.
188. Liang M, Han X, Fernandez M, Nguyen M, Rassidakis GZ, Drakos I, Medeiros LJ, Bueso-Ramos CE. Inhibition of HDM4 Induces p21 expression in mantle cell lymphoma. Mod Pathol 22((Supplement 1s)):274a, 2009. e-Pub 2009.
189. Gurevich I, Johnson M, Eiken C, Vadhan-Raj S, Fernandez M, Nguyen M, Kantarjian H, Medeiros LJ, Bueso-Ramos CE. The microRNA expression signature of lymphoplasmacytic lymphoma is distinct from chronic lymphocytic leukemia. Mod Pathol 22((Supplement 1s)):265a, 2009. e-Pub 2009.
190. Kantarjian H, O’Brien S, Ravandi F, Borthaku G, Faderl S, Bueso-Ramos C, Abruzzo L, Pierce S, Shan J, Issa JP, and Garcia-Manero G. The heterogeneous prognosis of patients with myelodysplastic syndrome (MDS) and chromosome 5 abnormalities: How does it relate to the original lenalidomide experience in MDS?: Poster. Blood 112:1644, 2008. e-Pub 2008.
191. Pham L, Tamayo A, Zhou HJ, Lee YC, Fu L, Bueso-Ramos CE, Drakos E, Medeiros JL, and Ford RJ. Networking modules of canonical and alternative NFkB signaling in growth and survival regulations of large B cell lymphomas: Poster. Blood 112:3776, 2008. e-Pub 2008.
192. Santos F, Faderl S, Garcia-Manero G, Koller C, Beran M, Borthakur G, Bueso-Ramos C, Keating M, Cortes J, Kantarjian H, Ravandi F. Acute erythroleukemia: An analysis of 108 patients treated with cytarabine-containing regimens at the M.D. anderson cancer center: Poster. Blood 112:925, 2008. e-Pub 2008.
193. Maddipoti S, Bueso-Ramos C, Yang H, Fernandez M, Kuang S, Fang Z, Stevenson W, Wei Y, Pierce S, Garcia-Manero G. Epigenetic silencing of the RUNX3 gene by promoter hypermethylation in patients with acute myeloid leukemia. Blood 112:3341, 2008. e-Pub 2008.
194. Khouri I, Bassett R, Hsu Y, Dickason T, Acholonu S, Harrell R, Okoroji GJ, Silva L, Korbling M, Alousi A, Hosing C, Popat U, Giralt S, Kebriaei P, Qazilbash M, Ledesma C, Keating C, Champlin R, and Bueso-Ramos C. Prognostic factors after nonmyeloablative allogeneic stem transplantation (NST) in chronic lymphocytic leukemia (CLL): Expression of P53 may not predict survival: Poster. Blood 112:1128, 2008. e-Pub 2008.
195. Schlette E, Tam C, MHerling M, Bueso-Ramos C, Wierda W, Ferrajoli A, O’Brien S, Keating M, Jones D. High T-cell lymphoma breakpoint 1 (TCL1) levels are associated with lack of response and inferior outcome following fludarabine, cyclophosphamide, rituximab (FCR) frontline therapy in patients with chronic lymphocytic leukemia (CLL): Poster. Blood 112:2086, 2008. e-Pub 2008.
196. Jelinek J, Kroeger H, He R, Saraf A, Lau S, Nguyen TV, Thomas M, Shpall E, Kornblau S, Bueso-Ramos C, Kantarjian H, and Issa JP. Hypermethylation of HOX genes is associated with longer survival in acute myeloid leukemia: Oral session. Blood 112:312, 2008. e-Pub 2008.
197. Johnson MR, Medeiros LJ, Bueso-Ramos CE. Angiogenesis, mast cells, and fribrosis in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia (LPLWM) in bone marrow (BM): Role of the nuclear factor-kappa B pathway. Mod Pathol 21((Supplement 1s)):259a, 2008. e-Pub 2008.
198. Dickason TJ, Bueso-Ramos CE, Jorgensen JL. Myeloperoxidase discordance between cytochemical and immunologic methods in acute leukemias. Mod Pathol 21((Supplement 1s)):252a, 2008. e-Pub 2008.
199. Ye D, Garcia-Manero G, Fernandez M, Nguyen M, Medeiros LJ, Bueso-Ramos C. Aurora kinase a expression in CD34+ blasts from acute myeloid leukemia and myelodysplastic syndromes. Mod Pathol 21((Supplement 1s)):282a, 2008. e-Pub 2008.
200. Johnson MR, Fritsche H, Gornet T, Bueso-Ramos CE. Novel chemiluminescence immunoassay for the detection of serum thymidine kinase correlates well with the radioenzyme method in patients with untreated chronic lymphocytic leukemia. Mod Pathol 21((Supplement 1s)):259a, 2008. e-Pub 2008.
201. Konoplev S, Nguyen M, Huang X, Rassidakis GZ, Garcia-Manero G, Yin CC, Amin H, Schlette E, Lin P, Vega-Vazquez F, Admirand J, Huh Y, You J, Jorgensen JL, Kantarjian HM, Medeiros LJ, Bueso-Ramos C. Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients. Mod Pathol 21((Supplement 1s)):260a, 2008. e-Pub 2008.
202. Wei EX, Bueso-Ramos CE, Medeiros LJ, Lin P. JAK2V617F+ and del(20q) are independent in myeloproliferative diseases. Mod Pathol 21((Supplement 1s)):281a, 2008. e-Pub 2008.
203. Liang M, Han X, Fernandez M, Nguyen M, Rassidakis GZ, Drakos I, Medeiros LJ, Bueso-Ramos CE. Analysis of HDM4 expression, a key regulator of p53, in B-cell non-hodgkin lymphomas: The HDM4-S splice mRNA variant is aberrantly overexpressed. Mod Pathol 21((Supplement 1s)):263a, 2008. e-Pub 2008.
204. Inamdar KV, O'Brien S, Abruzzo LV, Nguyen MN, Medeiros LJ, Bueso-Ramos CE. Chronic lymphocytic leukemia : Association between functional aurora-a kinase expression, chromosomal instability and active chromatin configuration. Mod Pathol 20((Supplement 2)):246a, 2007. e-Pub 2007.
205. Konoplev S, Sun X, Kantarjian HM, Estey EH, Medeiros LJ, Bueso-Ramos CE. Nuclear factor kappa B is overexpressed in acute myeloid leukemia with inv(16)(p13q22) compared with acute myelomonocytic leukemia (M4) without inv16. Mod Pathol 20((Supplement 2)):248a, 2007. e-Pub 2007.
206. Wei EX, Lin P, Bueso-Ramos CE, Medeiros LJ, Jorgensen LJ. Residual plasma cell monoclonality in lymphoplasmacytic lymphoma after treatment with rituximab. Mod Pathol 20((Supplement 2)):263a, 2007. e-Pub 2007.
207. Chen W, Rassidakis GZ, Leventaki V, Abruzzo LV, Bueso-Ramos CE, McKenna RW, Medeiros LJ. Expression of cyclins D1, D2, and D3 in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Mod Pathol 20((Supplement 2)):236a, 2007. e-Pub 2007.
208. Han X, Garcia-Manero G, Rassidakis GZ, Nguyen LM, Fernandez M, Bueso-Ramos CE. Down-regulation of HDM4 is associated with up-regulation of p21 and growth arrest in leukemia cells. Mod Pathol 20((Supplement 2)):243a, 2007. e-Pub 2007.
209. Chen W, Rassidakis G, Li J, Routbort M, Jones D, Medeiros LJ, Bueso-Ramos CE. A biological distinctive subgroup of acute myelogenous leukemia (AML) with characteristics nuclear morphology, high frequency of FLT3 and NPM gene mutations. Lab Invest 86((Supplement 1)):218a, 2006. e-Pub 2006.
210. Valbuena JR, Talwalkar SS, Abruzzo LV, Admirand J, Rassidakis GZ, Konoplev S, Bueso-Ramos CE, Medeiros LJ. Diffuse large B-cell lymphoma and MALT-lymphoma of breast uncommonly have MALT1 gene rearrangements. Lab Invest 86((Supplement 1)):249a, 2006. e-Pub 2006.
211. Garcia-Manero G, Bueso-Ramos CE, Xiao L, Hoshino K, Rosner G, Pierce S, Yang H. Detection of residual p73 DNA methylation predicts for shorter disease free and overall survival in patients with Philadelphia chromosomes negative acute lymphocytic leukemia (ALL) in remission. Blood 108(11):661a, 2006. e-Pub 2006.
212. Loboda A, Fantin VR, Bueso-Ramos CE, Randolph S, Hardwick JS, Ricker JL, Richon VM, Issa JP, Kantarjian HM, Frankel SR, Garcia-Manero G. Clinical responses to oral vorinostat (suberoylanilide hydroxamic acid, SAHA) are associated with specific gene expression signatures in patients with advanced leukemias: Results of a phase 1 trial. Blood 108(11):657a, 2006. e-Pub 2006.
213. Khouri IF, Saliba RM, Admirand J, O'Brien S, Lee MS, Samuels BI, Giralt S, de Lima M, Keating MJ, Champlin RE, Bueso-Ramos CE. ZAP-70 status does not predict outcome after nonmyeloablative allogeneic stem-cell transplantation (NST) in relapsed/refractory chronic lymphocytic leukemia (CLL) that fails to respond to conventional chemoimmunotherapy. Blood 108(11):860a, 2006. e-Pub 2006.
214. Kroeger H, Jelinek J, Bueso-Ramos CE, Issa JP. Aberrant CpG island methylation in AML is associated with disease progression and relapse. Blood 108(11):170a, 2006. e-Pub 2006.
215. Chen L, Medeiros LJ, Chen W, Bueso-Ramos CE, Abruzzo LV, Wang X, Lin P. Secondary cytogenetic aberrations do not affect survival in acute myeloid leukemia. Lab Invest 86((Supplement 1)):218a, 2006. e-Pub 2006.
216. De J, O'Brien S, Abruzzo L, Bueso-Ramos CE. Chronic lymphocytic leukemia: Prognostic indicators for fludarabine, cyclophosphamide and rituxab (FCR) therapy. Lab Invest 86((Supplement 1)):222a, 2006. e-Pub 2006.
217. Vadhan-Raj S, Trent J, Patel S, Collard M, Bueso-Ramos CE, Cleeland C, Benjamin R, Meyers CF. Effects of darbepoetin alfa administered once per cycle for the prevention of anemia on the incidence of transfusions, neurocognitive functions, and symptom assessment. Blood 108(11):137b, 2006. e-Pub 2006.
218. Konoplev S, Medeiros LJ, Bueso-Ramos CE. Lymphoplasmacytic lymphoma. XIII meeting of the european association for hematopathology, vienna, 2006. e-Pub 2006.
219. Merzianu M, Lin P, Medeiros LJ, Bueso-Ramos CE. BCL-10 nuclear expression is present in a subset of lymphoplasmacytiv lymphoma/Waldenstrom Macroglobulinemia cases and correlates with extensive bone marrow disease. Modern Pathol 18(1):242A, 2005. e-Pub 2005.
220. Kanungo K, Konoplev S, Lin P, Bueso-Ramos CE, Medeiros LJ. Immunophenotypical characteristcs of lymphoplasmacytic lymphoma/Waldenstrom Macrogobulinemia. Modern Pathol 18(1):236A, 2005. e-Pub 2005.
221. Yin C, Rassidakis GZ, Medeiros LJ, Bueso-Ramos CE, Abruzzo LV, Handy B, Lin P. Zap-70 expression in chronic lymphocytic leukemia associated with IgM paraprotein. Modern Pathol 17:277a, 2004. e-Pub 2004.
222. Alvarez R, Kantarjian HM, Bueso-Ramos CE, Talpaz M, O’Brien S, Giles F, Rios MB, Shan J, Cortes J. Significance of marrow gibrosis in chronic phase chronic myelogenous leukemia (CML) post interferon-a failure treated with imatinib mesylate therapy. Blood 104(11):803A, 2004. e-Pub 2004.
223. Lin P, Oyarzo MP, Glassman A, Bueso-Ramos CE, Luthra R, Medeiros LJ. AML with t(6;9)(p23;q34): Association with myelodysplasia, CD9 and c-kit expression, and flt3 abnormalities suggests origin from a hematopoietic progenitor with disrupted c-kit signaling. Modern Pathol 17:257a, 2004. e-Pub 2004.
224. Vahdan-Raj S, Bueso-Ramos CE, Hangoc G, Christopherson K, Collard M. Expansion of bone marrow (BM) progenitors and mobilization of mulitlineage progenitor cells associated with once per cycle administration of long-acting growth factors neulasta and aranesp with chemotherapy (CT): Biology and nature of response. Blood 104(11):794A, 2004. e-Pub 2004.
225. Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, Extrov Z, Smith TL, Nguyen MH, Aggarwal BB. Expression of constitutively active nuclear-kB RelA transcription factor in blasts of acute myeloid leukemia. Modern Pathol 17:241a, 2004. e-Pub 2004.
226. Vahdan S, Skibber J, Crane C, Bueso-Ramos CE, Rodriguez-Bigas M, Feig BW, Lin E, Ajani J, Collard M, Johnson M, Hamilton SR. Randomized, double-blind, placebo-controlled trial of epoetin alfa (Procrit) in patients with rectal and gastric cancer undergoing chemo-radiotherapy (Ct/RT) followed by surgery: Early termination of the trail due to increased incidence of thrombo-embolic events (TEE). Bolld 104(11):797A, 2004. e-Pub 2004.
227. Han X, McDonnell T, Lozano G, Garcia-Manero G, Mederiros LJ, Rassidakis G, Bueso-Ramos CE. MDMX is widely expressed in adult pre-B acute lymphoblastic leukemia (ALL) and Is a potential therapeutic target. Modern Pathol 18(1):233A, 2004. e-Pub 2004.
228. Hao S, Medeiros LJ, Bueso-Ramos CE, Handy BC, Lin P. Lymphoproliferative disorders associated with serum igM paraprotein other than LPL/WM. Modern Pathol 17:250a, 2004. e-Pub 2004.
229. Sanchez-Gonzalez B, Hoshino K, Bueso-Ramos CE, Yang H, Youssef E, Boumber Y, Santos-Malave C, Garcia-Manero G. In vitro effects of the Combination of idarubivin (IDA) with suberoylanilide hydroxamic acid (SAHA) of valproic acid (VPA) in leukemia cell lines. Blood 104(11):332A, 2004. e-Pub 2004.
230. Hao S, Huh YO, Estey E, Pierce S, Medeiros LJ, Bueso-Ramos CE, Glassman A, Lin P. Immunophenotype of 82 cases of acute promyelocytic leukemia. Modern Pathol 16:235a, 2003. e-Pub 2003.
231. Wahed A, Medeiros LJ, Mansoor A, Bueso-Ramos CE. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia (LPL/WM) in bone marrow: Pax-5 immunostain highlights a vascular-centered tumor growth with variations in cellular composition and architecture in lymphoplasmacytoid, lymphoplasmacytic and polymorphous subtypes. Modern Pathol 16:257a, 2003. e-Pub 2003.
232. Sun X, Medeiros LJ, Zhang W, Ramdas L, Glassman AB, Taylor E, Jones D, Estey EH, Bueso-Ramos CE. Unique signaling pathways in acute myeloid leukemia with inv(16)(p13q22) revealed by gene expression profiling. Blood 102:377a, 2003. e-Pub 2003.
233. Sun X, Medeiros LJ, Hu QL, Lu D, Bueso-Ramos CE. Prominent dysplasia and high proliferation rate are common in acute myeloid leukemia (AML) with inv(16)(p13q22). Modern Pathol 16:254a, 2003. e-Pub 2003.
234. Hu QL, Sun X, McDonnell T, Medeiros LJ, Brisbay S, Bueso-Ramos CE. Expression of survivin, active caspase-3 and ki-67 in bone marrow during disease progression of B-cell chronic lymphocytic leukemia - A tissue microarray study. Modern Pathol 16:237a, 2003. e-Pub 2003.
235. Bueso-Ramos CE, Medeiros LJ, Klein C, Prendergast G, McDonnell T. Bcl-2 related protein expression in Burkitt and Burkitt-like lymphomas involving medullary and extramedullary sites. Mod Pathol 15:233a, 2002. e-Pub 2002.
236. Vega F, Medeiros LJ, Thomazy VA, Lang WH, Mansoor A, Bueso-Ramos CE, Jones D. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumors. Modern Pathol 117:569-76, 2002. e-Pub 2002.
237. Lu D, Medeiros LJ, Claxton D, Johnson B, Bueso-Ramos CE. Immunofluorescent staining pattern of CBFb/MYH11 fusion protein in acute myeloid leukemia with abnormal bone marrow eosinophils. Mod Pathol 15:252a, 2002. e-Pub 2002.
238. Vega F, Medeiros LJ, Bueso-Ramos CE, Jones DM, Lai R, Abruzzo LV. Hepatosplenic yo T-Cell lymphoma (HSTCL) in bone marrow: An intra-sinusoidal neoplasm with blastic cytologic features. Mod Pathol 14:181a, 2001. e-Pub 2001.
239. Manero-Garcia G, Bueso-Ramos CE, Daniel J, Williamson J, Kantarjian H, Issa JP. DNA-methylation patterns at relapse in acute lymphocytic leukemia (ALL): Simultaneous hypermethylation of p15 and p16. Blood 98:314a, 2001. e-Pub 2001.
240. Mansoor A, Bueso-Ramos CE, Alexanian R, Lin P, Weber D, Lai R, Medeiros LJ. Diffuse large B-cell lymphoma occurring in patients with waldenstrom's macroglobulinemia: Clinicopathological features of 11 cases. Mod Pathol 14:172a, 2001. e-Pub 2001.
241. Onciu M, Lai R, Bueso-Ramos CE, Medeiros LJ. T-cell acute lymphoblastic leukemia in adults. Three clinicopathologic subsets. Mod Pathol 14:174a, 2001. e-Pub 2001.
242. Lin P, Wilson CS, Bueso-Ramos CE, Mansoor A, Medeiros LJ. Lymphoplasmacytic lymphoma/waldenstrom's macroglobulinemia involving extramedullary sites. Mod Pathol 14:170a, 2001. e-Pub 2001.
243. Schlette E, Lai R, Bueso-Ramos CE, Medeiros LJ. Mantle cell lymphoma presenting with marked lymphocytosis: Clinical and pathologic spectrum. Mod Pathol 14:178a, 2001. e-Pub 2001.
244. Mansoor A, Weber D, Alexanian R, Glassman A, Lin P, Medeiros LJ, Bueso-Ramos CE. The clinical significance of cytogenetic findings in Waldenstrom's Macroglobulinemia: Comparative analysis with prognostic factors and clinical course. Mod Pathol 14:172a, 2001. e-Pub 2001.
245. Onciu M, Lai R, Kantarjian H, Ball G, Smith T, Bueso-Ramos CE. Acute lymphoblastic leukemia in the elderly: The significance of the Philadelphia chromosome. Blood 96:195b, 2000. e-Pub 2000.
246. Mansoor A, Weber D, Alexanian R, Medeiros LJ, Bueso-Ramos CE. Lymphoplasmacytic lymphoma/waldenstrom’s macroglobulinemia: Bone marrow morphology identified a subset of patients with accelerated clinical course. Blood 96:278b, 2000. e-Pub 2000.
247. Pullarkat V, Bueso-Ramos CE, Lai R, Kroft S, Wilson C, Pullarkat S, McCourty A, Lee M, Brynes R. The ASP816HIS c-kit mutation is common in systemic mast cell disease associated with myeloid malignancy. Blood 96:105a, 2000. e-Pub 2000.
248. Schlette E, Bueso-Ramos CE, Medeiros LJ. B-cell prolymphocytic leukemia: 24 cases assessed for cyclin-D1 expression. Modern Pathol 13:162A, 2000. e-Pub 2000.
249. Vadhan-Raj S, Patel S, Broxmeyer HE, Bueso-Ramos CE, Hangoc G, Papadopolous NE, Burgess MA, Plager C, Brown CA, Hays CF, Benjamin RS. Schedule effect of recombinant human thrombopoietin (rhTPO) in attenuating thrombocytopenia in patients receiving dose intensive chemotherapy with adriamycin (A) and ifosfamide (I). Blood 96:455a, 2000. e-Pub 2000.
250. Makimoto A, Bueso-Ramos CE, Chan KW. Hematopoietic recovery after unrelated umbilical cord blood transplantation in children. Blood 94:322b, 1999. e-Pub 1999.
251. Huh Y, Berrak SG, Bueso-Ramos CE, Katz RL, Medeiros LJ. Discrepancy in immunophenotype of lymphoma cells in simultaneous specimens from the same patients. Blood 94:248b, 1999. e-Pub 1999.
252. Aneeza Irfan, Bueso-Ramos CE. Histopathological Spectrum of Hematolymphoid Neoplasms Following CAR-T Therapy. USCAP.
253. Kim Hoang Ly Nguyen, Bueso-Ramos CE, Tasnuva Rashid, Keyur Patel, Guiling Tang, Gokce Toruner, L. Jeffrey Medeiros, Rayiyakakshmi Luthra, Rashmi Kanagal-Shamanna. Chromoanagenesis Independently Predicts Poor Survival in Myelodysplastic Syndromes with Complex Karyotypes. USCAP.
254. Shaunak Dabir, Bueso-Ramos CE. Multi-Stage AI Pipeline Integrating the Segment Anything Model (SAM) and Multiple Instance Learning for AI Classification of Myeloid Neoplasms in Bone Marrow Whole-Slide Images. USCAP.

Book Chapters

1. Jain N, Bueso-Ramos C, O'Brien S, Wierda WG. Chronic Lymphocytic Leukemia and Associated Disorders. In: The MD Anderson Manual of Medical Oncology. Third. McGraw-Hill, 41-60, 2016.
2. Bueso-Ramos C, Garcia-Manero G. Myelodysplastic Syndromes: The MD Anderson Cancer Center Approach. In: The MD Anderson Manual of Medical Oncology. Third. McGraw-Hill, 81-101, 2016.
3. Carlos B. Toxoplasmosis. In: Diagnostic Pathology Nonneoplastic Pediatric. Elsevier, 2014.
4. Greaves WO, Bueso-Ramos CE. Hematopathology and diagnostic studies in leukemia. In: Leukemia: Emerging Cancer Therapeutics. Demos Medical Publising, 189-218, 2011.
5. Bueso-Ramos CE and Vardiman JW. Diagnosis and classification of the BCR-ABL1-negative myeloprofiliferative neoplasms. In: Myeloproliferative Neoplasms: Biology and Therapy, 2011.
6. Garg RJ, Bueso-Ramos CE, O'Brien S. Chronic lymphocytic leukemia and associated disorders. In: The MD Anderson Manual of Medical Oncology. Second. The McGraw-Hill Companies, Inc, 33-52, 2011.
7. Stevenson WS, Bueso-Ramos CE, Garcia-Manero G. Myelodysplastic Syndromes: The MD Anderson Cancer Center Approach. In: The MD Anderson Manual of Medical Oncology. Second. The McGraw-Hill Companies, Inc, 75-96, 2011.
8. Konoplev SN, Bueso-Ramos CE. Acute myeloid leukemia with myelodysplasia-related changes and therapy-related acute myeloid leukemia. In: Molecular Pathology of Hematolymphoid Diseases. Springer, 463-471, 2010.
9. Bueso-Ramos CE. Toxoplasma lymphadenitis. In: Diagnostic pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
10. Bueso-Ramos CE. B-lymphoblastic leukemia/lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
11. Bueso-Ramos CE. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
12. Bueso-Ramos CE. Burkitt lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
13. Bueso-Ramos CE. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
14. Bueso-Ramos CE. Adult T-cell leukemia/lymphoma, HTLV-1+. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
15. Bueso-Ramos CE. Angiomyomatous hamartoma. In: Diagnostic pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
16. Bueso-Ramos CE. Metastatic kaposi sarcoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
17. Bueso-Ramos CE. Myeloid/monocytic sarcoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
18. Bueso-Ramos CE, Miranda RN, Medeiros LJ. Mast cell disease. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
19. Bueso-Ramos CE. T-Lymphoblastic leukemia/lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
20. Bueso-Ramos CE. Vascular transformation of lymph node sinuses. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
21. Bueso-Ramos CE. Kikuchi-fujimoto disease. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys, Inc, 2010.
22. Bueso-Ramos CE. Acute myeloid leukemia. In: Neoplastic Hematopathology: Experimental and Clinical Approaches. Humana Press, 145-163, 2010.
23. Konoplev SN, Bueso-Ramos CE. Acute myeloid leukemias with recurrent cytogenetic abnormalities. In: Molecular Pathology of Hematolymphoid Diseases. Springer, 429-448, 2010.
24. Konoplev SN, Bueso-Ramos CE. Acute myeloid leukemias with normal cytogenetics. In: Molecular Pathology of Hematolymphoid Diseases. Springer, 449-462, 2010.
25. Bueso-Ramos C, Konoplev S, Koeppen H. Diagnosis of leukemias- traditional diagnostic approaches. In: Leukemias: Principles and Practice of Therapy. Blackwell Publishing Limited, 2008.
26. Holmer LD, Bueso-Ramos CE. Chronic lymphocytic leukemia and related lymphoproliferative disorders. In: Harmening D.M. (Ed), Clinical Hematology and Fundamentals of Hemostasis. 4th. F.A. Davis, 2007.
27. Ghelani D, Sneed TB, Bueso-Ramos CE, Cortes J. Chronic myelogenous leukemia. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill, 57-74, 2006.
28. Borthakur G, Bueso-Ramos CE, O'Brien S. Chronic lymphocytic leukemia and associated disorders. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill, 39-55, 2006.
29. De las Casas C, Bueso-Ramos CE, Estey E. Acute myelogenous leukemia. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill, 19-38, 2006.
30. Jabbour E, Borthakur G, Bueso-Ramos CE, Kantarjian HM, Fader S. Acute lymphoblsatic leukemia. In: The MD Anderson Manual of Medical Oncology. McGraw-Hill, 1-17, 2006.
31. Hamoudi W* HL, Bueso-Ramos CE. Chronic lymphocytic leukemia and related lymphoproliferative disorders. In: Clinical Hematology and Fundamentals of Hemostasis. F.A. Davis, 301-330, 2002.
32. Bueso-Ramos C. High-grade non-hodgkin's lymphomas. In: Malignant lymphomas, 2002.
33. Lai R, Ginsberg CH, Bueso-Ramos CE. The pathologic diagnosis of acute lymphoblastic leukemia. In: Hematology/Oncology Clinics of North America. W.B. Saunders, 1209-1235, 2000.
34. Osborne BM, Bueso-Ramos CE. Histologic grading of nodular sclerosing Hodgkin's disease: Is there significant, independent prognostic value?. In: Cancer Treat Res, 29-40, 1996.

Letters to the Editor

1. Kontoyiannis, PD, Peddireddy, A, Sasaki, K, Chien, KS, Senapati, J, Montalban Bravo, G, DiNardo, C, Borthakur, G, Kanagal-Shamanna, R, Bueso-Ramos, CE, Pierce, S, Kantarjian, HM, Garcia-Manero, G, Urrutia, S. Causes of death in patients with myelodysplastic syndrome and spliceosome mutations. Leukemia Research 147, 2024.
2. Montalban Bravo, G, Rodriguez-Sevilla, JJ, Swanson, DM, Kanagal Shamanna, R, Hammond, DE, Chien, KS, Sasaki, K, Jabbour, EJ, DiNardo, C, Takahashi, K, Short, NJ, Issa, GC, Pemmaraju, N, Kadia, TM, Ravandi-Kashani, F, Daver, N, Borthakur, G, Loghavi, S, Pierce, S, Bueso-Ramos, CE, Kantarjian, HM, Garcia-Manero, G. Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38: 1178-1181, 2024.
3. Ramia de Cap, M, Wu, LP, Pihan, GA, Narayanan, D, Morgan, EA, Pinkus, GS, Cin, PD, Hurwitz, SN, Bagg, A, Patel, S, Tam, W, Ouseph, MM, Gagan, J, Madanat, Y, Siddon, A, Raess, PW, Rogers, HJ, Bueso-Ramos, CE, Kanagal Shamanna, R, Kurzer, JH, Arber, DA, Hasserjian, RP, Weinberg, OK. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leukemia Research 123, 2022.
4. Hidalgo-Lopez JE, Higa MG, Ferrian S, Lin P, Blando J, Medeiros LJ, Bueso-Ramos CE. Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients. Ann Diagn Pathol 40: 174-175.
5. Wang, W, Chen, Z, Hu, Z, Yin, CC, Li, S, Bai, S, Bueso-Ramos, CE, Medeiros, LJ, Hu, S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood cancer journal 6, 2016.
6. Chen W, Rassidakis G, Li J, Routbort M, Jones D, Kantarjian HM, Medeiros LJ, Bueso-Ramos CE. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cup-like" nuclei). Blood 108: 1783-4, 2006.
7. Anderlini P, Valbuena JR, Champlin RE, Bueso-Ramos CE. Epstein-Barr virus-associated, CD20-polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation. Bone Marrow Transplant 34: 919-21, 2004.
8. Tsimberidou AM, Medina J, Earl M, Sierra M, Shriki JE, Bueso-Ramos CE, Giralt S, Beran M, Giles FJ, Garcia-Manero G. Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia. Bone Marrow Transplant 31: 413-4, 2003.
9. Bueso-Ramos CE, Medeiros LJ, Onciu M, Schlette E. Leukemic mantle cell lymphoma with cells resembling prolymphocytes. Am J Clin Pathol (American Society for Clinical Pathology) 18: 305 – 306, 2001.
10. Bueso-Ramos CE, Medeiros LJ, Zipf T, Nunez C, Tubergen D. Tenupodia formation by blasts in bone marrow aspirate smears from a patient with acute monoblastic leukemia. Blood 94: 3954-5, 1999.